Processing 00000000.tx.1: Thiazide-sensitive NaCl-cotransporter in the Intestine POSSIBLE ROLE OF HYDROCHLOROTHIAZIDE IN THE INTESTINAL Ca2+ UPTAKE* Claudia Bazzini, Valeria Vezzoli, Chiara Sironi, Silvia Dossena, Andrea Ravasio, Silvia De Biasi, MariaLisa Garavaglia, Simona Rodighiero, Giuliano Meyer, Umberto Fascio, Johannes Frst, Markus Ritter||, Guido Bott**, and Markus Paulmichl From the Department of Biomolecular Sciences and Biotechnology, Universit degli Studi di Milano, Via Celoria 26, I-20133 Milan, Italy, the Department of Physiology and Medical Physics, Innsbruck Medical University, Fritz-Pregl Strasse 3, A-6020 Innsbruck, Austria, the Centro Interdipartimentale di Microscopia Aranzata and Centro Interdisciplinare Materiali e Interfacce Nanostruturali, Via Celoria 26, I-20133 Milan, Italy, and the ||Paracelsus Private Medical University, Strubergasse 21, A-5020 Salzburg, Austria Received for publication, October 21, 2004 , and in revised form, March 21, 2005.  

Phrase: "Thiazide-sensitive NaCl-cotransporter in the Intestine POSSIBLE ROLE OF HYDROCHLOROTHIAZIDE"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   797   C1420092:THIAZIDE-SENSITIVE NA-CL COTRANSPORTER [Gene or Genome]
           Na-Cl Cotransporter
   797   C1567167:thiazide-sensitive Na-Cl cotransporter [Amino Acid, Peptide, or Protein,Receptor]
           thiazide-sensitive cotransporter
   738   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   738   C0332324:Sensitive [Functional Concept]
   738   C0541746:thiazide [Organic Chemical,Pharmacologic Substance]
   738   C1550474:sensitive [Idea or Concept]
   738   C1959973:% NaCl [Quantitative Concept]

Phrase: "IN THE INTESTINAL Ca2+ UPTAKE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "* Claudia Bazzini,"

Phrase: "Valeria Vezzoli,"

Phrase: "Chiara Sironi,"

Phrase: "Silvia Dossena,"

Phrase: "Andrea Ravasio,"

Phrase: "Silvia De Biasi,"

Phrase: "MariaLisa Garavaglia,"

Phrase: "Simona Rodighiero,"

Phrase: "Giuliano Meyer,"

Phrase: "Umberto Fascio,"

Phrase: "Johannes Frst,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442480:frst [Temporal Concept]

Phrase: "Markus Ritter||,"

Phrase: "Guido Bott"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179376:BOT [Manufactured Object]
   861   C1633989:BOT [Quantitative Concept]

Phrase: "*"

Phrase: "*,"

Phrase: "and"

Phrase: "Markus Paulmichl From the Department of Biomolecular Sciences"

Phrase: "and"

Phrase: "Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Universit degli Studi di Milano,"

Phrase: "Via Celoria 26,"

Phrase: "I-20133 Milan,"

Phrase: "Italy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: "the Department of Physiology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Medical Physics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031837:Physics [Occupation or Discipline]

Phrase: "Innsbruck Medical University,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0205476:Medical [Functional Concept]

Phrase: "Fritz-Pregl Strasse 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1414819:FRITZ [Gene or Genome]
   812   C2681211:fritz [Gene or Genome]

Phrase: "A-6020 Innsbruck,"

Phrase: "Austria,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004348:Austria [Geographic Area]
   928 E C0337795:austrian [Population Group]

Phrase: "the Centro Interdipartimentale di Microscopia Aranzata"

Phrase: "and"

Phrase: "Centro Interdisciplinare Materiali e Interfacce Nanostruturali,"

Phrase: "Via Celoria 26,"

Phrase: "I-20133 Milan,"

Phrase: "Italy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: "and"

Phrase: "the ||Paracelsus Private Medical University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041740:University [Manufactured Object,Organization]

Phrase: "Strubergasse 21,"

Phrase: "A-5020 Salzburg,"

Phrase: "Austria"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004348:Austria [Geographic Area]
   928 E C0337795:austrian [Population Group]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "October 21,"

Phrase: "2004 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "March 21,"

Phrase: "2005."
Processing 00000000.tx.2: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Thiazides, such as hydrochlorothiazide (HCTZ), are used to control blood pressure and to reduce renal calcium excretion. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Thiazides,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0541746:Thiazides [Organic Chemical,Pharmacologic Substance]
   928 E C0005084:Benzothiadiazines [Organic Chemical]
   928 E C2585225:benzothiadiazine [Organic Chemical]

Phrase: "such as hydrochlorothiazide (HCTZ),"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "are"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "blood pressure"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
  1000   C0005823:Blood Pressure [Organism Function]
  1000   C1271104:Blood Pressure [Finding]
  1000   C1272641:Blood pressure [Finding]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0033095:Pressure [Phenomenon or Process]
   861   C0229664:Blood [Body Substance]
   861   C0460139:Pressure [Finding]
   861   C1306345:Pressure [Functional Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "renal calcium excretion."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1373187:Renal Excretion [Organ or Tissue Function]
   827   C0221102:Excretion [Physiologic Function]
   827   C0504085:Excretion [Body Substance]
   827   C2699704:EXCRETION [Regulation or Law]
Processing 00000000.tx.3: These effects are a result of interactions with the NaCl-cotransporter (NCC). 

Phrase: "These effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "a result of interactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "with the NaCl-cotransporter (NCC)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420092:Na-Cl Cotransporter [Gene or Genome]
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]
Processing 00000000.tx.4: This is demonstrated by the fact that mutations within the NCC protein lead to salt-resistant hypotension and hypocalciuria, paralleled by an increase in bone mineral density. 

Phrase: "This"

Phrase: "is"

Phrase: "demonstrated by the fact"

Phrase: "that mutations within the NCC protein"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "lead to salt-resistant hypotension"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   797   C0332325:Resistant to [Functional Concept]
           Resistant
   797   C0589331:Lead salt [Element, Ion, or Isotope]
   760   C0020649:Hypotension [Finding]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0036140:Salt [Chemical Viewed Structurally]
   760   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0206136:Salt [Food,Inorganic Chemical]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C2827757:RESISTANT [Laboratory or Test Result]
   760   C3163620:Hypotension [Pathologic Function]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "hypocalciuria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020599:Hypocalciuria [Disease or Syndrome]

Phrase: "paralleled by an increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0442805:Increase [Functional Concept]
   737   C2348042:Parallel [Qualitative Concept]
   737   C2826345:PARALLEL [Research Activity]

Phrase: "in bone mineral density."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0005938:Bone Mineral Density [Clinical Attribute]
           Bone Density
  1000   C0177804:Bone Mineral Density [Diagnostic Procedure]
           bone density
   827   C0026162:Mineral [Inorganic Chemical]
   827   C0178587:density [Quantitative Concept]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   755 E C0439794:Dense [Qualitative Concept]
   755 E C0443157:Bony [Functional Concept]
Processing 00000000.tx.5: These symptoms are also known as Gitelman syndrome. 

Phrase: "These symptoms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683368:symptoms [Functional Concept]
  1000   C1457887:Symptoms [Sign or Symptom]

Phrase: "are"

Phrase: "also"

Phrase: "known as Gitelman syndrome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0268450:Gitelman Syndrome [Disease or Syndrome]
   770   C0039082:Syndrome [Disease or Syndrome]
   770   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.6: It has become increasingly evident that the effect of HCTZ on blood pressure and calcium homeostasis cannot be attributed exclusively to kidney functions, where the primary action of HCTZ on NCC is postulated to occur. 

Phrase: "It"

Phrase: "has"

Phrase: "become"

Phrase: "increasingly evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the effect of HCTZ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on blood pressure"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
  1000   C0005823:Blood Pressure [Organism Function]
  1000   C1271104:Blood Pressure [Finding]
  1000   C1272641:Blood pressure [Finding]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0033095:Pressure [Phenomenon or Process]
   861   C0229664:Blood [Body Substance]
   861   C0460139:Pressure [Finding]
   861   C1306345:Pressure [Functional Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "calcium homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "cannot"

Phrase: "be"

Phrase: "attributed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0449234:Attribute [Idea or Concept]
   966   C1704772:Attribute [Conceptual Entity]
   966   C1882133:Attribute [Qualitative Concept]

Phrase: "exclusively to kidney functions,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   819   C0232804:functions kidney [Organ or Tissue Function]
   770   C0022646:Kidney [Body Part, Organ, or Organ Component]
   770   C0227665:kidney [Body Part, Organ, or Organ Component]
   770   C0542341:Functions [Functional Concept]
   770   C1278978:Kidney [Body Part, Organ, or Organ Component]
   770   C1514845:KIDNEY [Tissue]
   737 E C0031843:function [Physiologic Function]
   737 E C0700205:FUNCTION [Classification]
   737 E C1705273:Function [Intellectual Product]

Phrase: "where"

Phrase: "the primary action of HCTZ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]

Phrase: "on NCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420092:Na-Cl Cotransporter [Gene or Genome]
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "is"

Phrase: "postulated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.7: We demonstrated the presence of the NCC transporter in the rat small intestine (ileum and jejunum) and human HT-29 cells, by using reverse transcription-PCR, Northern blot, Western blot, and immunofluorescence. 

Phrase: "We"

Phrase: "demonstrated"

Phrase: "the presence of the NCC transporter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the rat small intestine"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1882857:Rat Small Intestine [Body Part, Organ, or Organ Component]
   901   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
   901   C1268998:Small intestine [Body Part, Organ, or Organ Component]
   901   C1519375:SMALL INTESTINE [Tissue]
   845 E C1304890:Enteral [Spatial Concept]
   845 E C1522196:Enteral [Functional Concept]
   827   C0021853:Intestine [Body Part, Organ, or Organ Component]
   827   C0700321:Small [Quantitative Concept]
   827   C1708548:INTESTINE [Tissue]

Phrase: "(ileum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020885:ileum [Body Part, Organ, or Organ Component]
  1000   C1278923:Ileum [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "jejunum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022378:Jejunum [Body Part, Organ, or Organ Component]
  1000   C1278922:Jejunum [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "and"

Phrase: "human HT-29 cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   923   C0282639:HT-29 Cells [Cell]
   902   C0427861:Human cells [Laboratory or Test Result]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "reverse transcription-PCR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C0035380:Reverse Transcription [Genetic Function]

Phrase: "Northern blot,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005861:Northern Blot [Molecular Biology Research Technique]
  1000   C1621557:Northern Blot [Research Device]
   861   C1709269:Northern [Spatial Concept]

Phrase: "Western blot,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "immunofluorescence."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0016318:Immunofluorescence [Laboratory Procedure]
  1000   C0079603:Immunofluorescence [Laboratory Procedure]
   944 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   928 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.8: Furthermore, we show that HCTZ modulates Ca2+ uptake by intestinal cells, while affecting the electrical parameters of the cellular membrane, thus suggesting a functional interaction between NCC and the epithelial voltage-dependent calcium channel. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "Ca2+ uptake by intestinal cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "while"

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the electrical parameters of the cellular membrane,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0449381:Parameters [Finding]
   714 E C0549193:Parameter [Spatial Concept]
   714 E C1704769:Parameter [Conceptual Entity]
   714 E C2350001:Parameter [Quantitative Concept]

Phrase: "thus"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a functional interaction between NCC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the epithelial voltage-dependent calcium channel."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   840   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0006726:Calcium [Inorganic Chemical]
   804   C0439799:Channel [Spatial Concept]
   804   C0598352:Voltage [Quantitative Concept]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1701901:Dependent [Qualitative Concept]
   804   C1706095:Channel [Conceptual Entity]
   804   C2936886:Calcium [Pharmacologic Substance]
   804   C3244310:dependent [Functional Concept]
Processing 00000000.tx.9: The experiments presented here support the hypothesis of a direct involvement of the intestinal cells in the interaction between HCTZ and NaCl, as well as calcium homeostasis.  

Phrase: "The experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis of a direct involvement of the intestinal cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1512571:Hypothesis [Idea or Concept]

Phrase: "in the interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "between HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
  1000   C1959973:% NaCl [Quantitative Concept]

Phrase: "as well as"

Phrase: "calcium homeostasis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019868:Homeostasis [Biologic Function]
Processing 00000000.tx.10: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Thiazide diuretics are used in the treatment of most patients with hypertension, as suggested by the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7) (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Thiazide diuretics"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0012802:Thiazide Diuretics [Organic Chemical,Pharmacologic Substance]
   966 E C3536861:Thiazide Diuretic [Pharmacologic Substance]
   861   C0012798:Diuretics [Pharmacologic Substance]
   861   C0541746:thiazide [Organic Chemical,Pharmacologic Substance]
   805 E C0005084:Benzothiadiazines [Organic Chemical]
   805 E C2585225:benzothiadiazine [Organic Chemical]

Phrase: "are"

Phrase: "used in the treatment of most patients"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   757   C1524063:Use of [Functional Concept]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1273517:used [Finding]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "with hypertension,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]

Phrase: "as"

Phrase: "suggested by the seventh report of the Joint National Committee"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   739   C0022417:Joint [Body Space or Junction]
   739   C0205441:Seventh [Quantitative Concept]
   739   C0392905:Joint, NOS [Body System]
   739   C0684224:Report [Intellectual Product]
   739   C0700287:Report [Health Care Activity]
   739   C1269611:Joint [Body Space or Junction]
   739   C1706309:Joint [Medical Device]
   739   C2699414:Committee [Group]
   739   C3245503:national [Intellectual Product]
   739   C3273238:Report [Intellectual Product]
   706   C1705535:Suggest [Idea or Concept]

Phrase: "on Prevention,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0199176:Prevention [Therapeutic or Preventive Procedure]
  1000   C1706420:PREVENTION [Research Activity]
  1000   C2700409:prevention [Qualitative Concept]

Phrase: "Detection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "Evaluation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220825:Evaluation [Functional Concept]
  1000   C1261322:Evaluation [Health Care Activity]

Phrase: "and"

Phrase: "Treatment of High Blood Pressure"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0596197:Blood Treatment [Therapeutic or Preventive Procedure]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "(JNC-7"

Phrase: ")"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.11: The unique role of thiazide diuretics in the management of high blood pressure is a result of their dual effect on the NaCl, as well as the Ca2+ transport. 

Phrase: "The unique role of thiazide diuretics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the management"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001554:Management [Occupational Activity]
  1000   C0376636:management [Health Care Activity]
  1000   C1273870:Management [Occupational Activity]
  1000   C3273539:Management [Occupation or Discipline]

Phrase: "of high blood pressure"
Meta Candidates (Total=21; Excluded=7; Pruned=0; Remaining=14)
  1000   C0020538:Blood Pressure, High [Disease or Syndrome]
  1000   C2926615:High blood pressure [Clinical Attribute]
   901   C0005823:Blood Pressure [Organism Function]
   901   C1271104:Blood Pressure [Finding]
   901   C1272641:Blood pressure [Finding]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0205250:High [Qualitative Concept]
   827   C0229664:Blood [Body Substance]
   827   C0460139:Pressure [Finding]
   827   C1299351:High [Qualitative Concept]
   827   C1306345:Pressure [Functional Concept]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "is"

Phrase: "a result of their dual effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "on the NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
  1000   C1959973:% NaCl [Quantitative Concept]

Phrase: "as well as"

Phrase: "the Ca2+ transport."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]
Processing 00000000.tx.12: In the distal convolute tubule of the kidney they interact with the apical NaCl-cotransporter (NCC1), which in turn is responsible for the majority of salt transport, and whose inhibition causes an increase in renal sodium excretion. 

Phrase: "In the distal convolute tubule"

Phrase: "of the kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "they"

Phrase: "interact with the apical NaCl-cotransporter (NCC1),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1420092:Na-Cl Cotransporter [Gene or Genome]
   753   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0205111:Apical [Spatial Concept]
   753   C1959973:% NaCl [Quantitative Concept]

Phrase: "which in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "is"

Phrase: "responsible for the majority of salt transport,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "whose inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in renal sodium excretion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]
Processing 00000000.tx.13: In addition to reducing NaCl reabsorption, thiazide diuretics are also responsible for decreasing renal Ca2+ excretion. 

Phrase: "In addition to reducing NaCl reabsorption,"

Phrase: "thiazide diuretics"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0012802:Thiazide Diuretics [Organic Chemical,Pharmacologic Substance]
   966 E C3536861:Thiazide Diuretic [Pharmacologic Substance]
   861   C0012798:Diuretics [Pharmacologic Substance]
   861   C0541746:thiazide [Organic Chemical,Pharmacologic Substance]
   805 E C0005084:Benzothiadiazines [Organic Chemical]
   805 E C2585225:benzothiadiazine [Organic Chemical]

Phrase: "are"

Phrase: "also responsible for decreasing renal Ca2+ excretion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]
Processing 00000000.tx.14: The involvement of the NCC in Ca2+ homeostasis has been demonstrated by the fact that mutations in the NCC gene are associated with Gitelman syndrome. 

Phrase: "The involvement of the NCC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]

Phrase: "in Ca2+ homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated by the fact"

Phrase: "that mutations in the NCC gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "associated with Gitelman syndrome."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0268450:Gitelman Syndrome [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0039082:Syndrome [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.15: This disease complex is characterized by hypernatriuria and hypocalciuria, paralleled by an increase in bone mineral density (25). 

Phrase: "This disease complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "characterized by hypernatriuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "hypocalciuria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020599:Hypocalciuria [Disease or Syndrome]

Phrase: "paralleled by an increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0442805:Increase [Functional Concept]
   737   C2348042:Parallel [Qualitative Concept]
   737   C2826345:PARALLEL [Research Activity]

Phrase: "in bone mineral density"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0005938:Bone Mineral Density [Clinical Attribute]
           Bone Density
  1000   C0177804:Bone Mineral Density [Diagnostic Procedure]
           bone density
   827   C0026162:Mineral [Inorganic Chemical]
   827   C0178587:density [Quantitative Concept]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   755 E C0439794:Dense [Qualitative Concept]
   755 E C0443157:Bony [Functional Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.16: All these symptoms can also be individuated in NCC-knock-out mice (6). 

Phrase: "All"

Phrase: "these symptoms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683368:symptoms [Functional Concept]
  1000   C1457887:Symptoms [Sign or Symptom]

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "individuated in NCC-knock-out mice"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0206745:Knock-out Mice [Mammal]
   778   C0560617:knock out [Injury or Poisoning]
   778   C1420092:Na-Cl Cotransporter [Gene or Genome]
   778   C1522225:Knock-out [Experimental Model of Disease]
   774   C1517676:Knock-in [Research Activity]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C0439787:Out [Spatial Concept]
   748   C0849355:Out [Qualitative Concept]
   748   C1959973:% NaCl [Quantitative Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.17: The mechanism by which the apical NCC cotransporter in the kidney is functionally interconnected with the co-localized Ca2+ transport systems has not yet been understood in detail. 

Phrase: "The mechanism by which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "the apical NCC cotransporter in the kidney"

Phrase: "is"

Phrase: "functionally"

Phrase: "interconnected with the"

Phrase: "co-localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392752:Localized [Spatial Concept]

Phrase: "Ca2+ transport systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "has"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "understood in detail."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1522508:Detail [Qualitative Concept]
   790   C1561567:detail [Functional Concept]
   756   C0162340:Understand [Mental Process]
Processing 00000000.tx.18: However, it was shown that the inhibition of NCC by thiazide diuretics, such as hydrochlorothiazide (HCTZ) leads to hyperpolarization of the apical plasma membrane. 

Phrase: "However,"

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the inhibition of NCC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "by thiazide diuretics,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0012802:Thiazide Diuretics [Organic Chemical,Pharmacologic Substance]
   966 E C3536861:Thiazide Diuretic [Pharmacologic Substance]
   861   C0012798:Diuretics [Pharmacologic Substance]
   861   C0541746:thiazide [Organic Chemical,Pharmacologic Substance]
   805 E C0005084:Benzothiadiazines [Organic Chemical]
   805 E C2585225:benzothiadiazine [Organic Chemical]

Phrase: "such as hydrochlorothiazide"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "(HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "leads to hyperpolarization of the apical plasma membrane."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   800   C1167182:Apical plasma membrane [Cell Component]
   770   C0007603:Plasma membrane [Cell Component]
   767   C0596119:apical membrane [Cell Component]
   767   C2262820:membrane hyperpolarization [Cell Function]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0025255:Membrane [Tissue]
   744   C0032105:Plasma [Body Substance]
   744   C0181586:leads [Medical Device]
   744   C0205111:Apical [Spatial Concept]
   744   C0596901:Membrane [Cell Component]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   744   C1706182:Membrane [Manufactured Object]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.19: This would facilitate luminal Ca2+ entry (7, 8), possibly through epithelial Ca2+ channels (ECaC). 

Phrase: "This"

Phrase: "would"

Phrase: "facilitate"

Phrase: "luminal Ca2+ entry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705654:Entry [Intellectual Product]

Phrase: "(7,"

Phrase: "8"

Phrase: ")"

Phrase: ","

Phrase: "possibly through epithelial Ca2+ channels (ECaC)."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0221908:Epithelial [Qualitative Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C2362652:Possibly [Qualitative Concept]
   726   C0439799:Channel [Spatial Concept]
   726   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.20: It is generally accepted that the kidney is the cardinal target of thiazides. 

Phrase: "It"

Phrase: "is"

Phrase: "generally"

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "that"

Phrase: "the kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "is"

Phrase: "the cardinal target of thiazides."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.21: However, it was postulated that the distinct action of thiazide diuretics in the management of high blood pressure and calcium homeostasis cannot be attributed exclusively to this organ, but that in addition an effect of these drugs on the intestinum appears to be relevant (5, 9). 

Phrase: "However,"

Phrase: "it"

Phrase: "was"

Phrase: "postulated"

Phrase: "that"

Phrase: "the distinct action of thiazide diuretics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441472:Action [Functional Concept]
   753   C3266814:Action [Activity]

Phrase: "in the management"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001554:Management [Occupational Activity]
  1000   C0376636:management [Health Care Activity]
  1000   C1273870:Management [Occupational Activity]
  1000   C3273539:Management [Occupation or Discipline]

Phrase: "of high blood pressure"
Meta Candidates (Total=21; Excluded=7; Pruned=0; Remaining=14)
  1000   C0020538:Blood Pressure, High [Disease or Syndrome]
  1000   C2926615:High blood pressure [Clinical Attribute]
   901   C0005823:Blood Pressure [Organism Function]
   901   C1271104:Blood Pressure [Finding]
   901   C1272641:Blood pressure [Finding]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0205250:High [Qualitative Concept]
   827   C0229664:Blood [Body Substance]
   827   C0460139:Pressure [Finding]
   827   C1299351:High [Qualitative Concept]
   827   C1306345:Pressure [Functional Concept]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "calcium homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "cannot"

Phrase: "be"

Phrase: "attributed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0449234:Attribute [Idea or Concept]
   966   C1704772:Attribute [Conceptual Entity]
   966   C1882133:Attribute [Qualitative Concept]

Phrase: "exclusively to this organ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0178784:Organ [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "that in addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883712:Addition [Functional Concept]
   718 E C1524062:Additional [Functional Concept]

Phrase: "an effect of these drugs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C0728866:effect of drugs [Functional Concept]
           Drug effect
   781   C0728867:Drug effect [Pathologic Function]
   781   C1411996:drug effect [Biologic Function]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the intestinum"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   928   C0021853:Intestinal [Body Part, Organ, or Organ Component]
   900 E C1708548:INTESTINE [Tissue]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "relevant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347946:Relevant [Qualitative Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.22: The thiazide-sensitive NaCl-cotransporter was characterized as a renal-specific gene (10, 11). 

Phrase: "The thiazide-sensitive NaCl-cotransporter"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C1420092:THIAZIDE-SENSITIVE NA-CL COTRANSPORTER [Gene or Genome]
           Na-Cl Cotransporter
  1000   C1567167:thiazide-sensitive Na-Cl cotransporter [Amino Acid, Peptide, or Protein,Receptor]
           thiazide-sensitive cotransporter
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0332324:Sensitive [Functional Concept]
   812   C0541746:thiazide [Organic Chemical,Pharmacologic Substance]
   812   C1550474:sensitive [Idea or Concept]
   812   C1959973:% NaCl [Quantitative Concept]
   756 E C0005084:Benzothiadiazines [Organic Chemical]
   756 E C2585225:benzothiadiazine [Organic Chemical]

Phrase: "was"

Phrase: "characterized as a renal-specific gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017337:Gene [Gene or Genome]
   753   C0022646:Renal [Body Part, Organ, or Organ Component]
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
   753   C1880022:Characterized [Activity]

Phrase: "(10,"

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.23: However, information regarding the extra-renal expression of NCC has lately become increasingly available. 

Phrase: "However,"

Phrase: "information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1533716:Information [Idea or Concept]
   928 E C3242430:informational [Idea or Concept]

Phrase: "regarding"

Phrase: "the extra-renal expression of NCC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "lately"

Phrase: "become"

Phrase: "increasingly available."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470187:Available [Functional Concept]
Processing 00000000.tx.24: These studies were all conducted at the level of mRNA transcription by using RT-PCR (12) and/or Northern-Blots (13), and more recently by using cDNA microarrays (Gene Expression Omnibus Data Bank, www.ncbi.nlm.nih.gov/geo/). 

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "all"

Phrase: "conducted at the level of mRNA transcription"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1158816:mRNA transcription [Genetic Function]
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0040649:Transcription [Genetic Function]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]
   714   C0004927:Conduct [Individual Behavior]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RT-PCR (12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0599161:RT-PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]

Phrase: ")"

Phrase: "and/or"

Phrase: "Northern-Blots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005861:northern blots [Molecular Biology Research Technique]
  1000   C1621557:Northern Blots [Research Device]
   861   C1709269:Northern [Spatial Concept]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "more recently by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205172:More [Functional Concept]
   790   C0332185:Recently [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cDNA microarrays"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0887808:cDNA Microarrays [Medical Device,Research Device]
   983 E C1609488:cDNA Microarray [Research Activity]
   827   C1709016:Microarray [Manufactured Object]

Phrase: "(Gene Expression Omnibus Data Bank,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   897   C1517482:Gene Bank [Manufactured Object]
   840   C0242356:Data Bank [Intellectual Product]
   804   C0442598:Bank [Manufactured Object]
   804   C0872261:Bank [Manufactured Object]
   804   C1511726:Data [Idea or Concept]
   804   C3245479:data [Medical Device]

Phrase: "www.ncbi.nlm.nih.gov/geo/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0017454:GEO [Geographic Area]

Phrase: ")."
Processing 00000000.tx.25: In extra-renal cell types, NCC has only been investigated thus far at a functional and molecular level in osteoblasts (14), peripheral blood mononucleated cells (15) and, partially, in the pancreas (16). 

Phrase: "In extra-renal cell types,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0449475:Cell types [Intellectual Product]
   861   C0553257:Renal cell [Cell]
   827 E C0007634:Cell Type [Cell]
           Cell
   812   C0332307:Types [Qualitative Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1547052:*Type [Quantitative Concept]

Phrase: "NCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420092:Na-Cl Cotransporter [Gene or Genome]
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "has"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "been"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "thus far at a functional"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205108:far [Spatial Concept]
   760   C0205245:Functional [Functional Concept]
   760   C0542341:Functional [Functional Concept]
   760   C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "molecular level in osteoblasts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "peripheral blood mononucleated cells"
Meta Candidates (Total=21; Excluded=12; Pruned=0; Remaining=9)
   906   C0005773:Peripheral blood cell [Cell]
           Blood Cells
   861   C0229664:peripheral blood [Body Substance]
           Blood
   830 E C2328697:Hemal cell [Cell]
   819 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0007634:Cells [Cell]
   812   C0205100:Peripheral [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "(15"

Phrase: ")"

Phrase: "and"

Phrase: ","

Phrase: "partially,"

Phrase: "in the pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.26: For the gastrointestinal tract only indirect evidence indicating the presence of NCC (5, 12, 17, 18) has been obtained. 

Phrase: "For the gastrointestinal tract only indirect evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0332120:Evidence [Functional Concept]

Phrase: "indicating"

Phrase: "the presence of NCC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "12,"

Phrase: "17,"

Phrase: "18"

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "obtained."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.27: The goal of the present study was to investigate whether NCC and ECaC interact on a functional level in the intestine. 

Phrase: "The goal of the present study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0018017:Goal [Intellectual Product]
   753   C1571704:Goal [Idea or Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "NCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420092:Na-Cl Cotransporter [Gene or Genome]
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "interact on a functional level"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205245:Functional [Functional Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C0542341:Functional [Functional Concept]
   760   C1547707:Level [Geographic Area]
   760   C2700217:Functional [Conceptual Entity]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in the intestine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021853:Intestine [Body Part, Organ, or Organ Component]
  1000   C1708548:INTESTINE [Tissue]
Processing 00000000.tx.28: Here we show that (i) the thiazide-sensitive NaCl-cotransporter NCC and ECaC are indeed present in the intestine (rat small intestine and human HT-29 cell line), and (ii) that HCTZ modulates Ca2+ entry into the intestinal cells, by affecting the electrical parameters of the cellular membrane. 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "(i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the thiazide-sensitive NaCl-cotransporter NCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C1420092:THIAZIDE-SENSITIVE NA-CL COTRANSPORTER [Gene or Genome]
   734   C1567167:thiazide-sensitive Na-Cl cotransporter [Amino Acid, Peptide, or Protein,Receptor]
           thiazide-sensitive cotransporter

Phrase: "and"

Phrase: "ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "are"

Phrase: "indeed"

Phrase: "present in the intestine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021853:Intestine [Body Part, Organ, or Organ Component]
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C1708548:INTESTINE [Tissue]

Phrase: "(rat small intestine"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1882857:Rat Small Intestine [Body Part, Organ, or Organ Component]
   901   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
   901   C1268998:Small intestine [Body Part, Organ, or Organ Component]
   901   C1519375:SMALL INTESTINE [Tissue]
   845 E C1304890:Enteral [Spatial Concept]
   845 E C1522196:Enteral [Functional Concept]
   827   C0021853:Intestine [Body Part, Organ, or Organ Component]
   827   C0700321:Small [Quantitative Concept]
   827   C1708548:INTESTINE [Tissue]

Phrase: "and"

Phrase: "human HT-29 cell line"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   911   C0682523:Human Cell Line [Cell]
   884   C0282639:HT-29 Cell [Cell]
   875   C0427861:human cell [Laboratory or Test Result]
   840   C0007600:Cell Line [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:Line [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and ("

Phrase: "ii"

Phrase: ")"

Phrase: "that HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "Ca2+ entry into the intestinal cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705654:Entry [Intellectual Product]

Phrase: "by affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the electrical parameters of the cellular membrane."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0449381:Parameters [Finding]
   714 E C0549193:Parameter [Spatial Concept]
   714 E C1704769:Parameter [Conceptual Entity]
   714 E C2350001:Parameter [Quantitative Concept]
Processing 00000000.tx.29: Therefore, the experiments presented here underline the hypothesis of a direct involvement of the intestinal cells in the effect of HCTZ on blood pressure and calcium homeostasis.  

Phrase: "Therefore,"

Phrase: "the experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "underline"

Phrase: "the hypothesis of a direct involvement of the intestinal cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1512571:Hypothesis [Idea or Concept]

Phrase: "in the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "of HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "on blood pressure"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
  1000   C0005823:Blood Pressure [Organism Function]
  1000   C1271104:Blood Pressure [Finding]
  1000   C1272641:Blood pressure [Finding]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0033095:Pressure [Phenomenon or Process]
   861   C0229664:Blood [Body Substance]
   861   C0460139:Pressure [Finding]
   861   C1306345:Pressure [Functional Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "calcium homeostasis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019868:Homeostasis [Biologic Function]
Processing 00000000.tx.30: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Animal CareAnimal testing was performed according to the Italian Health Ministry animal care guidelines. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animal CareAnimal testing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1510899:Animal Testing [Research Activity]
   827   C0039593:Testing [Functional Concept]
   827   C0392366:testing [Intellectual Product]

Phrase: "was"

Phrase: "performed according to the Italian Health Ministry animal care guidelines."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   760   C0178478:animal care [Occupation or Discipline]
   757   C0086388:Health Care [Health Care Activity]
   757   C3534575:Animal Health [Disease or Syndrome]
   739   C0003062:Animal [Animal]
   739   C0018684:Health [Idea or Concept]
   739   C0022275:ITALIAN [Language]
   739   C0162791:Guidelines [Intellectual Product]
   739   C0220845:guidelines [Intellectual Product]
   739   C0282423:guidelines [Intellectual Product]
   739   C0337810:Italian [Population Group]
   739   C0680240:according [Social Behavior]
   739   C0884358:Performed [Functional Concept]
   739   C1947933:Care [Activity]
   706 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.31: Drugs and ChemicalsRPMI 1640 medium, fetal bovine serum, Trypsin-EDTA solution, glutamine, HEPES, EGTA, and all standard salts were purchased from Sigma. 

Phrase: "Drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "and"

Phrase: "ChemicalsRPMI 1640 medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "Trypsin-EDTA solution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "all standard salts"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0036140:Salts [Chemical Viewed Structurally]
   827 E C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827 E C0206136:Salt [Food,Inorganic Chemical]
   777 E C1537053:salty [Qualitative Concept]
   755 E C0678584:saltiness [Qualitative Concept]

Phrase: "were"

Phrase: "purchased from Sigma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.32: HT-29 Cell CultureCell cultures were performed according to standard methods. 

Phrase: "HT-29 Cell CultureCell cultures"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   853   C0007585:Cell Cultures [Laboratory Procedure]
   804   C0010453:Cultures [Idea or Concept]
   771 E C0220814:culture [Functional Concept]
   771 E C0430400:Culture [Laboratory Procedure]
   771 E C2242979:Culture [Laboratory Procedure]
   717   C0282639:HT-29 Cell [Cell]

Phrase: "were"

Phrase: "performed according to standard methods."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0449851:Methods [Functional Concept]
   760   C0680240:according [Social Behavior]
   760   C0884358:Performed [Functional Concept]
   760   C1442989:Standard [Qualitative Concept]
   760   C2828392:Standard [Intellectual Product]
   726 E C0871511:METHOD [Intellectual Product]
   726 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.33: The medium consisted of RPMI 1640 supplemented with 10% fetal bovine serum, 2 mM glutamine, 10 mM HEPES buffer, 2 mM Na-pyruvate, 100 units/ml penicillin, 100 g/ml streptomycin, and amphotericin 0.25 g/ml. 

Phrase: "The medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "consisted of RPMI 1640"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0332529:CONSIST [Qualitative Concept]

Phrase: "supplemented with 10% fetal bovine serum,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "2 mM glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "10 mM HEPES buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "2 mM Na-pyruvate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034354:pyruvate [Organic Chemical]
   812   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "100 units/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "100 g/ml streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "amphotericin 0.25 g/ml."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1300565:g/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.34: Cultures remained in a humidified atmosphere of 5% CO2 at 37 C. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "remained in a humidified atmosphere of 5% CO2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0004178:Atmosphere [Natural Phenomenon or Process]
   744   C0678214:atmosphere [Quantitative Concept]
   744   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "at 37 C."
Processing 00000000.tx.35: After cells had become confluent, a 10-min treatment with a trypsin-EDTA mixture (final concentration 0.50.2 g/liter) in phosphate-buffered saline (PBS) was used to detach the cells, which were subsequently reseeded at high density. 

Phrase: "After cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "become"

Phrase: "confluent, a 10-min treatment with a trypsin-EDTA mixture"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0039798:treatment [Functional Concept]
   739   C0087111:Treatment [Therapeutic or Preventive Procedure]
   739   C1522326:Treatment [Functional Concept]
   739   C1533734:Treatment [Therapeutic or Preventive Procedure]
   739   C1705169:Treatment [Conceptual Entity]
   739   C3538994:TREATMENT [Research Activity]

Phrase: "(final concentration 0.50.2 g/liter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0475211:liter [Quantitative Concept]

Phrase: ")"

Phrase: "in phosphate-buffered saline (PBS)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0687118:detach [Functional Concept]

Phrase: "the cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "were"

Phrase: "subsequently"

Phrase: "reseeded at high density."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0178587:density [Quantitative Concept]
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.36: RT-PCRMale albino rats (Wistar strain, Italian Charles River), weighing 200300 g, were used for the experiments. 

Phrase: "RT-PCRMale albino rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0684072:albino rat [Mammal]
   812   C0001916:Albino [Congenital Abnormality]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "(Wistar strain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0080194:Strain [Injury or Poisoning]
   861   C0456178:strain [Intellectual Product]
   861   C1518614:Strain [Organism]
   861   C2987481:Strain [Mental Process]

Phrase: "Italian Charles River"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0337050:River [Natural Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "weighing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1305866:Weighing [Diagnostic Procedure]

Phrase: "200300 g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "used for the experiments."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.37: Under 2,2,2-tribromoethanol anesthesia, the upper jejunum or ileum was removed, and enterocytes were collected by scraping off the mucosal layer from the excised small intestine. 

Phrase: "Under 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "2-tribromoethanol anesthesia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0002903:Anesthesia [Therapeutic or Preventive Procedure]
   827   C0002930:Anaesthesia [Biomedical Occupation or Discipline]
   711 E C0002932:Anaesthetic [Pharmacologic Substance]

Phrase: "the upper jejunum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022378:Jejunum [Body Part, Organ, or Organ Component]
   861   C1278922:Jejunum [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "ileum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020885:ileum [Body Part, Organ, or Organ Component]
  1000   C1278923:Ileum [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "enterocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0682610:Enterocytes [Cell]

Phrase: "were"

Phrase: "collected by scraping"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0184933:Scraping [Therapeutic or Preventive Procedure]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]
   756 E C0444082:scrape [Body Substance]

Phrase: "off the mucosal layer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0934502:Layer [Body Part, Organ, or Organ Component]
   861   C1522408:Layer [Qualitative Concept]
   861   C1561599:Layer [Intellectual Product]

Phrase: "from the excised small intestine."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
   901   C1268998:Small intestine [Body Part, Organ, or Organ Component]
   901   C1519375:SMALL INTESTINE [Tissue]
   845 E C1304890:Enteral [Spatial Concept]
   845 E C1522196:Enteral [Functional Concept]
   827   C0021853:Intestine [Body Part, Organ, or Organ Component]
   827   C0700321:Small [Quantitative Concept]
   827   C1708548:INTESTINE [Tissue]
Processing 00000000.tx.38: Rats were subsequently killed by exsanguination under anesthesia. 

Phrase: "Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "subsequently"

Phrase: "killed by exsanguination"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0162388:killed [Social Behavior]
   790   C0232100:Exsanguination [Pathologic Function]
   756 E C0681205:Kill [Idea or Concept]
   756 E C1550555:kill [Functional Concept]

Phrase: "under anesthesia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0002903:Anesthesia [Therapeutic or Preventive Procedure]
  1000   C0002930:Anaesthesia [Biomedical Occupation or Discipline]
   884 E C0002932:Anaesthetic [Pharmacologic Substance]
Processing 00000000.tx.39: Total RNA was isolated with the Qiagen RNeasy kit, as specified by the manufacturer. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated with the Qiagen RNeasy kit,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0205409:Isolated [Functional Concept]
   753   C0812225:KIT [Medical Device]
   753   C1150635:KIT [Molecular Function]
   753   C1548221:Isolated [Idea or Concept]
   753   C1705212:Kit [Medical Device]
   753   C1705213:KIT [Medical Device]
   753   C3273202:Kit [Manufactured Object]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "as"

Phrase: "specified by the manufacturer."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205369:Specified [Qualitative Concept]
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1705426:Manufacturer [Population Group]
   737 E C1521902:Specify [Qualitative Concept]
Processing 00000000.tx.40: RNA (2 g) was reverse transcribed by using Superscript II RT (Invitrogen). 

Phrase: "RNA (2 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Superscript II RT (Invitrogen"

Phrase: ")."
Processing 00000000.tx.41: When poly(A)mRNA was used, it was purified from total RNA with the Qiagen mRNA easy kit. 

Phrase: "When"

Phrase: "poly(A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "it"

Phrase: "was"

Phrase: "purified from total RNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   770   C1998793:Purified [Functional Concept]

Phrase: "with the Qiagen mRNA easy kit."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0812225:KIT [Medical Device]
   812   C1150635:KIT [Molecular Function]
   812   C1705212:Kit [Medical Device]
   812   C1705213:KIT [Medical Device]
   812   C3273202:Kit [Manufactured Object]
Processing 00000000.tx.42: In this context 0.5 g of poly(A)mRNA were used to induce the reverse-transcription reaction. 

Phrase: "In this context 0.5 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "of poly(A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the reverse-transcription reaction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   734   C0035380:Reverse Transcription [Genetic Function]
Processing 00000000.tx.43: The PCR reactions were performed using Taq polymerase (Bioline). 

Phrase: "The PCR reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Taq polymerase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0075813:Taq Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Bioline"

Phrase: ")."
Processing 00000000.tx.44: Sequences of PCR primers and annealing temperatures are outlined below in Table I. 

Phrase: "Sequences of PCR primers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0162326:Sequences [Nucleotide Sequence]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737 E C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "annealing temperatures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0039476:Temperatures [Quantitative Concept]
   827 E C0005903:temperature [Organism Attribute]

Phrase: "are"

Phrase: "outlined below"

Phrase: "in Table I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.45: The obtained amplification products were cloned into a pSTBlue1 vector to be sequenced subsequently (MWG, Germany). 

Phrase: "The obtained amplification products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "cloned into a pSTBlue1 vector to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0009013:cloned [Cell]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   719 E C1522642:Clone [Tissue]

Phrase: "be"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "subsequently"

Phrase: "(MWG,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.46: View this table: [in this window] [in a new window]  TABLE I Primers used for RT-PCRs Characters in bold in rTSC-1 sequences indicate the EcoRI (rTSC1-s) or BamHI (rTSC1-as) restriction sites used for cloning the product into the pBluescript vector.  

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE I Primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used for RT-PCRs Characters"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   773   C0599161:RT-PCR [Molecular Biology Research Technique]
   760   C0007952:Characters [Mental Process]
   760   C1273517:used [Finding]
   726   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C0486537:Character [Organism Attribute]
   726   C0677874:pCR [Finding]
   726 E C1947944:Use [Intellectual Product]
   726 E C2350015:Character [Qualitative Concept]

Phrase: "in bold"

Phrase: "in rTSC-1 sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "indicate"

Phrase: "the EcoRI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(rTSC1-"

Phrase: "s)"

Phrase: "or"

Phrase: "BamHI"

Phrase: "(rTSC1-as) restriction sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C1882940:Restriction Site [Nucleotide Sequence]
   812   C0205145:Sites [Spatial Concept]
   812   C0443288:Restriction [Functional Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "used for cloning"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0009015:Cloning [Research Activity]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "the product into the pBluescript vector."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1514468:product [Entity]
   753   C1704444:Product [Quantitative Concept]
Processing 00000000.tx.47: Riboprobe PreparationA cDNA corresponding to region 15981834 of the rat kidney NCC isoform (corresponding to the last three transmembrane domains) was obtained by RT-PCR from small intestine mRNA, by using rTSC1 primer pairs. 

Phrase: "Riboprobe PreparationA cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "corresponding to region 15981834 of the rat kidney NCC isoform"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C1276227:region of kidney [Body Location or Region]
   770   C1282130:Region of kidney [Body Location or Region]
   756   C1420092:Na-Cl Cotransporter [Gene or Genome]
   756   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   738   C0017446:Region [Geographic Area]
   738   C0022646:Kidney [Body Part, Organ, or Organ Component]
   738   C0034693:Rat, NOS [Mammal]
   738   C0034721:Rat [Mammal]
   738   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   738   C0205147:Region [Spatial Concept]
   738   C0227665:kidney [Body Part, Organ, or Organ Component]
   738   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   738   C1278978:Kidney [Body Part, Organ, or Organ Component]
   738   C1514845:KIDNEY [Tissue]
   738   C1959973:% NaCl [Quantitative Concept]

Phrase: "("

Phrase: "corresponding to the last three transmembrane domains"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205449:Three [Quantitative Concept]
   748   C1167322:transmembrane [Cell Component]
   748   C2752508:transmembrane [Cell Component]
   745   C1519623:Transmembrane Domain [Amino Acid Sequence]
   714   C1880389:Domain [Functional Concept]
   714   C1883221:Domain [Conceptual Entity]
   714   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "obtained by RT-PCR"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "from small intestine mRNA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
   734   C1268998:Small intestine [Body Part, Organ, or Organ Component]
   734   C1519375:SMALL INTESTINE [Tissue]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "rTSC1 primer pairs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.48: Such a riboprobe had already been used successfully in Northern blots performed using nonrenal tissue, which demonstrated the specificity for rat kidney NCC (14). 

Phrase: "Such"

Phrase: "a riboprobe"

Phrase: "had"

Phrase: "already"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "successfully in Northern blots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0005861:northern blots [Molecular Biology Research Technique]
   833   C1621557:Northern Blots [Research Device]
   770   C1709269:Northern [Spatial Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "nonrenal tissue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "which"

Phrase: "demonstrated"

Phrase: "the specificity for rat kidney NCC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037791:Specificity [Quantitative Concept]
   748   C1511884:Specificity [Quantitative Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.49: The cDNA fragment was cloned into the BamHI-EcoRI sites of the pBluescript KS vector (Stratagene) and sequenced thereafter. 

Phrase: "The cDNA fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "cloned into the BamHI-EcoRI sites of the pBluescript KS vector"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   739   C2945843:Site of [Qualitative Concept]
   738   C0009013:cloned [Cell]
   738   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0205145:Sites [Spatial Concept]
   738   C0442335:Vector [Spatial Concept]
   738   C1705099:Vector [Idea or Concept]
   738   C3541894:ks [Quantitative Concept]
   704 E C1515974:Site [Body Location or Region]
   704 E C1522642:Clone [Tissue]
   704 E C2825164:Site [Spatial Concept]

Phrase: "(Stratagene"

Phrase: ")"

Phrase: "and"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "thereafter."
Processing 00000000.tx.50: [32P]CTP-labeled cRNA was obtained by in vitro transcription by means of the Riboprobe System T3 kit (Promega, Italy). 

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]CTP-labeled cRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0056208:cRNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1321571:CRNA [Professional or Occupational Group]

Phrase: "was"

Phrase: "obtained by in vitro transcription"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]
   760   C0040649:Transcription [Genetic Function]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "by means of the Riboprobe System T3 kit (Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0072149:Promega [Lipid]

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: ")."
Processing 00000000.tx.51: The riboprobe was purified from unpolymerized nucleotides with a Sephadex S300 spin-column (Amersham Biosciences) to be used for the Northern blot analysis. 

Phrase: "The riboprobe"

Phrase: "was"

Phrase: "purified from unpolymerized nucleotides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1998793:Purified [Functional Concept]

Phrase: "with a Sephadex S300 spin-column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1185738:Column [Body Part, Organ, or Organ Component]
   812   C1706132:Column [Idea or Concept]

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "used for the Northern blot analysis."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   833   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   790   C1621557:Northern Blot [Research Device]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1273517:used [Finding]
   753   C1524024:analysis [Functional Concept]
   753   C1709269:Northern [Spatial Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.52: Northern Blot Analysis4 g of kidney total RNA (obtained as described above) and 8 g of small intestine poly(A)mRNA (purified from total RNA with the Qiagen Oligotex mRNA kit) were separated by 0.8% agarose-formaldehyde denaturizing electrophoresis, and transferred overnight by capillarity with the TurboBlotter system (Schleicher and Schuell) to a Hybond-N nylon membrane (Amersham Biosciences). 

Phrase: "Northern Blot Analysis4 g of kidney total RNA ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439267:g% [Quantitative Concept]

Phrase: "obtained as described above"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1301820:Obtained [Functional Concept]
   770   C1552738:described [Idea or Concept]
   737 E C1706701:Obtain [Activity]

Phrase: ")"

Phrase: "and"

Phrase: "8 g of small intestine poly(A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0032411:Poly G [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "mRNA ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "purified from total RNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   770   C1998793:Purified [Functional Concept]

Phrase: "with the Qiagen Oligotex mRNA kit)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0812225:KIT [Medical Device]
   812   C1150635:KIT [Molecular Function]
   812   C1705212:Kit [Medical Device]
   812   C1705213:KIT [Medical Device]
   812   C3273202:Kit [Manufactured Object]

Phrase: "were"

Phrase: "separated by 0.8% agarose-formaldehyde denaturizing electrophoresis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0013855:Electrophoresis [Laboratory Procedure]
   744   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   744   C0036681:Agarose [Carbohydrate]
   744   C0086972:Separated [Finding]
   744   C0443299:separated [Spatial Concept]
   744   C0687118:Separated [Functional Concept]

Phrase: "and"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "overnight by capillarity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006903:Capillarity [Natural Phenomenon or Process]
   790   C0439583:Overnight [Temporal Concept]

Phrase: "with the TurboBlotter system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(Schleicher"

Phrase: "and"

Phrase: "Schuell"

Phrase: ")"

Phrase: "to a Hybond-N nylon membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0025255:Membrane [Tissue]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.53: Following transfer, the membrane was UV-cross-linked. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "transfer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040671:Transfer [Mental Process]
  1000   C1705822:Transfer [Activity]

Phrase: "the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "UV-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041625:UV [Natural Phenomenon or Process]
  1000   C1961129:uV [Quantitative Concept]

Phrase: "cross-linked."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]
Processing 00000000.tx.54: Pre-hybridization and hybridization steps were performed as described (14). 

Phrase: "Pre-hybridization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020202:Hybridisation [Genetic Function]
   861   C1300517:Hybridization [Laboratory Procedure]

Phrase: "and"

Phrase: "hybridization steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]

Phrase: "were"

Phrase: "performed as described"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.55: The membrane was kept at 80 C up to 1 week for the final autoradiography procedure. 

Phrase: "The membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "kept at 80 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0333118:Keep [Functional Concept]

Phrase: "up to 1 week"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442452:1 Week [Temporal Concept]
   861   C0332174:/week [Temporal Concept]
   861   C0439230:week [Temporal Concept]

Phrase: "for the final autoradiography procedure."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.56: Western BlotThe small intestine and kidney cortex were homogenized in buffer A (0.25 M sucrose, 30 mM histidine, 1 mM EDTA, 300 M phenylmethylsulfonyl fluoride, 100 M N-tosyl-n-phenylalanine chloromethyl ketone, 1.5 M pepstatin, 1.5 M leupeptin, pH 7.4). 

Phrase: "Western BlotThe small intestine"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
   861   C1268998:Small intestine [Body Part, Organ, or Organ Component]
   861   C1519375:SMALL INTESTINE [Tissue]
   812   C0021853:Intestine [Body Part, Organ, or Organ Component]
   812   C0700321:Small [Quantitative Concept]
   812   C1708548:INTESTINE [Tissue]
   805 E C1304890:Enteral [Spatial Concept]
   805 E C1522196:Enteral [Functional Concept]

Phrase: "and"

Phrase: "kidney cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022655:Kidney Cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "were"

Phrase: "homogenized in buffer A (0.25 M sucrose,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "30 mM histidine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "300 M phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "100 M N-tosyl-n-phenylalanine chloromethyl ketone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0022634:Ketone [Organic Chemical]

Phrase: "1.5 M pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "1.5 M leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.57: Cellular debris was removed by centrifuging at 1,000 x g, 10 min, 4 C. 

Phrase: "Cellular debris"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0440266:Debris [Substance]

Phrase: "was"

Phrase: "removed by centrifuging at 1,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0849355:Removed [Qualitative Concept]
   726   C0179834:centrifuge [Medical Device]
   726 E C1883720:Remove [Activity]
   726 E C3244314:remove [Functional Concept]

Phrase: "000 x g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "4 C."
Processing 00000000.tx.58: Supernatant was centrifuged at 7,000 x g, 15 min, 4 C, and the resulting supernatant was centrifuged once more at 47,000 x g, 45 min, 4 C. 

Phrase: "Supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "centrifuged at 7,000 x g,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "15 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "4 C,"

Phrase: "and"

Phrase: "the resulting supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "once more at 47,000 x g,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439267:g% [Quantitative Concept]
   748   C1720092:Once [Intellectual Product]
   748   C1948045:Once [Temporal Concept]

Phrase: "45 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "4 C."
Processing 00000000.tx.59: Membranes were resuspended in ice-cold PBS (50 mM phosphate buffer, 150 mM NaCl, pH 7) containing 1% octylphenylpolyethylene glycol and 0.5% SDS. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "resuspended in ice-cold PBS"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0456963:Ice cold [Qualitative Concept]
   774   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0009264:Cold [Natural Phenomenon or Process]
   748   C0009443:Cold [Disease or Syndrome]
   748   C0020746:Ice [Inorganic Chemical]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0036082:Saline [Substance]
   748   C0234192:Cold [Physiologic Function]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(50 mM phosphate buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% octylphenylpolyethylene glycol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017945:Glycol [Organic Chemical]
   827   C0017951:Glycol [Organic Chemical]

Phrase: "and"

Phrase: "0.5% SDS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]
Processing 00000000.tx.60: HT-29 cells membrane proteins were obtained by Triton X-114-based lysis as reported previously (19). 

Phrase: "HT-29 cells membrane proteins"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   867   C0242391:Cell Membrane Proteins [Amino Acid, Peptide, or Protein,Receptor]
   851 E C1179841:Cell membrane protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0007603:cells membrane [Cell Component]
   840   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   823 E C3161472:Cell Membrane [Cell Component]
   804   C0025255:Membrane [Tissue]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0596901:Membrane [Cell Component]
   804   C1706182:Membrane [Manufactured Object]
   733 E C0205287:Membranous [Qualitative Concept]
   717   C0282639:HT-29 Cells [Cell]

Phrase: "were"

Phrase: "obtained by Triton X-114-based lysis"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   814   C0146953:Triton X-114 [Organic Chemical,Pharmacologic Substance]
   778   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   748   C0024348:Lysis [Pathologic Function]
   748   C0242759:Triton [Geographic Area]
   748   C1301820:Obtained [Functional Concept]
   748   C1527178:Based [Functional Concept]
   748   C1536403:lysis [Cell Function]
   748   C1705938:Based [Idea or Concept]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1706701:Obtain [Activity]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "as"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.61: Deglycosylation was performed with the N-glycosidase F deglycosylation kit (Roche Applied Science) according to manufacturer instructions. 

Phrase: "Deglycosylation"

Phrase: "was"

Phrase: "performed with the N-glycosidase F deglycosylation kit (Roche Applied Science"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   756   C0681834:Applied Science [Research Activity]
   738   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   738   C0017976:Glycosidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   738   C0036397:Science [Occupation or Discipline]
   738   C0185125:Applied [Health Care Activity]
   738   C0331965:Roche [Health Care Related Organization]
   738   C0439133:(f) [Intellectual Product]
   738   C0812225:KIT [Medical Device]
   738   C0884358:Performed [Functional Concept]
   738   C1150635:KIT [Molecular Function]
   738   C1553038:[f] [Quantitative Concept]
   738   C1705212:Kit [Medical Device]
   738   C1705213:KIT [Medical Device]
   738   C3273202:Kit [Manufactured Object]
   704 E C1632850:Apply [Functional Concept]
   704 E C1879355:Apply [Functional Concept]
   704 E C2947996:Perform [Pharmacologic Substance]

Phrase: ")"

Phrase: "according to manufacturer instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.62: Brush border or basolateral membranes were prepared as previously described by Mg2+ precipitation, followed by differential centrifugation (20, 21). 

Phrase: "Brush border"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1318418:Brush Border [Cell Component]
   861   C0179445:Brush [Manufactured Object]
   861   C0205284:Border [Spatial Concept]
   861   C1522411:Border [Body Location or Region]
   861   C1706090:Brush [Manufactured Object]
   861   C2828371:Border [Classification]

Phrase: "or"

Phrase: "basolateral membranes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   966   C0596156:basolateral membrane [Cell Component]
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "prepared as previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521827:Prepare [Functional Concept]

Phrase: "described by Mg2+ precipitation,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0032931:Precipitation [Natural Phenomenon or Process]
   770   C0032932:Precipitation [Molecular Function]
   770   C1417500:MG2 [Gene or Genome]
   770   C1552738:described [Idea or Concept]
   770   C1642401:% precipitation [Quantitative Concept]
   770   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "followed by differential centrifugation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0007703:Centrifugation [Laboratory Procedure]
   770   C0443199:Differential [Qualitative Concept]
   770   C1705242:Differential [Qualitative Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "(20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.63: Proteins from the kidney (25 g), intestines, brush border membranes, basolateral membranes, or HT-29 cells (100 g) were analyzed by 8% SDS-PAGE followed by Western blotting. 

Phrase: "Proteins from the kidney"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "intestines,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0021853:Intestines [Body Part, Organ, or Organ Component]
   966 E C1708548:INTESTINE [Tissue]

Phrase: "brush border membranes,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   966   C0178523:brush border membrane [Cell Component]
   901   C1318418:Brush Border [Cell Component]
   827   C0025255:Membranes [Tissue]
   827   C0179445:Brush [Manufactured Object]
   827   C0205284:Border [Spatial Concept]
   827   C1522411:Border [Body Location or Region]
   827   C1706090:Brush [Manufactured Object]
   827   C2828371:Border [Classification]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "basolateral membranes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   966   C0596156:basolateral membrane [Cell Component]
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "or"

Phrase: "HT-29 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0282639:HT-29 Cells [Cell]
           HT-29
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(100 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by 8% SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0936012:Analyzed [Research Activity]
   760   C1704732:Page [Intellectual Product]

Phrase: "followed by Western blotting."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0332283:Followed by [Temporal Concept]
           followed
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.64: The proteins, transferred to polyvinylidene difluoride membranes, were first incubated with rabbit polyclonal anti-rNCC2112 (raised against region 2112 of the rat kidney NCC) (22) 1:1500 or anti-rNCC198 (raised against region 198 of the rat kidney NCC) (23) 1:2,500 overnight at 4 C, followed by incubation for 1 h with a 1:2,500 dilution of peroxidase-coupled goat anti-rabbit antibody. 

Phrase: "The proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "transferred to polyvinylidene difluoride membranes,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0025255:Membranes [Tissue]
   760   C0348011:transferred [Functional Concept]
   726 E C0040671:Transfer [Mental Process]
   726 E C0596901:Membrane [Cell Component]
   726 E C1705822:Transfer [Activity]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "incubated with rabbit polyclonal anti-rNCC2112"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0034493:Rabbit [Mammal]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "("

Phrase: "raised against region 2112 of the rat kidney NCC"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   775   C1276227:region of kidney [Body Location or Region]
   775   C1282130:Region of kidney [Body Location or Region]
   760   C1420092:Na-Cl Cotransporter [Gene or Genome]
   760   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   739   C0017446:Region [Geographic Area]
   739   C0022646:Kidney [Body Part, Organ, or Organ Component]
   739   C0034693:Rat, NOS [Mammal]
   739   C0034721:Rat [Mammal]
   739   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   739   C0205147:Region [Spatial Concept]
   739   C0227665:kidney [Body Part, Organ, or Organ Component]
   739   C0442818:Raised [Quantitative Concept]
   739   C1278978:Kidney [Body Part, Organ, or Organ Component]
   739   C1514845:KIDNEY [Tissue]
   739   C1959973:% NaCl [Quantitative Concept]

Phrase: ")"

Phrase: "(22"

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1500"

Phrase: "or"

Phrase: "anti-rNCC198"

Phrase: "("

Phrase: "raised against region 198 of the rat kidney NCC"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   775   C1276227:region of kidney [Body Location or Region]
   775   C1282130:Region of kidney [Body Location or Region]
   760   C1420092:Na-Cl Cotransporter [Gene or Genome]
   760   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   739   C0017446:Region [Geographic Area]
   739   C0022646:Kidney [Body Part, Organ, or Organ Component]
   739   C0034693:Rat, NOS [Mammal]
   739   C0034721:Rat [Mammal]
   739   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   739   C0205147:Region [Spatial Concept]
   739   C0227665:kidney [Body Part, Organ, or Organ Component]
   739   C0442818:Raised [Quantitative Concept]
   739   C1278978:Kidney [Body Part, Organ, or Organ Component]
   739   C1514845:KIDNEY [Tissue]
   739   C1959973:% NaCl [Quantitative Concept]

Phrase: ")"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2,500 overnight at 4 C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439583:Overnight [Temporal Concept]

Phrase: "followed by incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "with a 1"

Phrase: ":"

Phrase: "2,500 dilution of peroxidase-coupled goat anti-rabbit antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0079240:Dilution [Laboratory Procedure]
   739   C1948037:Dilution [Functional Concept]
Processing 00000000.tx.65: Antibody-protein complexes were then detected using the ECL detection kit (Amersham Biosciences) followed by autoradiography. 

Phrase: "Antibody-protein complexes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   867   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867   C1523872:protein complex [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ECL detection kit (Amersham Biosciences"

Phrase: ")"

Phrase: "followed by autoradiography."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0004400:Autoradiography [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.66: HT-29 ImmunofluorescenceCells were grown on coverslips to 70% of confluence, fixed in 0.1 M PBS containing 3% paraformaldehyde, and permeabilized with PBS containing 0.1% Triton X-100 for 3 min at room temperature. 

Phrase: "HT-29 ImmunofluorescenceCells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0282639:HT-29 [Cell]

Phrase: "were"

Phrase: "grown on coverslips"

Phrase: "to 70%"

Phrase: "of confluence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205200:Confluent [Qualitative Concept]

Phrase: "fixed in 0.1 M PBS"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   744   C0031701:phosphate [Organophosphorus Compound]
   744   C0036082:Saline [Substance]
   744   C0231441:Fixed [Finding]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C0443218:Fixed [Qualitative Concept]
   744   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   744   C2827483:Fixed [Body Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "3% paraformaldehyde,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "permeabilized with PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% Triton X-100 for 3 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   744   C0242759:Triton [Geographic Area]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.67: After inhibition by means of 3% BSA in PBS, cells were incubated overnight at 4 C with anti-NCC198 antibody at 1:600 dilution in PBS containing 0.1% BSA. 

Phrase: "After inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "by means of 3% BSA"

Phrase: "in PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]

Phrase: "with anti-NCC198 antibody at 1"

Phrase: ":"

Phrase: "600 dilution in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079240:Dilution [Laboratory Procedure]
   753   C1948037:Dilution [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% BSA."
Processing 00000000.tx.68: After washing out the excessive primary antibody, cells were incubated for 1 h with CyTM2-conjugated anti-rabbit antibody (Jackson ImmunoResearch Laboratories) diluted 1:100. 

Phrase: "After"

Phrase: "washing out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022100:washing out [Therapeutic or Preventive Procedure]
   861   C0441648:Washing [Activity]

Phrase: "the excessive primary antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with CyTM2-conjugated anti-rabbit antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0034493:Rabbit [Mammal]

Phrase: "(Jackson ImmunoResearch Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100."
Processing 00000000.tx.69: 4',6-Diamidino-2-phenylindole dihydrochloride staining of nuclei was performed with standard methods. 

Phrase: "4',"

Phrase: "6-Diamidino-2-phenylindole dihydrochloride staining of nuclei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0487602:Staining [Laboratory Procedure]
   744   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "performed with standard methods."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1442989:Standard [Qualitative Concept]
   770   C2828392:Standard [Intellectual Product]
   737 E C0871511:METHOD [Intellectual Product]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.70: Cells were imaged using a Leica TCS-NT (Leica Microsystems, Heidelberg, Germany) confocal laser-scanning microscope, equipped with laser argon/krypton, 75-milliwatt multiline. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "imaged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Leica TCS-NT (Leica Microsystems,"

Phrase: "Heidelberg,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "confocal laser-scanning microscope,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   902   C1626420:Confocal microscope [Medical Device]
   812   C0023089:Laser [Manufactured Object]
   812   C0034606:Scanning [Diagnostic Procedure]
   812   C0181839:Microscope [Medical Device]
   812   C0441633:Scanning [Diagnostic Procedure]
   812   C0458142:Laser [Phenomenon or Process]
   812   C1023865:Laser [Plant]
   812   C1706315:Laser [Medical Device]
   812   C1706379:Microscope [Medical Device]
   779 E C2826292:SCAN [Finding]

Phrase: "equipped with laser argon/krypton,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   797   C0392247:Argon laser [Medical Device]
   797   C0392274:Krypton laser [Medical Device]
   760   C0003781:Argon [Element, Ion, or Isotope]
   760   C0022792:Krypton [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0023089:Laser [Manufactured Object]
   760   C0458142:Laser [Phenomenon or Process]
   760   C1023865:Laser [Plant]
   760   C1706315:Laser [Medical Device]
   760   C1948015:Argon [Eukaryote]

Phrase: "75-milliwatt multiline."
Processing 00000000.tx.71: A focal series of horizontal planes of section were monitored for fluorescein isothiocyanate by means of the 488 nm laser lines, and a fluorescein isothiocyanate band pass 530/30 nm filter, for 4',6-diamidino-2-phenylindole dihydrochloride with the Coherent Enterprise U.V. argon ion laser (Laser Innovations, Santa Paula, CA). 

Phrase: "A focal series of horizontal planes of section"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205549:Series [Quantitative Concept]
   744   C2348044:Series [Intellectual Product]

Phrase: "were"

Phrase: "monitored for fluorescein isothiocyanate"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0124209:Isothiocyanate [Organic Chemical]
   770   C0206359:isothiocyanate [Organic Chemical]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "by means of the 488 nm laser lines,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "a fluorescein isothiocyanate band pass 530/30 nm filter,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0180860:Filter [Manufactured Object]
   793   C0581406:Filter [Medical Device]
   793   C1522664:Filter [Intellectual Product]
   793   C1704449:Filter [Conceptual Entity]
   793   C1704684:Filter [Medical Device]
   793   C1875155:FILTER [Medical Device]

Phrase: "for 4',"

Phrase: "6-diamidino-2-phenylindole dihydrochloride"

Phrase: "with the Coherent Enterprise U.V. argon ion laser"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   845   C0392247:Argon ion laser [Medical Device]
           Argon laser
   818   C1289853:Ion laser [Manufactured Object]
   795   C0022023:Ion [Element, Ion, or Isotope]
   795   C0023089:Laser [Manufactured Object]
   795   C0458142:Laser [Phenomenon or Process]
   795   C1023865:Laser [Plant]
   795   C1700702:ION [Functional Concept]
   795   C1706315:Laser [Medical Device]

Phrase: "(Laser Innovations,"

Phrase: "Santa Paula,"

Phrase: "CA)."
Processing 00000000.tx.72: No signal was detectable in negative controls performed by omitting the primary antibody. 

Phrase: "No signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "detectable in negative controls"

Phrase: "performed by omitting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0750563:omitting [Idea or Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the primary antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.73: ImmunohistochemistryThe intestine was dissected from adult rats and fixed by immersion in 4% paraformaldehyde in 0.1 M PBS, pH 7.6 (5 h at 4 C), subsequently dehydrated in ethanol, and embedded in paraffin. 

Phrase: "ImmunohistochemistryThe intestine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021853:Intestine [Body Part, Organ, or Organ Component]
   861   C1708548:INTESTINE [Tissue]

Phrase: "was"

Phrase: "dissected from adult rats"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0001675:Adult [Age Group]
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0205239:dissected [Functional Concept]
   770   C1706450:Adult [Human]

Phrase: "and"

Phrase: "fixed by immersion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020940:Immersion [Therapeutic or Preventive Procedure]
   790   C0038561:Immersion [Injury or Poisoning]
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]
   790   C2827727:Immersion [Functional Concept]

Phrase: "in 4% paraformaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "in 0.1 M PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   810   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   799   C0031701:phosphate [Organophosphorus Compound]
   799   C0036082:Saline [Substance]
   799   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "(5 h at 4 C), subsequently"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]

Phrase: "dehydrated in ethanol,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001962:Ethanol [Organic Chemical]
   790   C0011175:Dehydrated [Disease or Syndrome]

Phrase: "and"

Phrase: "embedded in paraffin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0085185:embedded paraffin [Laboratory Procedure]
   790   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   790   C1707903:Embedded [Laboratory Procedure]
Processing 00000000.tx.74: Sections (10-mm thick) were dewaxed and processed for the immunoenzymatic detection of the NCC transporter using a standard avidin-biotin-peroxidase complex procedure. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "(10-mm"

Phrase: "thick"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1280412:Thick [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "dewaxed"

Phrase: "and"

Phrase: "processed for the immunoenzymatic detection of the NCC transporter"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C1420092:Na-Cl Cotransporter [Gene or Genome]
   739   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   739   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1511790:Detection [Therapeutic or Preventive Procedure]
   739   C1522240:Processed [Phenomenon or Process]
   739   C1959973:% NaCl [Quantitative Concept]
   706 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a standard avidin-biotin-peroxidase complex procedure."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C1292781:Complex procedure [Health Care Activity]
   799   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   799   C1948041:Procedure [Therapeutic or Preventive Procedure]
   799   C2700391:Procedure [Activity]
   799   C3274430:PROCEDURE [Health Care Activity]
   799   C3538935:Procedure [Idea or Concept]
   799   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.75: Briefly, after quenching of free aldehyde groups with 0.05 M NH4Cl in 0.01 M PBS, pH 7.4 (30 min), sections were treated with 1% H2O2 (15 min) to inactivate endogenous peroxidase, as well as preincubated in PBS containing 1% BSA and 0.2% Triton X-100 (30 min). 

Phrase: "Briefly,"

Phrase: "after"

Phrase: "quenching of free aldehyde"

Phrase: "groups with 0.05 M NH4Cl"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C0441847:Group M [Intellectual Product]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441833:Group [Idea or Concept]
   753   C0441923:M+ [Intellectual Product]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "in 0.01 M PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   810   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   799   C0031701:phosphate [Organophosphorus Compound]
   799   C0036082:Saline [Substance]
   799   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "(30 min),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "treated with 1% H2O2"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(15 min) to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "inactivate"

Phrase: "endogenous peroxidase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "as well as"

Phrase: "preincubated in PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% BSA"

Phrase: "and"

Phrase: "0.2% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "(30 min)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.76: After this, the sections were incubated with the polyclonal antiserum anti-NCC198 diluted 1:200 in PBS containing 0.1% BSA (48 h at 4 C in a humid chamber). 

Phrase: "After this,"

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated with the polyclonal antiserum anti-NCC198"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200 in PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% BSA (48 h at 4 C in"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0700308:h 1 [Element, Ion, or Isotope]
   742   C0033727:H+ [Element, Ion, or Isotope]
   742   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441932:H+ [Classification]
   742   C0564385:/h [Quantitative Concept]

Phrase: "a humid chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.77: After multiple rinses in PBS, sections were incubated at room temperature in biotinylated goat anti-rabbit IgG (Vector, Burlingame, CA) diluted 1:200 in PBS containing 0.1% BSA (75 min), rinsed in PBS, and incubated in the avidin-biotin-peroxidase complex (ABC kit, Vector) diluted 1:100 in PBS. 

Phrase: "After multiple rinses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1701810:Rinse [Functional Concept]
   827   C1882955:Rinse [Activity]

Phrase: "in PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated at room temperature"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1547703:Room [Spatial Concept]

Phrase: "in biotinylated goat anti-rabbit IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0034493:Rabbit [Mammal]

Phrase: "(Vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "Burlingame,"

Phrase: "CA)"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200 in PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% BSA (75 min),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0702093:/min [Temporal Concept]

Phrase: "rinsed in PBS,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726   C1701810:Rinse [Functional Concept]
   726   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "incubated in the avidin-biotin-peroxidase complex"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0004434:Avidin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   748   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0439855:Complex [Qualitative Concept]
   748   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C2700256:Biotin [Laboratory Procedure]

Phrase: "(ABC kit,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0812225:KIT [Medical Device]
   861   C1150635:KIT [Molecular Function]
   861   C1705212:Kit [Medical Device]
   861   C1705213:KIT [Medical Device]
   861   C3273202:Kit [Manufactured Object]

Phrase: "Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100 in PBS."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.78: After rinsing in PBS and in 0.05 M Tris-HCl buffer (pH 7.6), sections were reacted in a fresh solution of 0.05% diaminobenzidine tetrahydrochloride (Sigma) and 0.002% H2O2 in Tris-HCl buffer, and subsequently dehydrated and covered with a coverslip. 

Phrase: "After"

Phrase: "rinsing in PBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882955:Rinsing [Activity]

Phrase: "and in 0.05 M Tris-HCl buffer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C0814229:TRI [Intellectual Product]
   744   C1515981:And [Idea or Concept]

Phrase: "(pH 7.6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "reacted in a fresh solution of 0.05% diaminobenzidine tetrahydrochloride"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0037633:Solution [Substance]
   739   C0443224:Fresh [Qualitative Concept]
   739   C0525069:Solution [Biomedical or Dental Material]
   739   C2827486:Fresh [Body Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "0.002% H2O2 in Tris-HCl buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "subsequently"

Phrase: "dehydrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011175:Dehydrated [Disease or Syndrome]

Phrase: "and"

Phrase: "covered with a coverslip."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0439844:Covered [Functional Concept]
   770   C1999244:Covered [Functional Concept]
   737 E C0180153:cover [Medical Device]
   737 E C1707529:Cover [Medical Device]
Processing 00000000.tx.79: Control slides were incubated in the same solutions without the primary antiserum and processed as above. 

Phrase: "Control slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0444330:slides [Research Device]
   827 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "incubated in the same solutions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0037633:Solutions [Substance]
   760   C0445247:Same [Qualitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   726 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "without the primary antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "processed as above."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1522240:Processed [Phenomenon or Process]
   756 E C1184743:Process [Body Part, Organ, or Organ Component]
Processing 00000000.tx.80: As positive control, the polyclonal antiserum anti-NCC198 was also tested on paraffin sections of kidney, fixed, and processed as those of the intestine. 

Phrase: "As positive control,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1883676:Positive Control [Conceptual Entity]
   861   C0243148:control [Qualitative Concept]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825490:Positive [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "the polyclonal antiserum anti-NCC198"

Phrase: "was"

Phrase: "also"

Phrase: "tested on paraffin sections of kidney,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   753   C0022646:Kidney [Body Part, Organ, or Organ Component]
   753   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   753   C0227665:kidney [Body Part, Organ, or Organ Component]
   753   C0392366:tested [Intellectual Product]
   753   C1278978:Kidney [Body Part, Organ, or Organ Component]
   753   C1514845:KIDNEY [Tissue]
   719 E C0022885:Test [Laboratory Procedure]
   719 E C0039593:Test [Functional Concept]
   719   C0205155:Section [Spatial Concept]
   719   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   719   C1522472:Section [Substance]
   719   C1552923:Section [Quantitative Concept]
   719   C1705191:Section [Physical Object]

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: ","

Phrase: "and"

Phrase: "processed as those of the intestine."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0021853:Intestine [Body Part, Organ, or Organ Component]
   753   C1522240:Processed [Phenomenon or Process]
   753   C1708548:INTESTINE [Tissue]
   719 E C1184743:Process [Body Part, Organ, or Organ Component]
Processing 00000000.tx.81: Negative control sections of the intestine and kidney were processed without including the primary or secondary antiserum. 

Phrase: "Negative control sections of the intestine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   719   C0205155:Section [Spatial Concept]
   719   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   719   C1522472:Section [Substance]
   719   C1552923:Section [Quantitative Concept]
   719   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "were"

Phrase: "processed without"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1522240:Processed [Phenomenon or Process]
   799 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the primary"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205225:Primary [Qualitative Concept]
  1000   C0439631:Primary [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "secondary antiserum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.82: All sections were examined and photographed with a Zeiss III photomicroscope. 

Phrase: "All sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "and"

Phrase: "photographed with a Zeiss III photomicroscope."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439070:III [Intellectual Product]
   753   C1705160:III [Qualitative Concept]
   719   C0441468:photograph [Manufactured Object]
Processing 00000000.tx.83: No immunoreactivity was detected when sections were incubated without the primary or secondary antiserum. 

Phrase: "No immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "when"

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated without the primary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "secondary antiserum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.84: Short-circuit ExperimentsApproximately 5 cm of ileum was removed and placed in oxygenated, ice-cold Ringer solution, opened flat and washed for mounting in standard Ussing chambers (0.25-cm2 exposed area). 

Phrase: "Short-circuit ExperimentsApproximately 5 cm of ileum"

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "placed in oxygenated, ice-cold Ringer solution,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0073386:Ringer's solution [Inorganic Chemical,Pharmacologic Substance]
   778   C0456963:Ice cold [Qualitative Concept]
   748   C0009264:Cold [Natural Phenomenon or Process]
   748   C0009443:Cold [Disease or Syndrome]
   748   C0020746:Ice [Inorganic Chemical]
   748   C0037633:Solution [Substance]
   748   C0234192:Cold [Physiologic Function]
   748   C0525069:Solution [Biomedical or Dental Material]
   748   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   714   C0442504:Place [Spatial Concept]
   714   C1704765:Place [Functional Concept]
   714   C1882509:Place [Activity]
   714   C3496241:place [Disease or Syndrome]

Phrase: "opened"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175566:Opened [Spatial Concept]

Phrase: "flat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205324:Flat [Spatial Concept]
  1000   C0457933:Flat [Manufactured Object]

Phrase: "and"

Phrase: "washed for mounting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1548982:Washed [Idea or Concept]
   756 E C0441648:Wash [Activity]

Phrase: "in standard Ussing chambers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0179874:chambers [Medical Device]
   793 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "(0.25-cm2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439479:cm2 [Quantitative Concept]
   827   C0555206:CM2 [Congenital Abnormality]

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017446:Area [Geographic Area]
  1000   C0205146:Area [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.85: Both chambers were filled (5 ml each) for control experiments with the following solution (mM): 145.3 Na+, 6.0 K+, 125.3 Cl, 2.5 Ca2+, 1.2 Mg2+, 13.7 , 12.5 mannitol, 0.7 H2PO4, 2.5 , pH 7.4. 

Phrase: "Both chambers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0179874:chambers [Medical Device]
   966 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "filled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708059:Filled [Activity]

Phrase: "(5 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "each"

Phrase: ")"

Phrase: "for control experiments"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009932:control experiments [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0681814:Experiments [Research Activity]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "with the following solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(mM"

Phrase: ")"

Phrase: ":"

Phrase: "145.3 Na+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1272460:{NA} [Qualitative Concept]

Phrase: "6.0 K+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "125.3 Cl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "2.5 Ca2+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "1.2 Mg2+,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1417500:MG2 [Gene or Genome]
   827   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   734   C0580272:1/2 [Intellectual Product]
   734   C1519043:1-2 [Research Activity]

Phrase: "13.7 ,"

Phrase: "12.5 mannitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]

Phrase: "0.7 H2PO4,"

Phrase: "2.5 ,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450346:2 5 [Quantitative Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "pH 7.4."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.86: Test solutions contained also HCTZ (1 mM) or 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB) 50 M. 

Phrase: "Test solutions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0022885:Test [Laboratory Procedure]
   861   C0037633:Solutions [Substance]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]
   827 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "also HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   805 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   805 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   805 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "(1 mM)"

Phrase: "or"

Phrase: "5-nitro-2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(3-phenylpropylamino"

Phrase: ")"

Phrase: "benzoic acid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0053225:Benzoic Acid [Organic Chemical,Pharmacologic Substance]
           benzoic
  1000   C1161334:benzoic acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(NPPB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0049330:NPPB [Organic Chemical,Pharmacologic Substance]
  1000   C1417808:NPPB [Gene or Genome]

Phrase: ")"

Phrase: "50 M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.87: Bathing solutions were gassed with 100% O2. 

Phrase: "Bathing solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037633:Solutions [Substance]
   827 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "gassed with 100% O2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]
   737   C0017110:Gas [Chemical Viewed Structurally]
   737   C0596601:Gas [Sign or Symptom]
Processing 00000000.tx.88: Short-circuited conditions were obtained by using an automatic voltage clamp device manufactured in our workshop as previously described (24). 

Phrase: "Short-circuited"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1282927:short [Qualitative Concept]
   861   C1806781:Short [Quantitative Concept]
   861   C2350002:Short [Quantitative Concept]

Phrase: "conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "obtained by"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   833   C1301820:Obtained [Functional Concept]
   799 E C1706701:Obtain [Activity]
   761 E C1517378:Gain [Quantitative Concept]
   740 E C0205217:Increased [Quantitative Concept]
   740 E C0439661:Acquired [Temporal Concept]
   740 E C0442805:Increase [Functional Concept]
   740 E C0442808:Increasing [Functional Concept]
   740 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an automatic voltage clamp device"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175721:Clamp (device) [Medical Device]
   812   C0025080:Device [Medical Device]
   812   C0699733:Device [Manufactured Object]

Phrase: "manufactured in our workshop"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0242262:Workshop [Educational Activity]
   770   C0677507:Workshop [Manufactured Object]
   770   C0870840:manufactured [Occupational Activity]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.89: A chart recorder was used to register short-circuit current and transepithelial electric potential difference (Vms). 

Phrase: "A chart recorder"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0182914:Chart recorder [Medical Device]
   861   C0182913:Recorder [Medical Device]
   861   C1705115:Recorder [Medical Device]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "register"

Phrase: "short-circuit current"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C2984839:SHORT CIRCUIT [Functional Concept]
   827   C0521116:Current [Temporal Concept]
   827   C1282927:short [Qualitative Concept]
   827   C1705970:Current [Natural Phenomenon or Process]
   827   C1806781:Short [Quantitative Concept]
   827   C2350002:Short [Quantitative Concept]

Phrase: "and"

Phrase: "transepithelial electric potential difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1705241:*Difference [Quantitative Concept]
   812   C1705242:Difference [Qualitative Concept]
   741 E C0443199:Differential [Qualitative Concept]

Phrase: "(Vms"

Phrase: ")."
Processing 00000000.tx.90: Fura-2 ExperimentsExperiments were performed on subconfluent HT-29 cells cultured on a glass coverslip in Petri dishes. 

Phrase: "Fura-2 ExperimentsExperiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "were"

Phrase: "performed on subconfluent HT-29 cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   833   C0282639:HT-29 Cells [Cell]
           HT-29
   753   C0007634:Cells [Cell]
   753   C0018510:HT [Geographic Area]
   753   C0677607:HT [Disease or Syndrome]
   753   C0884358:Performed [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "cultured on a glass coverslip"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0017596:Glass [Manufactured Object]
   760   C1947936:Glass [Medical Device]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "in Petri dishes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1322960:Petri dish [Medical Device]
   827   C0020498:DISH [Disease or Syndrome]
Processing 00000000.tx.91: Cytoplasmic Ca2+ concentration was measured with Fura-2 as outlined further above (25). 

Phrase: "Cytoplasmic Ca2+ concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "measured with Fura-2"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "outlined"

Phrase: "further above"

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.92: Briefly, cells on a glass coverslip were loaded with 1 M Fura-2-pentakis(acetoxymethyl) ester and incubated for 20 min at 37 C. 

Phrase: "Briefly,"

Phrase: "cells on a glass coverslip"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "loaded with 1 M Fura-2-pentakis"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   778   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1708715:Loaded [Activity]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]

Phrase: "(acetoxymethyl) ester"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014898:Ester [Organic Chemical]

Phrase: "and"

Phrase: "incubated for 20 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37 C."
Processing 00000000.tx.93: The cells were mounted into a recording chamber and placed on the stage of a microscope (Olympus IX70) equipped with a monochromator (TILL Photonics Polychrome IV) and a charge-coupled device camera (TILL Photonics IMAGO) controlled by the imaging software TILLvisION 4.01. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "mounted into a recording chamber"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0449878:mounted [Finding]
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]
   726   C0034869:Record [Intellectual Product]
   726 E C0181909:Mount [Medical Device]

Phrase: "and"

Phrase: "placed on the stage of a microscope"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0181839:Microscope [Medical Device]
   748   C0205390:Stage [Temporal Concept]
   748   C1300072:Stage [Clinical Attribute]
   748   C1306673:Stage [Qualitative Concept]
   748   C1706379:Microscope [Medical Device]
   714   C0442504:Place [Spatial Concept]
   714   C1704765:Place [Functional Concept]
   714   C1882509:Place [Activity]
   714   C3496241:place [Disease or Syndrome]

Phrase: "(Olympus IX70"

Phrase: ")"

Phrase: "equipped with a monochromator"

Phrase: "(TILL Photonics Polychrome IV)"

Phrase: "and"

Phrase: "a charge-coupled device camera"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0598124:charge coupled device camera [Manufactured Object]
   861   C0179533:Camera, device [Medical Device]
           Camera
   861   C1706254:Device Camera [Medical Device]
           CAMERA
   812   C1654607:Camera [Eukaryote]
   756   C1455741:Charge coupled device [Medical Device]

Phrase: "(TILL Photonics IMAGO"

Phrase: ")"

Phrase: "controlled by the imaging software TILLvisION 4.01."
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   770   C0332298:Controlled by [Functional Concept]
   744   C0011923:Imaging [Diagnostic Procedure]
   744   C0037585:Software [Intellectual Product,Manufactured Object]
   744   C0079595:Imaging [Diagnostic Procedure]
   744   C2587213:Controlled [Functional Concept]
   734   C0449302:Image control [Therapeutic or Preventive Procedure]
   711 E C0243148:control [Qualitative Concept]
   711 E C1550141:Control [Substance]
   711 E C1704254:Image [Intellectual Product]
   711 E C1704922:Image [Entity]
   711 E C1882979:Control [Conceptual Entity]
   711 E C3274648:Control [Qualitative Concept]
   711 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.94: After rinsing the cells for at least 20 min with solution A (control solution, mM: NaCl 135.0, KCl 5.0, CaCl2 2.0, MgCl2 1.2, glucose 5.0, and HEPES 10.0, pH 7.4), the dye was alternatively excited by 340 and 380 nm wavelengths through a 40x oil immersion objective, and the emitted fluorescence was measured at 510 nm from regions of interest within the cells. 

Phrase: "After"

Phrase: "rinsing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1882955:Rinsing [Activity]
   966 E C1701810:Rinse [Functional Concept]

Phrase: "the cells for"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   866   C0007634:THE CELL [Cell]
           Cells
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "at least 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "with solution A (control solution,"

Phrase: "mM"

Phrase: ":"

Phrase: "NaCl 135.0,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "KCl 5.0,"

Phrase: "CaCl2 2.0,"

Phrase: "MgCl2 1.2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "glucose 5.0,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "HEPES 10.0,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "the dye"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "alternatively"

Phrase: "excited by 340"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0549255:Excited [Activity]

Phrase: "and"

Phrase: "380 nm wavelengths through a 40x oil immersion objective,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449819:wavelengths [Quantitative Concept]

Phrase: "and"

Phrase: "the emitted fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "measured at 510 nm"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "from regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "of interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "within the cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.95: Intracellular Ca2+ concentration variations were evaluated by analyzing the 340/380 ratio with Microsoft Excel following background subtraction. 

Phrase: "Intracellular Ca2+ concentration variations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:variations [Qualitative Concept]

Phrase: "were"

Phrase: "evaluated by analyzing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0220825:Evaluated [Functional Concept]

Phrase: "the 340/380 ratio with Microsoft"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "Excel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2740529:Excel [Pharmacologic Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "background subtraction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348589:Subtraction [Phenomenon or Process]
Processing 00000000.tx.96: Ca2+-free solutions were obtained by omitting CaCl2 from solution A in the presence of 1 mm EGTA. 

Phrase: "Ca2+-free solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037633:Solutions [Substance]
   793 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "obtained by omitting CaCl2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0750563:omitting [Idea or Concept]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "from solution A"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 1 mm EGTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.97: HCTZ (1 mM) was freshly dissolved 12 h prior to the experiment in solution A. 

Phrase: "HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "(1 mM)"

Phrase: "was"

Phrase: "freshly"

Phrase: "dissolved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1549535:Dissolve [Functional Concept]

Phrase: "12 h prior to the experiment in solution A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0033727:H+ [Element, Ion, or Isotope]
   742   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441932:H+ [Classification]
   742   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.98: Patch-clamp ExperimentsHT29 cells for electrophysiological recordings were seeded on round coverslips (10-mm diameter), cultured as usual and employed 1648 h after splitting. 

Phrase: "Patch-clamp ExperimentsHT29 cells for electrophysiological recordings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   721   C0678837:cell electrophysiology [Cell Function]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded on round coverslips"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0332490:Round [Spatial Concept]
   737   C0036563:Seed [Plant]
   737   C1705192:Seed [Laboratory Procedure]
   737   C1882540:{Seed} [Quantitative Concept]
   737   C2346495:Seed [Conceptual Entity]

Phrase: "(10-mm diameter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1301886:Diameter [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "cultured as usual"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C3538928:Usual [Qualitative Concept]
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "1648 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "after"

Phrase: "splitting."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1444777:Splitting [Finding]
  1000   C1534709:Splitting [Functional Concept]
  1000   C1881714:SPLITTING [Phenomenon or Process]
Processing 00000000.tx.99: Before sealing the patch pipette to the cell, cells were kept in a nominally Ca2+-free solution containing (mM): 150 NaCl, 6 CsCl, 1 MgCl2, 10 HEPES, 10 glucose, and 50 mannitol, pH 7.4 with CsOH to prevent Ca2+ overload. 

Phrase: "Before sealing"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0349677:Sealing [Functional Concept]
   966 E C0036492:Seal [Mammal]
   966 E C0325125:seal [Mammal]
   966 E C1704637:Seal [Manufactured Object]

Phrase: "the patch pipette to the cell,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0182301:Pipette [Medical Device]
   753   C1706407:Pipette [Medical Device]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "kept in a nominally Ca2+-free solution"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0037633:Solution [Substance]
   748   C0332296:free [Functional Concept]
   748   C0525069:Solution [Biomedical or Dental Material]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1880497:Free [Qualitative Concept]
   748   C1996904:Free [Qualitative Concept]
   714   C0333118:Keep [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "(mM"

Phrase: ")"

Phrase: ":"

Phrase: "150 NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "6 CsCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0055134:CsCl [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1 MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10 HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "10 glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "50 mannitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]

Phrase: "pH 7.4 with CsOH to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1882074:pH 7 [Qualitative Concept]
   783   C2678549:PH-4 [Gene or Genome]
   753   C0020283:[pH] [Quantitative Concept]
   753   C0450407:ph+ [Finding]
   753   C0450408:ph++ [Finding]
   753   C0450409:ph+++ [Finding]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "overload."
Processing 00000000.tx.100: The extracellular divalent cation free solution (bath) contained (mM) 150 NaCl, 6 CsCl, 10 HEPES, 5 EGTA, 10 glucose, and 50 mannitol, pH 7.4, with CsOH. 

Phrase: "The extracellular divalent cation free solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0037633:Solution [Substance]
   804   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(bath"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150141:Bath [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "(mM) 150 NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "6 CsCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0055134:CsCl [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10 HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "5 EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "10 glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "50 mannitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "with CsOH."
Processing 00000000.tx.101: The hyperosmolarity of the extracellular solution is routinely used to prevent activation of volume-regulated anion channels. 

Phrase: "The hyperosmolarity of the extracellular solution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0259752:Hyperosmolarity [Finding]

Phrase: "is"

Phrase: "routinely"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "activation of volume-regulated anion channels."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]
Processing 00000000.tx.102: The internal (pipette) solution contained (mM): 20 CsCl, 100 cesium aspartate, 1 MgCl2, 10 EGTA, 4 Na2ATP, and 10 HEPES, pH 7.2 with CsOH. 

Phrase: "The internal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205102:Internal [Spatial Concept]
  1000   C1553872:Internal [Intellectual Product]
  1000   C1619620:Internal [Intellectual Product]

Phrase: "(pipette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0182301:Pipette [Medical Device]
  1000   C1706407:Pipette [Medical Device]

Phrase: ")"

Phrase: "solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "(mM"

Phrase: ")"

Phrase: ":"

Phrase: "20 CsCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0055134:CsCl [Inorganic Chemical,Pharmacologic Substance]

Phrase: "100 cesium aspartate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "1 MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10 EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "4 Na2ATP,"

Phrase: "and"

Phrase: "10 HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.2 with CsOH."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1882074:pH 7 [Qualitative Concept]
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
Processing 00000000.tx.103: Whole cell currents were measured under voltage clamp conditions, with an EPC-9 amplifier (HEKA Elektronik, Germany; sampling rate 100 s; four-pole Bessel filter, 2.9 kHz) interfaced with a Macintosh computer running the Pulse software (HEKA Elektronik). 

Phrase: "Whole cell currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0521116:currents [Temporal Concept]
   793 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "measured under voltage clamp conditions,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0872303:voltage clamp [Research Activity]
   760   C0175721:Clamp [Medical Device]
   760   C0444706:Measured [Qualitative Concept]
   760   C0598352:Voltage [Quantitative Concept]
   760   C1705942:Clamp [Manufactured Object]
   760   C1883710:Clamp [Functional Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726   C0012634:condition [Disease or Syndrome]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "with an EPC-9 amplifier"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002684:amplifier [Manufactured Object]
   827   C1706099:Amplifier [Manufactured Object]

Phrase: "(HEKA Elektronik,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ";"

Phrase: "sampling"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0441621:Sampling [Diagnostic Procedure]
  1000   C0870078:Sampling [Idea or Concept]
   966 E C0370003:Sample [Substance]
   966 E C2347026:Sample [Conceptual Entity]

Phrase: "rate 100 s"

Phrase: "; four-pole Bessel filter,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0180860:Filter [Manufactured Object]
   812   C0581406:Filter [Medical Device]
   812   C1522664:Filter [Intellectual Product]
   812   C1704449:Filter [Conceptual Entity]
   812   C1704684:Filter [Medical Device]
   812   C1875155:FILTER [Medical Device]

Phrase: "2.9 kHz)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0556965:kHz [Quantitative Concept]

Phrase: "interfaced with a Macintosh computer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0009622:Computer [Manufactured Object]
   760   C0453947:Mackintosh [Manufactured Object]
   726   C1708533:Interface [Manufactured Object]
   726   C2698172:Interface [Intellectual Product]

Phrase: "running"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0035953:Running [Daily or Recreational Activity]
  1000   C2346414:Running [Finding]
   966 E C0600140:run [Finding]
   966 E C1704688:Run [Functional Concept]

Phrase: "the Pulse software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(HEKA Elektronik"

Phrase: ")."
Processing 00000000.tx.104: The step protocol consisted of a series of 50-ms long voltage steps applied from a holding potential of +20 mV to voltages between 100 and +100 mV, at increments of 20 mV. 

Phrase: "The step protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "consisted of a series of 50-ms long voltage steps"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   739   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205166:Long [Qualitative Concept]
   739   C0205549:Series [Quantitative Concept]
   739   C0598352:Voltage [Quantitative Concept]
   739   C1261552:steps [Conceptual Entity]
   739   C1706317:Long [Qualitative Concept]
   739   C2348044:Series [Intellectual Product]
   739   C2349943:Ms. [Conceptual Entity]
   739   C3539704:MS [Gene or Genome]
   706   C0332529:CONSIST [Qualitative Concept]
   706 E C1704379:Step [Functional Concept]
   706 E C1705117:Step [Quantitative Concept]
   706 E C2825408:Step [Manufactured Object]

Phrase: "applied from a holding potential of +20 mV"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   744   C0185125:Applied [Health Care Activity]
   744   C3245505:Potential [Qualitative Concept]
   711   C1553387:Hold [Idea or Concept]
   711 E C1632850:Apply [Functional Concept]
   711 E C1879355:Apply [Functional Concept]
   711   C1948035:Hold [Activity]

Phrase: "to voltages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0598352:Voltage [Quantitative Concept]

Phrase: "between 100"

Phrase: "and +"

Phrase: "100 mV,"

Phrase: "at increments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705117:Increment [Quantitative Concept]

Phrase: "of 20 mV."
Processing 00000000.tx.105: To generate current voltage relation, the mean current between two cursors shown in Fig. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "current voltage relation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0080103:Relation [Family Group]
   827   C0869014:relation [Social Behavior]
   755 E C0439849:Related [Qualitative Concept]
   755 E C0445223:Related [Finding]

Phrase: "the mean current between two cursors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0521116:Current [Temporal Concept]
   753   C1705970:Current [Natural Phenomenon or Process]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.106: 8 was calculated with the Pulse Fit software. 

Phrase: "8"

Phrase: "was"

Phrase: "calculated with the Pulse Fit software."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0036572:Fit [Sign or Symptom]
   753   C0037585:Software [Intellectual Product,Manufactured Object]
   753   C0232117:PULSE [Clinical Attribute]
   753   C0391850:Pulse [Physiologic Function]
   753   C0424576:Fit [Finding]
   753   C0444686:Calculated [Functional Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C1947910:Pulse [Phenomenon or Process]
   753   C2349186:Fit [Activity]
Processing 00000000.tx.107: Electrode resistances were between 7 and 8 M; 

Phrase: "Electrode resistances"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   777 E C0332325:Resistant [Functional Concept]
   777 E C1550464:resistent [Idea or Concept]
   777 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "were between 7"

Phrase: "and"

Phrase: "8 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.108: the total cell capacitance was routinely compensated, and measured 15  1 picofarads (n = 8); 

Phrase: "the total cell capacitance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242264:capacitance [Quantitative Concept]

Phrase: "was"

Phrase: "routinely"

Phrase: "compensated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205432:Compensated [Qualitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "15  1 picofarads"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1882376:Picofarad [Quantitative Concept]

Phrase: "(n = 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.109: series resistances were also compensated and currents were leak-corrected; 

Phrase: "series resistances"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0205549:Series [Quantitative Concept]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C2348044:Series [Intellectual Product]
   777 E C0332325:Resistant [Functional Concept]
   777 E C1550464:resistent [Idea or Concept]
   777 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "were"

Phrase: "also"

Phrase: "compensated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205432:Compensated [Qualitative Concept]

Phrase: "and"

Phrase: "currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521116:currents [Temporal Concept]
   966 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "leak-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332234:Leak [Functional Concept]
  1000   C1608322:Leak NOS [Finding]
  1000   C1881366:LEAK [Phenomenon or Process]

Phrase: "corrected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205202:Corrected [Qualitative Concept]
   966 E C2349182:Correct [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.110: all experiments were performed at room temperature. 

Phrase: "all experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed at room temperature."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1547703:Room [Spatial Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.111: StatisticsUnless otherwise specified, the experimental values are expressed as mean  S.E. of n experiments. 

Phrase: "StatisticsUnless otherwise"

Phrase: "specified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205369:Specified [Qualitative Concept]
   966 E C1521902:Specify [Qualitative Concept]

Phrase: ","

Phrase: "the experimental values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444504:Mean [Quantitative Concept]
   790   C2347634:Mean [Quantitative Concept]
   790   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "of n experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.112: Student's t or analysis of variance tests were used (with unpaired data unless otherwise specified) for the statistical analysis. 

Phrase: "Student's t"

Phrase: "or"

Phrase: "analysis of variance tests"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   909   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "("

Phrase: "with unpaired data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2825413:Unpaired Data [Idea or Concept]
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "unless"

Phrase: "otherwise"

Phrase: "specified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205369:Specified [Qualitative Concept]
   966 E C1521902:Specify [Qualitative Concept]

Phrase: ")"

Phrase: "for the statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.113: The value of p > 0.05 is indicated by ns.  

Phrase: "The value of p > 0.05"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1522609:Value [Quantitative Concept]

Phrase: "is"

Phrase: "indicated by ns."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.114: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Molecular Characterization and Localization of the Small Intestine NCC Cotransporter Expression of the NCC Protein in the Rat Small IntestineWe verified the expression of NCC mRNA in the rat small intestine by performing RT-PCRs with three different sets of primer pairs (Table I) and by using enterocyte cDNA as a template. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Molecular Characterization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "Localization of the Small Intestine NCC Cotransporter Expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]

Phrase: "of the NCC Protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420092:Na-Cl Cotransporter [Gene or Genome]

Phrase: "in the Rat Small IntestineWe"

Phrase: "verified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verified [Functional Concept]

Phrase: "the expression of NCC mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1515670:mRNA Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the rat small intestine"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1882857:Rat Small Intestine [Body Part, Organ, or Organ Component]
   901   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
   901   C1268998:Small intestine [Body Part, Organ, or Organ Component]
   901   C1519375:SMALL INTESTINE [Tissue]
   845 E C1304890:Enteral [Spatial Concept]
   845 E C1522196:Enteral [Functional Concept]
   827   C0021853:Intestine [Body Part, Organ, or Organ Component]
   827   C0700321:Small [Quantitative Concept]
   827   C1708548:INTESTINE [Tissue]

Phrase: "by performing RT-PCRs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   867   C0599161:RT-PCR [Molecular Biology Research Technique]
   793   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   793   C0677874:pCR [Finding]

Phrase: "with three different sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1705195:Set [Conceptual Entity]

Phrase: "of primer pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709450:Pair [Qualitative Concept]

Phrase: "(Table I)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "enterocyte cDNA as a template."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.115: In all PCRs a band at the expected molecular weight was obtained (Fig. 1). 

Phrase: "In all PCRs a band"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0230715:A band [Cell Component]
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "at the expected molecular weight"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0026385:Molecular Weight [Quantitative Concept]
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1521991:Molecular [Qualitative Concept]
   827   C1705104:Weight [Idea or Concept]
   755 E C0567416:Molecule [Substance]

Phrase: "was"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.116: With the primer pair rTSC3 the PCR was performed on cDNA from ileum and jejunum, and in both experiments a positive result was obtained. 

Phrase: "With the primer pair rTSC3"

Phrase: "the PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed on cDNA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from ileum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020885:ileum [Body Part, Organ, or Organ Component]
  1000   C1278923:Ileum [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "jejunum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022378:Jejunum [Body Part, Organ, or Organ Component]
  1000   C1278922:Jejunum [Body Part, Organ, or Organ Component]

Phrase: "and in both experiments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1515981:And [Idea or Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "a positive result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]

Phrase: "was"

Phrase: "obtained."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.117: The amplified fragments were sequenced and aligned with the corresponding amino acid sequence of the rat kidney NCC (GenBankTM accession number NP_062218 [GenBank] ), revealing that, within the tested regions, the intestinal and renal rat NCC sequences are identical. 

Phrase: "The amplified fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "aligned with the corresponding amino acid sequence of the rat kidney NCC"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
   766   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   750   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   750   C1420092:Na-Cl Cotransporter [Gene or Genome]
   750   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   750   C2917660:Amino Acid [Pharmacologic Substance]
   735   C0001128:Acid [Chemical]
   735   C0004793:Sequence [Nucleotide Sequence]
   735   C0022646:Kidney [Body Part, Organ, or Organ Component]
   735   C0034693:Rat, NOS [Mammal]
   735   C0034721:Rat [Mammal]
   735   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   735   C0162326:Sequence [Nucleotide Sequence]
   735   C0162327:Sequence [Nucleotide Sequence]
   735   C0202406:Acid [Laboratory Procedure]
   735   C0227665:kidney [Body Part, Organ, or Organ Component]
   735   C1278978:Kidney [Body Part, Organ, or Organ Component]
   735   C1514845:KIDNEY [Tissue]
   735   C1519249:Sequence [Functional Concept]
   735   C1706765:Aligned [Quantitative Concept]
   735   C1959973:% NaCl [Quantitative Concept]
   702 E C2369992:Align [Pharmacologic Substance]

Phrase: "(GenBankTM accession number NP_062218"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1510755:Accession Number [Intellectual Product]
           Accession
   804   C0237753:*Number [Quantitative Concept]
   804   C0449788:Number [Quantitative Concept]
   804   C1706078:Accession [Activity]
   804   C1706141:NP [Gene or Genome]

Phrase: "[GenBank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598211:GenBank [Intellectual Product]

Phrase: "]"

Phrase: ")"

Phrase: ","

Phrase: "revealing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:revealing [Qualitative Concept]

Phrase: "that,"

Phrase: "within the tested regions,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "the intestinal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0021853:Intestinal [Body Part, Organ, or Organ Component]
   928 E C1708548:INTESTINE [Tissue]

Phrase: "and"

Phrase: "renal rat NCC sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   804   C0162326:Sequences [Nucleotide Sequence]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "identical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.118: We confirmed the expression of the NCC mRNA by Northern blot. 

Phrase: "We"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the expression of the NCC mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1515670:mRNA Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by Northern blot."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005861:Northern Blot [Molecular Biology Research Technique]
  1000   C1621557:Northern Blot [Research Device]
   861   C1709269:Northern [Spatial Concept]
Processing 00000000.tx.119: A 32P-labeled probe corresponding to the region 15981834 of the renal NCC isoform (GenBankTM accession number NM_019345 [GenBank] ) was used to identify the full-length transcript of small intestine enterocyte NCC mRNA. 

Phrase: "A 32P-labeled probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0182400:Probe [Medical Device]
   827   C1704681:Probe [Gene or Genome]
   827   C2347609:Probe [Chemical Viewed Functionally]
   827   C3536729:Probe [Manufactured Object]

Phrase: "corresponding to the region 15981834 of the renal NCC isoform"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C1420092:Na-Cl Cotransporter [Gene or Genome]
   738   C0017446:Region [Geographic Area]
   738   C0022646:Renal [Body Part, Organ, or Organ Component]
   738   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   738   C0205147:Region [Spatial Concept]
   738   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   738   C1959973:% NaCl [Quantitative Concept]

Phrase: "(GenBankTM accession number NM_019345"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1510755:Accession Number [Intellectual Product]
           Accession
   804   C0237753:*Number [Quantitative Concept]
   804   C0312860:NM [Cell Function]
   804   C0449788:Number [Quantitative Concept]
   804   C1706078:Accession [Activity]

Phrase: "[GenBank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598211:GenBank [Intellectual Product]

Phrase: "]"

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the full-length transcript of small intestine enterocyte NCC mRNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.120: Cortical kidney total RNA was used as positive control, where (Fig. 2) two distinct signals corresponding to 4.4 and 3.3 kb could be identified, in good agreement with earlier reports (26) showing that both bands correspond to NCC and varying solely by the 3'-untranslated regions. 

Phrase: "Cortical kidney total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "used as positive control,"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   833   C1883676:Positive Control [Conceptual Entity]
   770   C0243148:control [Qualitative Concept]
   770   C0439178:% Positive [Quantitative Concept]
   770   C1273517:used [Finding]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C2825490:Positive [Qualitative Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "where"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "two distinct signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "corresponding to 4.4"

Phrase: "and"

Phrase: "3.3 kb"

Phrase: "could"

Phrase: "be"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "in good agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680240:Agreement [Social Behavior]

Phrase: "with earlier reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "(26"

Phrase: ")"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "both bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "correspond to NCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1420092:Na-Cl Cotransporter [Gene or Genome]
   770   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "varying"

Phrase: "solely by the 3'-untranslated regions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0600680:Untranslated Regions [Nucleic Acid, Nucleoside, or Nucleotide]
   719   C0017446:Region [Geographic Area]
   719   C0205147:Region [Spatial Concept]
Processing 00000000.tx.121: Using the intestine mRNA only one band at 4.4 kb could be observed. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the intestine mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "only one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "band at 4.4 kb"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0175723:Band [Medical Device]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]

Phrase: "could"

Phrase: "be"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.122: Even a prolonged exposure (1 week) did not reveal a second band at 3.3 kb. 

Phrase: "Even"

Phrase: "a prolonged exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]
   861   C0439590:Prolonged [Temporal Concept]

Phrase: "(1 week"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442452:1 Week [Temporal Concept]
   861   C0332174:/week [Temporal Concept]
   861   C0439230:week [Temporal Concept]

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a second band at 3.3 kb."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0230715:A band [Cell Component]
   748   C0175723:Band [Medical Device]
   748   C0439645:Band [Spatial Concept]
   748   C1521913:band [Cell Component]
Processing 00000000.tx.123: View larger version (52K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(52K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.124: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.125: RT-PCR experiments demonstrate that the NCC mRNA is transcribed in the small intestine. 

Phrase: "RT-PCR experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the NCC mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1420092:Na-Cl Cotransporter [Gene or Genome]

Phrase: "is"

Phrase: "transcribed in the small intestine."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
   806   C1268998:Small intestine [Body Part, Organ, or Organ Component]
   806   C1519375:SMALL INTESTINE [Tissue]
   760   C0021853:Intestine [Body Part, Organ, or Organ Component]
   760   C0700321:Small [Quantitative Concept]
   760   C1708548:INTESTINE [Tissue]
   751 E C1304890:Enteral [Spatial Concept]
   751 E C1522196:Enteral [Functional Concept]
Processing 00000000.tx.126: RT-PCRs performed with three different primer sets (rTSC1, rTSC2, and rTSC3, see Table I) on jejunum or ileum mRNA. 

Phrase: "RT-PCRs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0599161:RT-PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]

Phrase: "performed with three different primer sets"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0036849:Set [Mental Process]
   753   C0205449:Three [Quantitative Concept]
   753   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0884358:Performed [Functional Concept]
   753   C1442518:Set [Functional Concept]
   753   C1705195:Set [Conceptual Entity]
   753   C1705242:Different [Qualitative Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(rTSC1,"

Phrase: "rTSC2,"

Phrase: "and"

Phrase: "rTSC3,"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table I) on jejunum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021966:I- [Inorganic Chemical]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "ileum mRNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.127: PCR with rTSC3 primers was also performed on the intestinal sub-mucosa.  

Phrase: "PCR with rTSC3 primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "also"

Phrase: "performed on the intestinal sub-mucosa."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   783   C0021839:Intestinal Mucosa [Tissue]
   753   C0021853:Intestinal [Body Part, Organ, or Organ Component]
   753   C0026724:Mucosa [Tissue]
   753   C0542339:Sub- [Spatial Concept]
   753   C0884358:Performed [Functional Concept]
   753   C1264637:SUB [Quantitative Concept]
   753   C1561514:Mucosa [Intellectual Product]
   719 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.128: The expression of the NCC protein was directly assessed also by Western blot experiments, performed on membrane protein preparations obtained from small intestine epithelial cells. 

Phrase: "The expression of the NCC protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "also by Western blot experiments,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0949466:Western Blot [Laboratory Procedure]
   760   C0681814:Experiments [Research Activity]
   760   C1705493:Western [Spatial Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "performed on membrane protein preparations"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0025255:Membrane [Tissue]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0596901:Membrane [Cell Component]
   760   C0884358:Performed [Functional Concept]
   760   C1706182:Membrane [Manufactured Object]
   726   C0455052:Preparation [Health Care Activity]
   726   C1521827:Preparation [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "obtained from small intestine epithelial cells."
Meta Candidates (Total=19; Excluded=6; Pruned=0; Remaining=13)
   790   C0014597:Epithelial Cells [Cell]
   790   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
   790   C1268998:Small intestine [Body Part, Organ, or Organ Component]
   790   C1273342:Epithelial Cells [Laboratory Procedure]
   790   C1519375:SMALL INTESTINE [Tissue]
   753   C0007634:Cells [Cell]
   753   C0021853:Intestine [Body Part, Organ, or Organ Component]
   753   C0221908:Epithelial [Qualitative Concept]
   753   C0700321:Small [Quantitative Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1708548:INTESTINE [Tissue]
   753   C3282337:Cells [Cell]
   734 E C1304890:Enteral [Spatial Concept]
   734 E C1522196:Enteral [Functional Concept]
   731   C0814997:Intestinal cell [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1706701:Obtain [Activity]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.129: Membrane proteins from rat cortical kidney were used as positive control in this context as well. 

Phrase: "Membrane proteins from rat cortical kidney"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0025255:Membrane [Tissue]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   701   C0746835:Membranous nephritis NOS [Disease or Syndrome]

Phrase: "were"

Phrase: "used as positive control"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   833   C1883676:Positive Control [Conceptual Entity]
   770   C0243148:control [Qualitative Concept]
   770   C0439178:% Positive [Quantitative Concept]
   770   C1273517:used [Finding]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C2825490:Positive [Qualitative Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "in this context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "as well."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]
Processing 00000000.tx.130: A signal at the expected molecular weight was obtained with two different antibodies that recognize overlapping epitopes, i.e. anti-NCC2112 (22) (Fig. 3, a and b), and anti-NCC198 (23) (Fig. 3, c and d). 

Phrase: "A signal at the expected molecular weight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "obtained with two different antibodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0205448:Two [Quantitative Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C1705242:Different [Qualitative Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726 E C1706701:Obtain [Activity]

Phrase: "that"

Phrase: "recognize"

Phrase: "overlapping epitopes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitopes [Immunologic Factor]

Phrase: "i.e. anti-NCC2112"

Phrase: "(22"

Phrase: ")"

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: "and"

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "anti-NCC198"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "c"

Phrase: "and"

Phrase: "d)."
Processing 00000000.tx.131: Using both antibodies the characteristic broad band (from 130 to 180 kDa) of NCC could be observed in the kidney preparation (Fig. 3, a and c). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "the characteristic broad band"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0175723:Band [Medical Device]
   827   C0332464:Broad [Spatial Concept]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "("

Phrase: "from 130"

Phrase: "to 180 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "of NCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420092:Na-Cl Cotransporter [Gene or Genome]
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "observed in the kidney preparation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0022646:Kidney [Body Part, Organ, or Organ Component]
   760   C0227665:kidney [Body Part, Organ, or Organ Component]
   760   C0455052:Preparation [Health Care Activity]
   760   C1278978:Kidney [Body Part, Organ, or Organ Component]
   760   C1441672:Observed [Functional Concept]
   760   C1514845:KIDNEY [Tissue]
   760   C1521827:Preparation [Functional Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: "and"

Phrase: "c)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.132: The same antibodies were able to detect a band at about 140 kDa in intestine protein preparations (Fig. 3, ac). 

Phrase: "The same antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a band at about 140 kDa"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0230715:A band [Cell Component]
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]

Phrase: "in intestine protein preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "ac"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.133: In accordance with the RT-PCR data, the NCC protein was seen both in the ileum and jejunum (Fig. 3a). 

Phrase: "In accordance with the RT-PCR data,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: "the NCC protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420092:Na-Cl Cotransporter [Gene or Genome]

Phrase: "was"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "both in the ileum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0020885:ileum [Body Part, Organ, or Organ Component]
   770   C0238767:Both [Spatial Concept]
   770   C1278923:Ileum [Body Part, Organ, or Organ Component]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "jejunum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022378:Jejunum [Body Part, Organ, or Organ Component]
  1000   C1278922:Jejunum [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 3a"

Phrase: ")."
Processing 00000000.tx.134: Because the kidney NCC is extensively glycosylated (27, 28), we tested if the same applies to the intestinal isoform. 

Phrase: "Because"

Phrase: "the kidney NCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1420092:Na-Cl Cotransporter [Gene or Genome]
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "is"

Phrase: "extensively"

Phrase: "glycosylated"

Phrase: "(27,"

Phrase: "28"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "if"

Phrase: "the same"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]

Phrase: "applies to the intestinal isoform."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0021853:Intestinal [Body Part, Organ, or Organ Component]
   760   C0185125:Apply [Health Care Activity]
   760   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   760   C1632850:Apply [Functional Concept]
   760   C1879355:Apply [Functional Concept]
Processing 00000000.tx.135: Western blot experiments were performed on untreated or F-glycosidase-treated intestinal membrane protein preparations (Fig. 3b). 

Phrase: "Western blot experiments"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   734   C0949466:Western Blot [Laboratory Procedure]

Phrase: "were"

Phrase: "performed on untreated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332155:untreated [Finding]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "or"

Phrase: "F-glycosidase-treated intestinal membrane protein preparations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0455052:Preparation [Health Care Activity]
   762   C1521827:Preparation [Functional Concept]
   710   C2945724:f-protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 3b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.136: The NCC signal was shifted from 140 to 110 kDa after F-glycosidase treatment, indicating that intestinal NCC is a glycosylated protein and the size of the molecular mass of the core protein is identical to that of the kidney isoform (27, 28) i.e. 

Phrase: "The NCC signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1710082:Signal [Phenomenon or Process]
   734   C1420092:Na-Cl Cotransporter [Gene or Genome]

Phrase: "was"

Phrase: "shifted from 140"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0333051:shifted [Functional Concept]
   756 E C2347509:Shift [Phenomenon or Process]

Phrase: "to 110 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "after F-glycosidase treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "indicating"

Phrase: "that intestinal NCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1420092:Na-Cl Cotransporter [Gene or Genome]
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "is"

Phrase: "a glycosylated protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "the size of the molecular mass of the core protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   777   C0424860:Size of mass [Finding]
   757   C0596969:molecular size [Quantitative Concept]
   739   C0456389:size [Spatial Concept]

Phrase: "is"

Phrase: "identical to that of the kidney isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205280:Identical [Qualitative Concept]

Phrase: "(27,"

Phrase: "28"

Phrase: ")"

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.137: 110 kDa. 

Phrase: "110 kDa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.138: View larger version (46K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(46K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.139: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.140: Northern blot experiment performed on small intestine RNA. 

Phrase: "Northern blot experiment"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0681814:Experiment [Research Activity]
   827   C1706386:Experiment [Conceptual Entity]
   755 E C1517586:Experimental [Qualitative Concept]
   734   C0005861:Northern Blot [Molecular Biology Research Technique]
   734   C1621557:Northern Blot [Research Device]

Phrase: "performed on small intestine RNA."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
   806   C1268998:Small intestine [Body Part, Organ, or Organ Component]
   806   C1519375:SMALL INTESTINE [Tissue]
   760   C0021853:Intestine [Body Part, Organ, or Organ Component]
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0700321:Small [Quantitative Concept]
   760   C0884358:Performed [Functional Concept]
   760   C1708548:INTESTINE [Tissue]
   751 E C1304890:Enteral [Spatial Concept]
   751 E C1522196:Enteral [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.141: Rat intestinal poly(A)RNA was probed with a 32P-labeled cRNA. 

Phrase: "Rat intestinal poly(A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   812   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "probed with a 32P-labeled cRNA."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0056208:cRNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1321571:CRNA [Professional or Occupational Group]
   753   C1553631:32p [Medical Device]
   753   C1708632:Labeled [Qualitative Concept]
   719 E C0181496:Label [Manufactured Object]
   719   C0182400:Probe [Medical Device]
   719   C1704681:Probe [Gene or Genome]
   719   C2347609:Probe [Chemical Viewed Functionally]
   719 E C2827499:Label [Governmental or Regulatory Activity]
   719   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.142: Rat kidney total RNA was used as a positive control. 

Phrase: "Rat kidney total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "used as a positive control."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C1883676:Positive Control [Conceptual Entity]
   760   C0243148:control [Qualitative Concept]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1273517:used [Finding]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825490:Positive [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.143: Two autoradiography exposure times (24 h and 1 week) are shown for the intestine.  

Phrase: "Two autoradiography exposure times"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   902   C1948050:Two Times [Quantitative Concept]
   827   C2348485:Exposure Time [Quantitative Concept]
   812   C0040223:times [Temporal Concept]
   812   C0274281:Exposure, NOS [Injury or Poisoning]
   812   C0332157:Exposure [Clinical Attribute]
   812   C1632851:Times [Quantitative Concept]
   779 E C3541383:Time [Temporal Concept]
   741 E C0442043:Temporal [Spatial Concept]
   741 E C2362314:Temporal [Temporal Concept]

Phrase: "(24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "1 week"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442452:1 Week [Temporal Concept]
   861   C0332174:/week [Temporal Concept]
   861   C0439230:week [Temporal Concept]

Phrase: ")"

Phrase: "are"

Phrase: "shown for the intestine."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0021853:Intestine [Body Part, Organ, or Organ Component]
   770   C1708548:INTESTINE [Tissue]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.144: View larger version (56K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(56K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.145: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.146: Western blot experiments performed with anti-rNCC-antibodies. a, Western blot (anti-NCC2112 antibody) of membrane protein preparations from rat kidney (positive control), jejunum, and ileum. b, Western blot (anti-NCC2112 antibody) of F-glycosidase-treated small intestine or kidney protein preparations (+ glyc F). 

Phrase: "Western blot experiments"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   734   C0949466:Western Blot [Laboratory Procedure]

Phrase: "performed with anti-rNCC-antibodies."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   781 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0884358:Performed [Functional Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a,"

Phrase: "Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "(anti-NCC2112 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "of membrane protein preparations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]
   734   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from rat kidney"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   861   C0022646:Kidney [Body Part, Organ, or Organ Component]
   861   C0227665:kidney [Body Part, Organ, or Organ Component]
   861   C1278978:Kidney [Body Part, Organ, or Organ Component]
   861   C1514845:KIDNEY [Tissue]
   768 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "(positive control"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1883676:Positive Control [Conceptual Entity]
   861   C0243148:control [Qualitative Concept]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825490:Positive [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "jejunum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022378:Jejunum [Body Part, Organ, or Organ Component]
  1000   C1278922:Jejunum [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ileum. b,"

Phrase: "Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "(anti-NCC2112 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "of F-glycosidase-treated small intestine"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   840   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
   840   C1268998:Small intestine [Body Part, Organ, or Organ Component]
   840   C1519375:SMALL INTESTINE [Tissue]
   804   C0021853:Intestine [Body Part, Organ, or Organ Component]
   804   C0700321:Small [Quantitative Concept]
   804   C1708548:INTESTINE [Tissue]
   784 E C1304890:Enteral [Spatial Concept]
   784 E C1522196:Enteral [Functional Concept]

Phrase: "or"

Phrase: "kidney protein preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]

Phrase: "(+ glyc F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.147: Negative control was performed without including the F-glycosidase ( glyc F) in the deglycosylation procedure. c, Western blot of membrane protein preparations from rat kidney (positive control) and small intestine performed with the anti-rNCC198 antibody. d, Western blot of intestinal brush border (BBM) and basolateral (BLM) membrane protein preparations (anti-rNCC198 antibody).  

Phrase: "Negative control"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "performed without"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0884358:Performed [Functional Concept]
   799 E C2947996:Perform [Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the F-glycosidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017976:Glycosidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "( glyc F) in the deglycosylation procedure. c,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   748   C0439133:(f) [Intellectual Product]
   748   C1553038:[f] [Quantitative Concept]

Phrase: "Western blot of membrane protein preparations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0949466:Western Blot [Laboratory Procedure]
   753   C1705493:Western [Spatial Concept]

Phrase: "from rat kidney"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   861   C0022646:Kidney [Body Part, Organ, or Organ Component]
   861   C0227665:kidney [Body Part, Organ, or Organ Component]
   861   C1278978:Kidney [Body Part, Organ, or Organ Component]
   861   C1514845:KIDNEY [Tissue]
   768 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "(positive control"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1883676:Positive Control [Conceptual Entity]
   861   C0243148:control [Qualitative Concept]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825490:Positive [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "small intestine"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
  1000   C1268998:Small intestine [Body Part, Organ, or Organ Component]
  1000   C1519375:SMALL INTESTINE [Tissue]
   944 E C1304890:Enteral [Spatial Concept]
   944 E C1522196:Enteral [Functional Concept]
   861   C0021853:Intestine [Body Part, Organ, or Organ Component]
   861   C0700321:Small [Quantitative Concept]
   861   C1708548:INTESTINE [Tissue]

Phrase: "performed with the anti-rNCC198 antibody. d,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   800   C0140430:anti-d antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti D
   778   C0369095:antibody d [Immunologic Factor]
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0884358:Performed [Functional Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "Western blot of intestinal brush border"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0949466:Western Blot [Laboratory Procedure]
   753   C1705493:Western [Spatial Concept]

Phrase: "(BBM)"

Phrase: "and"

Phrase: "basolateral"

Phrase: "(BLM) membrane protein preparations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0455052:Preparation [Health Care Activity]
   779   C1521827:Preparation [Functional Concept]
   708   C0384701:BLM protein [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(anti-rNCC198 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.148: Localization of the Intestinal NCC CotransporterTo investigate the cellular localization of the NCC protein, Western blot experiments were performed on brush border membrane and basolateral membrane protein preparations of isolated enterocytes, using anti-NCC198 antiserum. 

Phrase: "Localization of the Intestinal NCC CotransporterTo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the cellular localization of the NCC protein,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   789   C2612729:cellular protein localisation [Cell Function]
   770   C1660642:cellular localisation [Cell Function]
   767   C0597704:protein localisation [Cell Function]
   767   C1159772:Protein Localization [Cell Function]
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]

Phrase: "Western blot experiments"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   734   C0949466:Western Blot [Laboratory Procedure]

Phrase: "were"

Phrase: "performed on brush border membrane"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   862   C0178523:brush border membrane [Cell Component]
   806   C1318418:Brush Border [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0179445:Brush [Manufactured Object]
   760   C0205284:Border [Spatial Concept]
   760   C0596901:Membrane [Cell Component]
   760   C0884358:Performed [Functional Concept]
   760   C1522411:Border [Body Location or Region]
   760   C1706090:Brush [Manufactured Object]
   760   C1706182:Membrane [Manufactured Object]
   760   C2828371:Border [Classification]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "basolateral membrane protein preparations of isolated enterocytes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0455052:Preparation [Health Care Activity]
   714   C1521827:Preparation [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-NCC198 antiserum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.149: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.150: 3d, a signal was only detected in brush border membranes, suggesting an apical localization of the transporter. 

Phrase: "3d,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450363:3D [Spatial Concept]
  1000   C2986797:3D [Functional Concept]

Phrase: "a signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "detected in brush border membranes,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   828   C0178523:brush border membrane [Cell Component]
   806   C1318418:Brush Border [Cell Component]
   760   C0025255:Membranes [Tissue]
   760   C0179445:Brush [Manufactured Object]
   760   C0205284:Border [Spatial Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1522411:Border [Body Location or Region]
   760   C1706090:Brush [Manufactured Object]
   760   C2828371:Border [Classification]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "an apical localization of the transporter."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]
Processing 00000000.tx.151: Immunohistochemistry experiments confirmed that the transporter is indeed specifically localized on the apical membrane of enterocytes (Fig. 4). 

Phrase: "Immunohistochemistry experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the transporter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "indeed specifically"

Phrase: "localized on the apical membrane of enterocytes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0596119:apical membrane [Cell Component]
   748   C0025255:Membrane [Tissue]
   748   C0205111:Apical [Spatial Concept]
   748   C0392752:Localized [Spatial Concept]
   748   C0596901:Membrane [Cell Component]
   748   C0682610:Enterocytes [Cell]
   748   C1706182:Membrane [Manufactured Object]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.152: In all sections of the jejunum, a signal was detected in the apical membrane of the epithelial cells lining the villi (Fig. 4, ac), whereas only a faint signal was observed in the cryptal cells (Fig. 4a). 

Phrase: "In all sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "of the jejunum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022378:Jejunum [Body Part, Organ, or Organ Component]
  1000   C1278922:Jejunum [Body Part, Organ, or Organ Component]

Phrase: "a signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "detected in the apical membrane of the epithelial cells"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   764   C0014597:Epithelial Cells [Cell]
   764   C0596119:apical membrane [Cell Component]
   764   C1273342:Epithelial Cells [Laboratory Procedure]
   762   C0007603:cells membrane [Cell Component]
   745 E C3161472:Cell Membrane [Cell Component]
   742   C0007634:Cells [Cell]
   742   C0025255:Membrane [Tissue]
   742   C0205111:Apical [Spatial Concept]
   742   C0221908:Epithelial [Qualitative Concept]
   742   C0442726:Detected [Finding]
   742   C0596901:Membrane [Cell Component]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   742   C1706182:Membrane [Manufactured Object]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "lining"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lining [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "the villi"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0227266:Villus [Body Part, Organ, or Organ Component]
   966   C1519988:Villus [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "ac"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a faint signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "observed in the cryptal cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   762   C0677646:cells crypt [Cell]
   760   C0007634:Cells [Cell]
   760   C1441672:Observed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.153: As expected, in the kidney the NCC protein could only be verified on the apical membrane of distal tubular segments (Fig. 4d). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "in the kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "the NCC protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420092:Na-Cl Cotransporter [Gene or Genome]

Phrase: "could"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "be"

Phrase: "verified on the apical membrane of distal tubular segments"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0596119:apical membrane [Cell Component]
   742   C0025255:Membrane [Tissue]
   742   C0205108:Distal [Spatial Concept]
   742   C0205111:Apical [Spatial Concept]
   742   C0332208:Tubular [Spatial Concept]
   742   C0596901:Membrane [Cell Component]
   742   C1706182:Membrane [Manufactured Object]
   742   C1711411:Verified [Functional Concept]
   708   C0441635:Segment [Spatial Concept]

Phrase: "(Fig. 4d"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.154: View larger version (164K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(164K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.155: 4. 

Phrase: "4."
Processing 00000000.tx.156: Immunohistochemical localization of NCC in sections of rat small intestine (a c) and kidney (d). 

Phrase: "Immunohistochemical localization of NCC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "in sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "of rat small intestine"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1882857:Rat Small Intestine [Body Part, Organ, or Organ Component]
   901   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
   901   C1268998:Small intestine [Body Part, Organ, or Organ Component]
   901   C1519375:SMALL INTESTINE [Tissue]
   845 E C1304890:Enteral [Spatial Concept]
   845 E C1522196:Enteral [Functional Concept]
   827   C0021853:Intestine [Body Part, Organ, or Organ Component]
   827   C0700321:Small [Quantitative Concept]
   827   C1708548:INTESTINE [Tissue]

Phrase: "(a c)"

Phrase: "and"

Phrase: "kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "("

Phrase: "d)."
Processing 00000000.tx.157: NCC immunoreactivity is selectively localized on the apical membrane (arrows) of intestinal epithelial cells (epi), located at the tip of the villi (ac) and of distal tubular segments in the kidney (d); 

Phrase: "NCC immunoreactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597879:immunoreactivity [Molecular Function]
   734   C1420092:Na-Cl Cotransporter [Gene or Genome]

Phrase: "is"

Phrase: "selectively"

Phrase: "localized on the apical membrane"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0596119:apical membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0205111:Apical [Spatial Concept]
   760   C0392752:Localized [Spatial Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "of intestinal epithelial cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   901   C0014597:Epithelial Cells [Cell]
   901   C1273342:Epithelial Cells [Laboratory Procedure]
   896   C0814997:Intestinal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0021853:Intestinal [Body Part, Organ, or Organ Component]
   827   C0221908:Epithelial [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C1708548:INTESTINE [Tissue]

Phrase: "(epi"

Phrase: ")"

Phrase: ","

Phrase: "located at the tip of the villi"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C2827057:Villus Tip [Body Part, Organ, or Organ Component]
   748   C1710425:Tip [Medical Device]
   748   C3282898:Tip [Qualitative Concept]
   714   C0227266:Villus [Body Part, Organ, or Organ Component]
   714   C1519988:Villus [Body Part, Organ, or Organ Component]

Phrase: "(ac)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: "and of distal tubular segments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205108:Distal [Spatial Concept]
   760   C0332208:Tubular [Spatial Concept]
   760   C1515981:And [Idea or Concept]
   726   C0441635:Segment [Spatial Concept]

Phrase: "in the kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "("

Phrase: "d)"

Phrase: ";"
Processing 00000000.tx.158: glo, unlabeled glomeruli. 

Phrase: "glo,"

Phrase: "unlabeled glomeruli."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0022663:Glomerulus [Body Part, Organ, or Organ Component]
   777 E C0268731:GLOMERULAR [Disease or Syndrome]
Processing 00000000.tx.159: Original magnifications: a = 370x; 

Phrase: "Original magnifications"

Phrase: ":"

Phrase: "a = 370x"

Phrase: ";"
Processing 00000000.tx.160: b and c = 640x; 

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "c = 640x"

Phrase: ";"
Processing 00000000.tx.161: d = 270x.  

Phrase: "d ="

Phrase: "270x."
Processing 00000000.tx.162: Functional Characterization of the Intestinal Thiazide-sensitive NaCl-Cotransporter Activity Effect of HCTZ in the Rat JejunumTo investigate the functional role of the intestinal NCC, we performed short-circuit current experiments using an Ussing-chamber. 

Phrase: "Functional Characterization of the Intestinal Thiazide-sensitive NaCl-Cotransporter Activity Effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1880022:Characterization [Activity]

Phrase: "of HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "in the Rat JejunumTo"

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the functional role of the intestinal NCC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1705810:Functional Role [Conceptual Entity]
           Role
   744   C0035820:Role [Social Behavior]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "short-circuit current experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Ussing-chamber."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0935616:Chamber [Body Part, Organ, or Organ Component]
Processing 00000000.tx.163: To minimize the activity of both, the Na+/H,+ as well as the Cl/HCO3 exchanger, the bath solutions used for the experiment did not contain bicarbonate and were bubbled with 100% O2. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "the activity of both,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "the Na+/H,+"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "as well as"

Phrase: "the Cl/HCO3 exchanger,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0106269:Cl- HCO3- Exchanger [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1621574:exchanger [Molecular Function]

Phrase: "the bath solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037633:Solutions [Substance]
   827 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "used for the experiment"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0681814:Experiment [Research Activity]
   770   C1273517:used [Finding]
   770   C1706386:Experiment [Conceptual Entity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "bicarbonate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
  1000   C0973231:Bicarbonate [Inorganic Chemical]
  1000   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "were"

Phrase: "bubbled with 100% O2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.164: A representative trace of the time course of the Vms in the absence of HCTZ is shown in Fig. 

Phrase: "A representative trace of the time course of the Vms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0442822:Trace [Quantitative Concept]
   739   C1524031:Trace [Qualitative Concept]
   739   C1883002:Trace [Functional Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.165: 5a. 

Phrase: "5a."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553637:5a [Medical Device]
Processing 00000000.tx.166: Vms decreased exponentially over time, reflecting the expected time-dependent reduction of tissue vitality. 

Phrase: "Vms"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "exponentially over time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040223:Time [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "the expected time-dependent reduction of tissue vitality."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.167: Changing repeatedly the mucosal solution with a solution of the same composition did not cause any alteration of Vms (Fig. 5a). 

Phrase: "Changing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changing [Functional Concept]
  1000   C0443172:changing [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "repeatedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205341:Repeatedly [Functional Concept]

Phrase: "the mucosal solution with a solution of the same composition"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "any alteration of Vms (Fig. 5a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515926:Alteration [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.168: In contrast, the presence of 1 mM HCTZ in the mucosal solution caused a reversible and statistically significant depolarization of Vms (Fig. 5, b and c). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the presence of 1 mM HCTZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the mucosal solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a reversible"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205343:Reversible [Functional Concept]
   928 E C0449261:Reversibility [Temporal Concept]

Phrase: "and"

Phrase: "statistically significant depolarization of Vms (Fig. 5,"

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "c)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.169: The concentration of 1 mM HCTZ was chosen according to dose-response curves reported for experiments in intact epithelia (29, 30). 

Phrase: "The concentration of 1 mM HCTZ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "chosen according to dose-response curves"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   799   C0683162:dose-response curve [Quantitative Concept]
   753   C0178602:Dose [Quantitative Concept]
   753   C0680240:according [Social Behavior]
   753   C0869039:Dose [Quantitative Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C1707391:Chosen [Activity]
   753   C2911692:Response [Mental Process]
   719   C0205134:Curve [Spatial Concept]

Phrase: "reported for experiments"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0681814:Experiments [Research Activity]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C1706386:Experiment [Conceptual Entity]
   756 E C3273238:Report [Intellectual Product]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "in intact epithelia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014609:Epithelium [Tissue]
   777 E C0221908:Epithelial [Qualitative Concept]

Phrase: "(29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.170: A possible nonspecific effect of HCTZ is the inhibition of carbonic anhydrase (31). 

Phrase: "A possible nonspecific effect of HCTZ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "the inhibition of carbonic anhydrase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.171: Such an effect was ruled out in our experiments, because we used bicarbonate-free solutions (see above) and, in addition, acetazolamide, a known blocker for the carbonic anhydrase, does not change Vms (0.43  1.61%, n = 9). 

Phrase: "Such"

Phrase: "an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "ruled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruled [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out in our experiments,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439787:Out [Spatial Concept]
   770   C0681814:Experiments [Research Activity]
   770   C0849355:Out [Qualitative Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "because"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "bicarbonate-free solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037633:Solutions [Substance]
   793 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: ","

Phrase: "in addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "acetazolamide,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0000981:Acetazolamide [Organic Chemical,Pharmacologic Substance]
   944 E C0591362:Diamox [Organic Chemical,Pharmacologic Substance]

Phrase: "a known blocker for the carbonic anhydrase,"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "Vms (0.43  1.61%,"

Phrase: "n = 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.172: The HCTZ-induced depolarization of Vms could only be observed if the drug was added to the mucosal side, whereas the addition of the drug to the serosal side had no effects on Vms (data not shown), consistent with an apical localization of the cotransporter. 

Phrase: "The HCTZ-induced depolarization of Vms"

Phrase: "could"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "if"

Phrase: "the drug"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0013227:Drug [Pharmacologic Substance]
  1000   C1254351:Drug [Pharmacologic Substance]
   944 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   944 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   907 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "was"

Phrase: "added to the mucosal side,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0026724:Mucosal [Tissue]
   760   C0441987:Side [Spatial Concept]
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "whereas"

Phrase: "the addition of the drug"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "to the serosal side"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441987:Side [Spatial Concept]

Phrase: "had"

Phrase: "no effects on Vms (data"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1301751:No effect [Qualitative Concept]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "consistent with an apical localization of the cotransporter."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.173: Given that the NCC cotransporter is electroneutral, the observed rapid and immediate depolarization cannot be attributed to the inhibition of the NCC cotransporter itself. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that"

Phrase: "the NCC cotransporter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1420092:Na-Cl Cotransporter [Gene or Genome]

Phrase: "is"

Phrase: "electroneutral,"

Phrase: "the observed rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "immediate depolarization"

Phrase: "cannot"

Phrase: "be"

Phrase: "attributed to the inhibition of the NCC cotransporter"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C1420092:Na-Cl Cotransporter [Gene or Genome]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C1959973:% NaCl [Quantitative Concept]
   742   C3463820:Inhibition [Activity]
   708   C0449234:Attribute [Idea or Concept]
   708   C1704772:Attribute [Conceptual Entity]
   708   C1882133:Attribute [Qualitative Concept]

Phrase: "itself."
Processing 00000000.tx.174: In analogy to what has been proposed for the kidney distal convoluted tubule (DCT) (7, 8), we propose that HCTZ hyperpolarizes the apical membrane, thus causing an overall decrease of the transepithelial potential (Vms = Vm  Vs; Vs is normally greater than Vm) by reducing the driving force for chloride to exit the cell through a chloride conductance (7, 32). 

Phrase: "In analogy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0679213:analogy [Idea or Concept]
   900 E C0243071:Analog [Chemical Viewed Structurally]

Phrase: "to what"

Phrase: "has"

Phrase: "been"

Phrase: "proposed for the kidney distal convoluted tubule (DCT)"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   817   C0022676:Distal convoluted renal tubule [Body Part, Organ, or Organ Component]
           Distal convoluted tubule
           Distal Kidney Tubule
   817   C1283881:Distal convoluted renal tubule [Body Part, Organ, or Organ Component]
   781   C0227652:Convoluted renal tubule [Body Part, Organ, or Organ Component]
   781   C1283879:Convoluted renal tubule [Body Part, Organ, or Organ Component]
   778   C1707510:Convoluted Tubule [Tissue]
   774   C0022674:Tubule, Kidney [Body Part, Organ, or Organ Component]
   748   C0022646:Kidney [Body Part, Organ, or Organ Component]
   748   C0205108:Distal [Spatial Concept]
   748   C0205401:Convoluted [Qualitative Concept]
   748   C0227665:kidney [Body Part, Organ, or Organ Component]
   748   C1278978:Kidney [Body Part, Organ, or Organ Component]
   748   C1441414:PROPOSED [Idea or Concept]
   748   C1514845:KIDNEY [Tissue]
   748   C1553874:Proposed [Qualitative Concept]
   748   C1578820:Proposed [Idea or Concept]
   748   C1880179:Convoluted [Spatial Concept]
   746 E C1283878:Renal tubule [Body Part, Organ, or Organ Component]

Phrase: "(7,"

Phrase: "8"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "propose"

Phrase: "that HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "hyperpolarizes"

Phrase: "the apical membrane,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0596119:apical membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "thus"

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "an overall decrease of the transepithelial potential"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "(Vms = Vm"

Phrase: "Vs"

Phrase: ";"

Phrase: "Vs"

Phrase: "is"

Phrase: "normally greater than Vm)"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0439093:Greater Than [Quantitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "by reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the driving force for chloride to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441722:Force [Phenomenon or Process]
   753   C0563538:Force [Phenomenon or Process]

Phrase: "exit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337094:Exit [Spatial Concept]
  1000   C1550550:exit [Temporal Concept]

Phrase: "the cell through a chloride conductance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0007634:THE CELL [Cell]
           Cell
   783   C0678840:cell conductance [Cell Function]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "(7,"

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.175: According to this hypothesis, the inhibition of chloride channels in the absence of HCTZ should also lead to a depolarization of Vms by blocking the depolarizing resting chloride current. 

Phrase: "According to this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "the inhibition of chloride"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "channels in the absence of HCTZ"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   753   C0332197:absence [Quantitative Concept]
   753   C0439799:Channel [Spatial Concept]
   753   C1689985:Absence [Anatomical Abnormality]
   753   C1706095:Channel [Conceptual Entity]

Phrase: "should"

Phrase: "also"

Phrase: "lead to a depolarization of Vms"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "by blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the depolarizing resting chloride current."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0008203:Chloride, NOS [Inorganic Chemical]
   812   C0521116:Current [Temporal Concept]
   812   C0596019:Chloride [Element, Ion, or Isotope]
   812   C1705970:Current [Natural Phenomenon or Process]
Processing 00000000.tx.176: We indeed measured a depolarization of Vms by 7.4  1.7% (n = 9) after the addition of 50 M NPPB, a known blocker of epithelial chloride channels, to the mucosal side of the epithelium. 

Phrase: "We indeed"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "a depolarization of Vms"

Phrase: "by 7.4  1.7%"

Phrase: "(n = 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "after the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 50 M NPPB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0049330:NPPB [Organic Chemical,Pharmacologic Substance]
   827   C1417808:NPPB [Gene or Genome]

Phrase: "a known blocker of epithelial chloride channels,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   757   C0870261:channel blocker [Pharmacologic Substance]

Phrase: "to the mucosal side"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441987:Side [Spatial Concept]

Phrase: "of the epithelium."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014609:Epithelium [Tissue]
   928 E C0221908:Epithelial [Qualitative Concept]
Processing 00000000.tx.177: Accordingly, the addition of HCTZ in the presence of NPPB did not further depolarize Vms (6.3  0.7%; n = 9; this value is not statistically different from the 7.4  1.7%, mentioned above). 

Phrase: "Accordingly,"

Phrase: "the addition of HCTZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of NPPB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0049330:NPPB [Organic Chemical,Pharmacologic Substance]
  1000   C1417808:NPPB [Gene or Genome]

Phrase: "did"

Phrase: "not further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1518422:Not [Functional Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "depolarize"

Phrase: "Vms (6.3  0.7%"

Phrase: "; n = 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"

Phrase: "this value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "is"

Phrase: "not statistically different from the 7.4  1.7%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1705242:Different [Qualitative Concept]

Phrase: "mentioned"

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.178: View larger version (54K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(54K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.179: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.180: Short-circuit experiments performed on excised intestine. a and b, original tracings obtained in short-circuit experiments showing the time course of the transepithelial electric potential (Vms). 

Phrase: "Short-circuit experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C2984839:SHORT CIRCUIT [Functional Concept]

Phrase: "performed on excised intestine."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021853:Intestine [Body Part, Organ, or Organ Component]
   770   C0884358:Performed [Functional Concept]
   770   C1708548:INTESTINE [Tissue]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a"

Phrase: "and"

Phrase: "b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "original tracings"

Phrase: "obtained in short-circuit experiments"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C2984839:SHORT CIRCUIT [Functional Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1282927:short [Qualitative Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C1806781:Short [Quantitative Concept]
   760   C2350002:Short [Quantitative Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1706701:Obtain [Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the time course of the transepithelial electric potential"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0449247:Time course [Temporal Concept]
   744   C0040223:Time [Temporal Concept]
   744   C0750729:Course [Temporal Concept]
   744   C3541383:Time [Temporal Concept]

Phrase: "(Vms"

Phrase: ")."
Processing 00000000.tx.181: The upper trace corresponds to an experiment performed under control conditions; 

Phrase: "The upper trace"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0442822:Trace [Quantitative Concept]
   861   C1524031:Trace [Qualitative Concept]
   861   C1883002:Trace [Functional Concept]

Phrase: "corresponds to an experiment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0681814:Experiment [Research Activity]
   770   C1706386:Experiment [Conceptual Entity]

Phrase: "performed under control conditions"
Meta Candidates (Total=15; Excluded=6; Pruned=0; Remaining=9)
   770   C0243148:control [Qualitative Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
   737 E C2947996:Perform [Pharmacologic Substance]
   715 E C0040607:Training [Educational Activity]
   715 E C0220931:Training [Educational Activity]
   715 E C0336809:Train [Manufactured Object]
   715 E C1552514:Train [Manufactured Object]
   715 E C2673163:training [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.182: the arrows indicate the substitution of the mucosal solution with an identical solution. 

Phrase: "the arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "the substitution of the mucosal solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1555721:Substitution [Idea or Concept]
   753   C1706204:Substitution [Activity]

Phrase: "with an identical solution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.183: In the lower trace, three treatment periods (10 min each) with 1 mM HCTZ are shown. 

Phrase: "In the lower trace,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0442822:Trace [Quantitative Concept]
   861   C1524031:Trace [Qualitative Concept]
   861   C1883002:Trace [Functional Concept]

Phrase: "three treatment periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   793   C0439531:/period [Temporal Concept]
   793   C1948053:Period [Temporal Concept]
   743 E C0332182:Periodic [Temporal Concept]
   743 E C1706381:PERIODIC [Intellectual Product]
   721 E C0031084:Periodicities [Temporal Concept]

Phrase: "(10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "each"

Phrase: ")"

Phrase: "with 1 mM HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   771 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   771 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   771 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.184: "C" (control) or "HCTZ" indicate the substitution of the mucosal solution with an identical one or with the solution containing HCTZ. 

Phrase: """C"" (control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "or ""HCTZ"""
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   805 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   805 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   805 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "indicate"

Phrase: "the substitution of the mucosal solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1555721:Substitution [Idea or Concept]
   753   C1706204:Substitution [Activity]

Phrase: "with an identical one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "or with the solution containing HCTZ."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   753   C0037633:Solution [Substance]
   753   C0332256:Containing [Functional Concept]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C2700400:Containing [Activity]
Processing 00000000.tx.185: c, summary of the HCTZ-induced depolarization (12.0  2.4%, n = 56), the depolarization induced by NPPB (7.4  1.7%, n = 9), and the effect of HCTZ in the presence of NPPB (6.3  0.7%, n = 9). 

Phrase: "c,"

Phrase: "summary of the HCTZ-induced depolarization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1552616:summary [Intellectual Product]
   753   C1706244:Summary [Intellectual Product]

Phrase: "(12.0  2.4%,"

Phrase: "n = 56"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the depolarization"

Phrase: "induced by NPPB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0049330:NPPB [Organic Chemical,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]
   790   C1417808:NPPB [Gene or Genome]

Phrase: "(7.4  1.7%,"

Phrase: "n = 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the effect of HCTZ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of NPPB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0049330:NPPB [Organic Chemical,Pharmacologic Substance]
  1000   C1417808:NPPB [Gene or Genome]

Phrase: "(6.3  0.7%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1630409:6/3 [Finding]

Phrase: "n = 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.186: In the presence of NPPB, HCTZ is not able to further depolarize Vms.  

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of NPPB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0049330:NPPB [Organic Chemical,Pharmacologic Substance]
  1000   C1417808:NPPB [Gene or Genome]

Phrase: "HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "not able to further"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0085732:Able [Organism Attribute]
   812   C1299581:Able [Finding]
   812   C1517331:Further [Spatial Concept]
   812   C1518422:Not [Functional Concept]
   779 E C0205108:far [Spatial Concept]

Phrase: "depolarize"

Phrase: "Vms."
Processing 00000000.tx.187: Effect of HCTZ on Intestinal HT-29 Human Cell Lines NCC and ECaC Expression in HT-29 CellsPrior to performing functional tests on HT-29 cells we tested whether or not NCC and ECaC are expressed in those cells. 

Phrase: "Effect of HCTZ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on Intestinal HT-29 Human Cell Lines NCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1420092:Na-Cl Cotransporter [Gene or Genome]
   793   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   793   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "ECaC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "Expression in HT-29 CellsPrior"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "to performing functional tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022885:Tests [Laboratory Procedure]
   827   C0392366:Tests [Intellectual Product]
   793 E C0039593:Test [Functional Concept]

Phrase: "on HT-29 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0282639:HT-29 Cells [Cell]
           HT-29
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "or"

Phrase: "not NCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1420092:Na-Cl Cotransporter [Gene or Genome]
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "are"

Phrase: "expressed in those cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.188: Using RT-PCR (Fig. 6a), we identified the NCC cotransporter and the epithelial Ca2+ channel ECaC in the human intestinal cell line HT-29. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RT-PCR (Fig. 6a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553638:6a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "the NCC cotransporter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1420092:Na-Cl Cotransporter [Gene or Genome]

Phrase: "and"

Phrase: "the epithelial Ca2+ channel ECaC"

Phrase: "in the human intestinal cell line"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0682523:Human Cell Line [Cell]
   875   C0427861:human cell [Laboratory or Test Result]
   861   C0007600:Cell Line [Cell]
   861   C0814997:Intestinal cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "HT-29."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282639:HT-29 [Cell]
   861   C0018510:HT [Geographic Area]
   861   C0677607:HT [Disease or Syndrome]
Processing 00000000.tx.189: Using the anti-NCC198 antibody, the presence of NCC in HT-29 cells was also confirmed by Western blot (Fig. 6b) and immunofluorescence (Fig. 7). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the anti-NCC198 antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "the presence of NCC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in HT-29 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0282639:HT-29 Cells [Cell]
           HT-29
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "also"

Phrase: "confirmed by Western blot"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1705493:Western [Spatial Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "(Fig. 6b"

Phrase: ")"

Phrase: "and"

Phrase: "immunofluorescence"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0016318:Immunofluorescence [Laboratory Procedure]
  1000   C0079603:Immunofluorescence [Laboratory Procedure]
   944 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   928 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.190: The predicted human NCC is slightly bigger (20 amino acids) compared with the corresponding rat protein, and this could explain the slight shift of the major band, using a HT-29 protein preparation (Fig. 6b; the higher molecular weight bands are most likely the result of glycosylated NCC, as demonstrated in Fig. 3 for the intestine). 

Phrase: "The predicted human NCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420092:Na-Cl Cotransporter [Gene or Genome]
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "is"

Phrase: "slightly bigger"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0443228:bigger [Quantitative Concept]
   861   C1704243:Bigger [Quantitative Concept]
   827 E C0549177:Big [Quantitative Concept]

Phrase: "(20 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "compared with the corresponding rat protein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "this"

Phrase: "could"

Phrase: "explain"

Phrase: "the slight shift of the major band,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333051:Shift [Functional Concept]
   748   C2347509:Shift [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a HT-29 protein preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0455052:Preparation [Health Care Activity]
   812   C1521827:Preparation [Functional Concept]

Phrase: "(Fig. 6b"

Phrase: ";"

Phrase: "the higher molecular weight bands"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0175723:Bands [Medical Device]
   779 E C0439645:Band [Spatial Concept]
   779 E C1521913:band [Cell Component]
   740   C1979900:High molecular weight [Qualitative Concept]

Phrase: "are"

Phrase: "most likely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0750501:most likely [Idea or Concept]
   861   C0205393:Most [Quantitative Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "the result of glycosylated NCC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "as"

Phrase: "demonstrated in Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]

Phrase: "for the intestine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021853:Intestine [Body Part, Organ, or Organ Component]
  1000   C1708548:INTESTINE [Tissue]

Phrase: ")."
Processing 00000000.tx.191: Immunofluorescence experiments were performed on HT-29 cells grown in standard RPMI medium and on cells grown in the presence of 2 mM butyrate, which is reported to induce intestinal cell differentiation toward the mature enterocyte phenotype, as shown by the appearance of microvilli at the cell surface of HT-29 cells (33). 

Phrase: "Immunofluorescence experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed on HT-29 cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   862   C0282639:HT-29 Cells [Cell]
           HT-29
   760   C0007634:Cells [Cell]
   760   C0018510:HT [Geographic Area]
   760   C0677607:HT [Disease or Syndrome]
   760   C0884358:Performed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "grown in standard RPMI medium"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1442989:Standard [Qualitative Concept]
   760   C1705217:Medium [Substance]
   760   C2828392:Standard [Intellectual Product]
   760   C3244283:medium [Intellectual Product]

Phrase: "and on cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1515981:And [Idea or Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "grown in the presence of 2 mM butyrate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0006521:butyrate [Lipid]
   744   C0220802:butyrate [Lipid]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "is"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "intestinal cell differentiation toward the mature enterocyte phenotype,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   744   C1511938:Differentiation [Clinical Attribute]
   744   C2945687:Differentiation [Functional Concept]

Phrase: "as"

Phrase: "shown by the appearance of microvilli"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0026049:Microvilli [Cell Component]
   753   C0233426:Appearance [Organism Attribute]
   753   C0700364:Appearance [Qualitative Concept]
   719   C1547282:Show [Intellectual Product]

Phrase: "at the cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "of HT-29 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0282639:HT-29 Cells [Cell]
           HT-29
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.192: Interestingly, although apparently all butyrate-treated HT-29 cells showed a positive staining, in the case of untreated cells only about 50% of cells were positive (Fig. 7) indicating a less homogeneous cell population under these conditions. 

Phrase: "Interestingly,"

Phrase: "although"

Phrase: "apparently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750541:apparently [Idea or Concept]

Phrase: "all butyrate-treated HT-29 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0282639:HT-29 Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a positive staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of untreated cells only about 50%"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   804   C0007634:Cells [Cell]
   804   C0205171:Only [Quantitative Concept]
   804   C0332155:untreated [Finding]
   804   C1720467:Only [Intellectual Product]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "of cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "indicating"

Phrase: "a less homogeneous cell population under these conditions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0032659:Population [Quantitative Concept]
   744   C1257890:Population [Population Group]
Processing 00000000.tx.193: ECaC are inwardly rectifying Ca2+-permeable channels that can be activated by negative voltages, can be blocked by ruthenium red, and show a prominent monovalent permeability in divalent cation-free solutions (34). 

Phrase: "ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "are"

Phrase: "inwardly"

Phrase: "rectifying"

Phrase: "Ca2+-permeable channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "activated by negative voltages,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0205160:Negative [Qualitative Concept]
   770   C1513916:Negative [Finding]
   770   C1879547:Activated [Activity]
   770   C2825415:Negative [Conceptual Entity]
   770   C2825491:Negative [Qualitative Concept]
   737   C0598352:Voltage [Quantitative Concept]
   737 E C1515877:Activate [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "blocked by ruthenium red,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0035975:Ruthenium Red [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   770   C0028778:Blocked [Pathologic Function]
   770   C0035973:Ruthenium [Element, Ion, or Isotope]
   770   C0332206:Blocked [Functional Concept]
   770   C0332575:Red [Finding]
   770   C1260956:Red [Qualitative Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a prominent monovalent permeability in divalent cation-free solutions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0031164:Permeability [Natural Phenomenon or Process]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.194: According to protocols that exploit the characteristic fingerprints for ECaC (35, 36), we carried out patch-clamp experiments aimed to investigate whether ECaC-related currents can be shown in HT-29 cells. 

Phrase: "According to protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442711:Protocols [Intellectual Product]
   966 E C1507394:Protocol [Intellectual Product]
   966 E C1522729:Protocol [Intellectual Product]
   966 E C2348563:Protocol [Intellectual Product]

Phrase: "that"

Phrase: "exploit"

Phrase: "the characteristic fingerprints for ECaC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0016126:Fingerprints [Manufactured Object]

Phrase: "(35,"

Phrase: "36"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out patch-clamp experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "aimed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1947946:Aim [Idea or Concept]
   966   C2948600:Aim [Pharmacologic Substance]
   966   C3540471:AIM [Gene or Genome]
   966   C3540472:AIM [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "ECaC-related currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0521116:currents [Temporal Concept]
   771 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "can"

Phrase: "be"

Phrase: "shown in HT-29 cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   862   C0282639:HT-29 Cells [Cell]
           HT-29
   760   C0007634:Cells [Cell]
   760   C0018510:HT [Geographic Area]
   760   C0677607:HT [Disease or Syndrome]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1547282:Show [Intellectual Product]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.195: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.196: 8, native HT-29 cells, exposed to a divalent cation-free solution and stimulated via a step protocol from 100 mV to +100 mV (+20-mV steps; the holding potential was +20 mV), exhibited a strong inwardly rectifying current, which could be blocked reversibly (75% at 100 mV) by the addition of 10 M ruthenium red to the bath solution. 

Phrase: "8,"

Phrase: "native HT-29 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   923   C0282639:HT-29 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to a divalent cation-free solution"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0007448:divalent cation [Chemical Viewed Structurally]
   778   C0332157:Exposed to [Clinical Attribute]
           Exposed
   748   C0007447:Cation [Chemical Viewed Structurally]
   748   C0037633:Solution [Substance]
   748   C0332296:free [Functional Concept]
   748   C0525069:Solution [Biomedical or Dental Material]
   748   C1880497:Free [Qualitative Concept]
   748   C1996904:Free [Qualitative Concept]

Phrase: "and"

Phrase: "stimulated via a step protocol"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0442711:Protocol [Intellectual Product]
   760   C1261552:Step [Conceptual Entity]
   760   C1507394:Protocol [Intellectual Product]
   760   C1522729:Protocol [Intellectual Product]
   760   C1704379:Step [Functional Concept]
   760   C1705117:Step [Quantitative Concept]
   760   C1948023:Stimulated [Natural Phenomenon or Process]
   760   C2348563:Protocol [Intellectual Product]
   760   C2825408:Step [Manufactured Object]

Phrase: "from 100 mV to +100 mV (+20-mV steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   793   C1261552:steps [Conceptual Entity]
   760 E C1704379:Step [Functional Concept]
   760 E C1705117:Step [Quantitative Concept]
   760 E C2825408:Step [Manufactured Object]

Phrase: ";"

Phrase: "the holding potential"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C3245505:Potential [Qualitative Concept]
   827   C1553387:Hold [Idea or Concept]
   827   C1948035:Hold [Activity]

Phrase: "was +"

Phrase: "20 mV"

Phrase: ")"

Phrase: ","

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a strong inwardly"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442821:Strong [Qualitative Concept]
   789 E C0237897:Strength [Quantitative Concept]
   789 E C0808080:Strength [Idea or Concept]
   789 E C1705922:Strength [Qualitative Concept]

Phrase: "rectifying"

Phrase: "current,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0521116:Current [Temporal Concept]
  1000   C1705970:Current [Natural Phenomenon or Process]

Phrase: "which"

Phrase: "could"

Phrase: "be"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "reversibly"

Phrase: "(75% at 100 mV)"

Phrase: "by the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 10 M ruthenium red"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035975:Ruthenium Red [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   812   C0035973:Ruthenium [Element, Ion, or Isotope]
   812   C0332575:Red [Finding]
   812   C1260956:Red [Qualitative Concept]

Phrase: "to the bath solution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.197: The observed biophysical characteristics of the currents correspond to ECaC currents observed in other systems (34, 37). 

Phrase: "The observed biophysical characteristics of the currents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521970:Characteristics [Qualitative Concept]

Phrase: "correspond to ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0221908:Epithelial [Qualitative Concept]
   770   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521116:currents [Temporal Concept]
   966 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "observed in other systems"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1441672:Observed [Functional Concept]
   737   C0449913:System [Functional Concept]
   737   C1553451:System [Manufactured Object]
   737   C1704459:System [Medical Device]

Phrase: "(34,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.198: It is not clear at the moment, why, in the presence of 10 M ruthenium red, in three of five experiments an outward current could be measured. 

Phrase: "It"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear at the moment,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2963144:Clear [Qualitative Concept]

Phrase: "why,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 10 M ruthenium red,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035975:Ruthenium Red [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   812   C0035973:Ruthenium [Element, Ion, or Isotope]
   812   C0332575:Red [Finding]
   812   C1260956:Red [Qualitative Concept]

Phrase: "in three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "of five experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "an outward current"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0521116:Current [Temporal Concept]
   861   C1705970:Current [Natural Phenomenon or Process]

Phrase: "could"

Phrase: "be"

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.199: Further work is necessary to elucidate whether these currents are the result of an unspecific effect of ruthenium red on the membrane at potentials more positive than +40 mV, or if ruthenium red is able to activate or unmask an outwardly rectifying anionic current at the respective positive holding potentials. 

Phrase: "Further work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "is"

Phrase: "necessary to"

Phrase: "elucidate"

Phrase: "whether"

Phrase: "these currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521116:currents [Temporal Concept]
   966 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "are"

Phrase: "the result of an unspecific effect of ruthenium red"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C2825142:Result [Finding]

Phrase: "on the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "at potentials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3245505:potentials [Qualitative Concept]

Phrase: "more positive than +40 mV,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439178:% Positive [Quantitative Concept]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C2825490:Positive [Qualitative Concept]

Phrase: "or"

Phrase: "if"

Phrase: "ruthenium red"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035975:Ruthenium Red [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   861   C0035973:Ruthenium [Element, Ion, or Isotope]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "or"

Phrase: "unmask"

Phrase: "an outwardly"

Phrase: "rectifying"

Phrase: "anionic current at the respective positive holding potentials."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0521116:Current [Temporal Concept]
   744   C1705970:Current [Natural Phenomenon or Process]
Processing 00000000.tx.200: View larger version (50K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(50K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.201: 6. 

Phrase: "6."
Processing 00000000.tx.202: NCC and ECaC are expressed in human HT-29 cells. a, RT-PCR performed with specific NCC and ECaC1/2 primers (Table I) using total RNA of HT-29 cells. b, Western blot of membrane protein preparations from rat small intestine and HT-29 cells (anti-NCC198 antibody).  

Phrase: "NCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420092:Na-Cl Cotransporter [Gene or Genome]
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "are"

Phrase: "expressed in human HT-29 cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   833   C0282639:HT-29 Cells [Cell]
           HT-29
   783   C0427861:Human cells [Laboratory or Test Result]
   753   C0007634:Cells [Cell]
   753   C0018510:HT [Geographic Area]
   753   C0086418:Human [Human]
   753   C0677607:HT [Disease or Syndrome]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "a,"

Phrase: "RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "performed with specific NCC"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1420092:Na-Cl Cotransporter [Gene or Genome]
   760   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0205369:Specific [Qualitative Concept]
   760   C0884358:Performed [Functional Concept]
   760   C1552740:specific [Intellectual Product]
   760   C1959973:% NaCl [Quantitative Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "ECaC1/2 primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Table I)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "total RNA of HT-29 cells. b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Western blot of membrane protein preparations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0949466:Western Blot [Laboratory Procedure]
   753   C1705493:Western [Spatial Concept]

Phrase: "from rat small intestine"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1882857:Rat Small Intestine [Body Part, Organ, or Organ Component]
   901   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
   901   C1268998:Small intestine [Body Part, Organ, or Organ Component]
   901   C1519375:SMALL INTESTINE [Tissue]
   845 E C1304890:Enteral [Spatial Concept]
   845 E C1522196:Enteral [Functional Concept]
   827   C0021853:Intestine [Body Part, Organ, or Organ Component]
   827   C0700321:Small [Quantitative Concept]
   827   C1708548:INTESTINE [Tissue]

Phrase: "and"

Phrase: "HT-29 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0282639:HT-29 Cells [Cell]
           HT-29
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(anti-NCC198 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.203: View larger version (19K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.204: 7. 

Phrase: "7."
Processing 00000000.tx.205: Immunofluorescence of butyrate-treated (right) or untreated (left) HT-29 cells probed with the antirNCC1-98 antibody (green signal). 

Phrase: "Immunofluorescence of butyrate-treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0016318:Immunofluorescence [Laboratory Procedure]
   770   C0079603:Immunofluorescence [Laboratory Procedure]
   715 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "HT-29 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0282639:HT-29 Cells [Cell]
           HT-29
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "probed with the antirNCC1-98 antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   719   C0182400:Probe [Medical Device]
   719   C1704681:Probe [Gene or Genome]
   719   C2347609:Probe [Chemical Viewed Functionally]
   719   C3536729:Probe [Manufactured Object]

Phrase: "(green signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.206: Nuclei were stained by 4',6-diamidino-2-phenylindole dihydrochloride (blue signal).  

Phrase: "Nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "stained by 4',"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "6-diamidino-2-phenylindole dihydrochloride"

Phrase: "(blue signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.207: HCTZ Is Able to Modify the Ca2+ Uptake in HT-29 Cells Because the intestinal cells, similarly to DCT cells, express both NCC and ECaC (3840), we tested whether or not they also show an NCC-dependent Ca2+ transport, as reported in DCT (8, 41, 42). 

Phrase: "HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "Is"

Phrase: "Able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "Modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the Ca2+ Uptake in HT-29 Cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243144:Uptake [Physiologic Function]
   748   C0347980:% uptake [Quantitative Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Because"

Phrase: "the intestinal cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0814997:Intestinal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "similarly to DCT cells,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   833   C0022676:Distal convoluted tubule [Body Part, Organ, or Organ Component]
   790   C1707510:Convoluted Tubule [Tissue]
   767   C0333859:Convoluted cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0205108:Distal [Spatial Concept]
   753   C0205401:Convoluted [Qualitative Concept]
   753   C1880179:Convoluted [Spatial Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "both NCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420092:Na-Cl Cotransporter [Gene or Genome]
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "(3840"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "or"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "they also"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an NCC-dependent Ca2+ transport,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0005528:Transport, NOS [Cell Function]
   804   C1317949:Transport [Manufactured Object]
   804   C3495449:transport [Medical Device]

Phrase: "as"

Phrase: "reported in DCT"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0022676:Distal convoluted tubule [Body Part, Organ, or Organ Component]
   806   C1707510:Convoluted Tubule [Tissue]
   760   C0205108:Distal [Spatial Concept]
   760   C0205401:Convoluted [Qualitative Concept]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1880179:Convoluted [Spatial Concept]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "(8,"

Phrase: "41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.208: Our working hypothesis was that in HT-29 cells the inhibition of the thiazide-sensitive cotransporter by HCTZ would induce, similarly to the whole intestine, a hyperpolarization of the membrane, which in turn could trigger the opening of the voltage-gated ECaC, thus leading to a facilitation of the Ca2+ influx. 

Phrase: "Our working hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043227:Working [Occupational Activity]
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "was"

Phrase: "that in HT-29 cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   862   C0282639:HT-29 Cells [Cell]
           HT-29
   760   C0007634:Cells [Cell]
   760   C0018510:HT [Geographic Area]
   760   C0677607:HT [Disease or Syndrome]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "the inhibition of the thiazide-sensitive cotransporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "would"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: ","

Phrase: "similarly to the whole intestine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0021853:Intestine [Body Part, Organ, or Organ Component]
   760   C0444667:Whole [Quantitative Concept]
   760   C1708548:INTESTINE [Tissue]

Phrase: "a hyperpolarization of the membrane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C2262820:membrane hyperpolarization [Cell Function]

Phrase: "which in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "could"

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "the opening of the voltage-gated ECaC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0175566:Opening [Spatial Concept]
   742   C1882151:Opening [Spatial Concept]

Phrase: "thus"

Phrase: "leading to a facilitation of the Ca2+ influx."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   744   C0234112:Facilitation [Organ or Tissue Function]
   744   C0332152:Leading [Temporal Concept]
   744   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1522538:Leading [Functional Concept]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.209: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.210: 9, HCTZ led to a transient increase of the intracellular Ca2+ concentration (cyan line in Fig. 9). 

Phrase: "9,"

Phrase: "HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "led to a transient increase of the intracellular Ca2+ concentration"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   739   C0040704:Transient [Population Group]
   739   C0086045:Concentration [Mental Process]
   739   C0175996:intracellular [Cell Component]
   739   C0178719:Intracellular [Spatial Concept]
   739   C0205374:Transient [Temporal Concept]
   739   C0442805:Increase [Functional Concept]
   739   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C1446561:Concentration [Quantitative Concept]
   739   C1708698:LED [Manufactured Object]
   706 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   706 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   706 E C1522538:Lead [Functional Concept]
   706 E C2348269:Lead [Element, Ion, or Isotope]
   706 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(cyan line in Fig. 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205132:Line [Spatial Concept]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.211: This increase was blocked in the absence of extracellular Ca2+ (green line in Fig. 9). 

Phrase: "This increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "blocked in the absence of extracellular Ca2+"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   748   C0028778:Blocked [Pathologic Function]
   748   C0332197:absence [Quantitative Concept]
   748   C0332206:Blocked [Functional Concept]
   748   C0521119:Extracellular [Cell Component]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "(green line in Fig. 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205132:Line [Spatial Concept]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.212: According to our hypothesis, the prior blocking of ECaC by ruthenium red should inhibit an HCTZ-induced calcium increase. 

Phrase: "According to our hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "the prior"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Prior [Temporal Concept]
  1000   C2826257:PRIOR [Event]

Phrase: "blocking of ECaC"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0221908:Epithelial [Qualitative Concept]
   760   C0233660:Blocking [Mental or Behavioral Dysfunction]
   760   C0332206:Blocking [Functional Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   726 E C0028778:Block [Pathologic Function]
   726   C0439799:Channel [Spatial Concept]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726   C1706095:Channel [Conceptual Entity]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "by ruthenium red"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035975:Ruthenium Red [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   861   C0035973:Ruthenium [Element, Ion, or Isotope]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]

Phrase: "should"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "an HCTZ-induced calcium increase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442805:Increase [Functional Concept]
Processing 00000000.tx.213: Indeed, in the presence of ruthenium red the measured calcium signal remained unchanged (+0.1  0.1%, n = 112). 

Phrase: "Indeed,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of ruthenium red"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035975:Ruthenium Red [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   861   C0035973:Ruthenium [Element, Ion, or Isotope]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]

Phrase: "the measured calcium signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "remained"

Phrase: "unchanged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "(+0.1  0.1%,"

Phrase: "n = 112"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.214: Monitoring single cells demonstrated that the Ca2+ response to HCTZ was very heterogeneous. 

Phrase: "Monitoring"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0150369:Monitoring [Health Care Activity]
  1000   C1516647:monitoring [Research Activity]
   966 E C0030695:monitor [Health Care Activity]
   966 E C0181904:Monitor [Medical Device]
   966 E C0596972:Monitor [Medical Device]
   966 E C1521743:Monitor [Professional or Occupational Group]
   966 E C1704646:Monitor [Manufactured Object]

Phrase: "single cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the Ca2+ response to HCTZ"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "very heterogeneous."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneous [Qualitative Concept]
Processing 00000000.tx.215: Some cells did not show any intracellular Ca2+ variation, whereas others showed variable Ca2+ oscillations in the presence of HCTZ (Fig. 10). 

Phrase: "Some cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "any intracellular Ca2+ variation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variation [Qualitative Concept]

Phrase: "whereas"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "variable Ca2+ oscillations in the presence of HCTZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.216: Asynchronous intracellular calcium oscillations have been reported for cultured epithelial cells subjected to different stimuli (43). 

Phrase: "Asynchronous intracellular calcium oscillations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0600430:Calcium Oscillations [Cell Function]
   812   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "have"

Phrase: "been"

Phrase: "reported for cultured epithelial cells"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   806   C0014597:Epithelial Cells [Cell]
   806   C1273342:Epithelial Cells [Laboratory Procedure]
   797   C0007600:cultured cells [Cell]
   797   C0007635:Cultured Cells [Cell]
   797   C3282338:Cells, Cultured [Cell]
   760   C0007634:Cells [Cell]
   760   C0221908:Epithelial [Qualitative Concept]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3282337:Cells [Cell]
   760   C3496591:Reported [Clinical Attribute]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C3273238:Report [Intellectual Product]

Phrase: "subjected to different stimuli"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0234402:Stimuli [Phenomenon or Process]
   770   C1705242:Different [Qualitative Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.217: In such cases the Ca2+ oscillations observed in single cells are asynchronous with variable frequency (44) leading to sustained Ca2+ increase as a result of combined single cellular events. 

Phrase: "In such cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the Ca2+ oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "observed in single cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0007634:Cells [Cell]
   770   C0037179:Single [Population Group]
   770   C0087136:single [Finding]
   770   C0205171:Single [Quantitative Concept]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "asynchronous with variable frequency"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439581:Asynchronous [Temporal Concept]
   770   C1547530:Asynchronous [Intellectual Product]

Phrase: "(44"

Phrase: ")"

Phrase: "leading to sustained Ca2+ increase"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0332152:Leading [Temporal Concept]
   760   C0442805:Increase [Functional Concept]
   760   C0443318:Sustained [Functional Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1522538:Leading [Functional Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of combined single cellular events."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0585347:Single event [Temporal Concept]
   812   C0441471:Events [Event]
   812   C3541888:Events [Classification]
Processing 00000000.tx.218: Averaged signals from multiple cells yielded the traces shown in Fig. 

Phrase: "Averaged signals from multiple cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0037083:cell signals [Cell Function]
   726   C1710082:Signal [Phenomenon or Process]

Phrase: "yielded"

Phrase: "the traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.219: 9. 

Phrase: "9."
Processing 00000000.tx.220: The experiments performed on cells treated for at least 48 h with sodium butyrate (Fig. 9, red line, and Fig. 10a) led to slightly different results. 

Phrase: "The experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "performed on cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0884358:Performed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "treated for"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332293:treated [Therapeutic or Preventive Procedure]
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "at least 48 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "with sodium butyrate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0142812:Sodium Butyrate [Lipid,Pharmacologic Substance]
   861   C0006521:butyrate [Lipid]
   861   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   861   C0220802:butyrate [Lipid]
   861   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(Fig. 9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "red line,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205132:Line [Spatial Concept]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "Fig. 10a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553642:10a [Medical Device]

Phrase: ")"

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to slightly different results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1274040:Result [Functional Concept]
   779   C1546471:Result [Idea or Concept]
   779   C2825142:Result [Finding]
Processing 00000000.tx.221: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.222: 10a, HCTZ led to an increase of the intracellular Ca2+ concentration. 

Phrase: "10a,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553642:10a [Medical Device]

Phrase: "HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "led to an increase of the intracellular Ca2+ concentration."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   742   C0086045:Concentration [Mental Process]
   742   C0175996:intracellular [Cell Component]
   742   C0178719:Intracellular [Spatial Concept]
   742   C0442805:Increase [Functional Concept]
   742   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C1446561:Concentration [Quantitative Concept]
   742   C1708698:LED [Manufactured Object]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708 E C1522538:Lead [Functional Concept]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.223: However, in contrast to the untreated cells, the increase was sustained and not transient. 

Phrase: "However,"

Phrase: "in contrast to the untreated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "sustained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0443318:Sustained [Functional Concept]
   966 E C2732140:Sustain [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "not transient."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040704:Transient [Population Group]
   861   C0205374:Transient [Temporal Concept]
Processing 00000000.tx.224: The sustained raise of the intracellular Ca2+ concentration was the result of lumped asynchronous Ca2+ oscillations measured in individual cells of the observed population (Fig. 10b). 

Phrase: "The sustained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443318:Sustained [Functional Concept]

Phrase: "raise of the intracellular Ca2+ concentration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0086045:Concentration [Mental Process]
   753   C0175996:intracellular [Cell Component]
   753   C0178719:Intracellular [Spatial Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "the result of lumped asynchronous Ca2+ oscillations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "measured in individual cells of the observed population"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   750   C2350001:Population Measure [Quantitative Concept]
   744   C0007634:Cells [Cell]
   744   C0027361:Individual [Population Group]
   744   C0032659:Population [Quantitative Concept]
   744   C0237401:Individual [Human]
   744   C0444706:Measured [Qualitative Concept]
   744   C1257890:Population [Population Group]
   744   C1441672:Observed [Functional Concept]
   744   C3282337:Cells [Cell]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 10b"

Phrase: ")."
Processing 00000000.tx.225: The frequency of the Ca2+ oscillations, however, increased in the cells pre-treated with sodium butyrate as opposed to untreated cells.  

Phrase: "The frequency of the Ca2+ oscillations,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "however,"

Phrase: "increased in the cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "pre-treated with sodium butyrate"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C0142812:Sodium Butyrate [Lipid,Pharmacologic Substance]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0006521:butyrate [Lipid]
   760   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   760   C0220802:butyrate [Lipid]
   760   C0332152:Pre [Temporal Concept]
   760   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0740175:Pre [Qualitative Concept]
   760   C1522326:Treated [Functional Concept]
   760   C2257086:PRE [Genetic Function]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "as"

Phrase: "opposed to untreated cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0332155:untreated [Finding]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.226: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  The remarkable role the kidney plays in controlling blood pressure is explained by the fact that this organ is responsible for mediating the sodium handling of the organism. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The remarkable role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "the kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "plays in controlling blood pressure"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0005823:Blood Pressure [Organism Function]
   806   C1271104:Blood Pressure [Finding]
   806   C1272641:Blood pressure [Finding]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0032214:Play [Daily or Recreational Activity]
   760   C0033095:Pressure [Phenomenon or Process]
   760   C0229664:Blood [Body Substance]
   760   C0332298:controlling [Functional Concept]
   760   C0460139:Pressure [Finding]
   760   C0600138:Plays [Finding]
   760   C1306345:Pressure [Functional Concept]
   760   C2587213:Controlling [Functional Concept]

Phrase: "is"

Phrase: "explained by the fact"

Phrase: "that"

Phrase: "this organ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178784:Organ [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "responsible for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1273518:Responsible [Finding]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "the sodium handling of the organism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0018578:Handling [Behavior]
   753   C1832073:Handling [Finding]
Processing 00000000.tx.227: Reabsorption and secretion of sodium is tightly balanced along the renal tubules. 

Phrase: "Reabsorption"

Phrase: "and"

Phrase: "secretion of sodium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0036536:secretion [Biologic Function]
   790   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "tightly"

Phrase: "balanced along the renal tubules."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0022674:renal tubules [Body Part, Organ, or Organ Component]
   773 E C1283878:Renal tubule [Body Part, Organ, or Organ Component]
   760   C0022646:Renal [Body Part, Organ, or Organ Component]
   760   C0205415:Balanced [Functional Concept]
   726 E C0014653:Balance [Organism Function]
   726 E C0560184:Balance [Finding]
Processing 00000000.tx.228: The fine-tuning of the sodium balance is performed at the level of the distal tubular segment, where NCC is one of the key players for sodium transport. 

Phrase: "The"

Phrase: "fine-tuning of the sodium balance"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0014653:Balance [Organism Function]
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0205232:Fine [Qualitative Concept]
   753   C0205415:Balance [Functional Concept]
   753   C0560184:Balance [Finding]
   753   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0687757:fine [Regulation or Law]

Phrase: "is"

Phrase: "performed at the level of the distal tubular segment,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   742   C0205108:Distal [Spatial Concept]
   742   C0332208:Tubular [Spatial Concept]
   742   C0441635:Segment [Spatial Concept]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C0884358:Performed [Functional Concept]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "where NCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1420092:Na-Cl Cotransporter [Gene or Genome]
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "is"

Phrase: "one of the key players"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "for sodium transport."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159690:sodium transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]
Processing 00000000.tx.229: This is demonstrated by the fact that mutations within the NCC protein, able to reduce its activity, lead to salt-resistant hypotension, also known as the Gitelman syndrome (10, 45). 

Phrase: "This"

Phrase: "is"

Phrase: "demonstrated by the fact"

Phrase: "that mutations within the NCC protein,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "reduce"

Phrase: "its activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "lead to salt-resistant hypotension,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   797   C0332325:Resistant to [Functional Concept]
           Resistant
   797   C0589331:Lead salt [Element, Ion, or Isotope]
   760   C0020649:Hypotension [Finding]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0036140:Salt [Chemical Viewed Structurally]
   760   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0206136:Salt [Food,Inorganic Chemical]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C2827757:RESISTANT [Laboratory or Test Result]
   760   C3163620:Hypotension [Pathologic Function]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "also"

Phrase: "known as the Gitelman syndrome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0268450:Gitelman Syndrome [Disease or Syndrome]
   760   C0039082:Syndrome [Disease or Syndrome]
   760   C0205309:Known [Qualitative Concept]

Phrase: "(10,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.230: Whereas the cardinal role of NCC in renal Ca2+ absorption is generally accepted, little is known whether or not NCC is also important for Ca2+ absorption in the intestine. 

Phrase: "Whereas"

Phrase: "the cardinal role of NCC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in renal Ca2+ absorption"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C2610986:renal absorption [Physiologic Function]
   827   C0000854:Absorption [Natural Phenomenon or Process]
   827   C0220777:absorption [Functional Concept]
   827   C2347023:Absorption [Phenomenon or Process]
   827   C2347080:Absorption [Phenomenon or Process]
   827   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   827   C2825050:Absorption [Phenomenon or Process]

Phrase: "is"

Phrase: "generally"

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: ","

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "whether"

Phrase: "or"

Phrase: "not NCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1420092:Na-Cl Cotransporter [Gene or Genome]
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "is"

Phrase: "also important for Ca2+ absorption"

Phrase: "in the intestine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021853:Intestine [Body Part, Organ, or Organ Component]
  1000   C1708548:INTESTINE [Tissue]
Processing 00000000.tx.231: Our results demonstrate the presence of the NCC cotransporter in rat small intestine (ileum and jejunum) and human HT-29 cells. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "the presence of the NCC cotransporter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in rat small intestine"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1882857:Rat Small Intestine [Body Part, Organ, or Organ Component]
   901   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
   901   C1268998:Small intestine [Body Part, Organ, or Organ Component]
   901   C1519375:SMALL INTESTINE [Tissue]
   845 E C1304890:Enteral [Spatial Concept]
   845 E C1522196:Enteral [Functional Concept]
   827   C0021853:Intestine [Body Part, Organ, or Organ Component]
   827   C0700321:Small [Quantitative Concept]
   827   C1708548:INTESTINE [Tissue]

Phrase: "(ileum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020885:ileum [Body Part, Organ, or Organ Component]
  1000   C1278923:Ileum [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "jejunum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022378:Jejunum [Body Part, Organ, or Organ Component]
  1000   C1278922:Jejunum [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "and"

Phrase: "human HT-29 cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   923   C0282639:HT-29 Cells [Cell]
   902   C0427861:Human cells [Laboratory or Test Result]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.232: RT-PCRs and Northern blot experiments conducted on rat small intestine suggest that the intestinal NCC isoform is identical to the kidney isoform. 

Phrase: "RT-PCRs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0599161:RT-PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "Northern blot experiments"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0005861:Northern Blot [Molecular Biology Research Technique]
   734   C1621557:Northern Blot [Research Device]

Phrase: "conducted on rat small intestine"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   862   C1882857:Rat Small Intestine [Body Part, Organ, or Organ Component]
   806   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
   806   C1268998:Small intestine [Body Part, Organ, or Organ Component]
   806   C1519375:SMALL INTESTINE [Tissue]
   760   C0021853:Intestine [Body Part, Organ, or Organ Component]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0700321:Small [Quantitative Concept]
   760   C1708548:INTESTINE [Tissue]
   751 E C1304890:Enteral [Spatial Concept]
   751 E C1522196:Enteral [Functional Concept]
   726   C0004927:Conduct [Individual Behavior]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the intestinal NCC isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "identical to the kidney isoform."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.233: In the kidney, a probe corresponding to the last three highly conserved transmembrane segments recognized three bands at 11, 4.4, and 3.3 kb, a pattern similar to the one reported by other authors (13, 14, 26). 

Phrase: "In the kidney,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "a probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "corresponding to the last three highly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205250:Highly [Qualitative Concept]
   753   C0205449:Three [Quantitative Concept]

Phrase: "conserved"

Phrase: "transmembrane segments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C1167322:transmembrane [Cell Component]
   861   C2752508:transmembrane [Cell Component]
   827   C0441635:Segment [Spatial Concept]
   777 E C0205122:Segmental [Spatial Concept]

Phrase: "recognized"

Phrase: "three bands at 11,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0175723:Bands [Medical Device]
   737 E C0439645:Band [Spatial Concept]
   737 E C1521913:band [Cell Component]

Phrase: "4.4,"

Phrase: "and"

Phrase: "3.3 kb,"

Phrase: "a pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449774:Pattern [Spatial Concept]

Phrase: "similar to the one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "reported by other authors"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1709908:Reported By [Group]
   770   C0221193:Authors [Professional or Occupational Group]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(13,"

Phrase: "14,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.234: It has been shown, that the 4.4-kb band as well as the 3.3-kb band code for NCC, and the sequence differences are limited to the 3'-untranslated region (26, 46). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "that"

Phrase: "the 4.4-kb band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]

Phrase: "as well as"

Phrase: "the 3.3-kb band code for NCC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0009219:code [Occupational Activity]
   742   C0805701:Code [Intellectual Product]

Phrase: "and"

Phrase: "the sequence differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "are"

Phrase: "limited to the 3'-untranslated region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   753   C0439801:Limited [Functional Concept]
   753   C3542948:Limited [Intellectual Product]
   719 E C1549649:Limit [Idea or Concept]
   719 E C2349209:Limit [Conceptual Entity]

Phrase: "(26,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.235: The nature of the 11-kb transcript is, although described also in UMR-106 osteosarcoma cells (14), still elusive. 

Phrase: "The nature of the 11-kb transcript"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0349590:Nature [Idea or Concept]
   748   C1262865:Nature [Functional Concept]

Phrase: "is"

Phrase: ","

Phrase: "although"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "also in UMR-106 osteosarcoma cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0007634:Cells [Cell]
   753   C0029463:Osteosarcoma [Neoplastic Process]
   753   C0585442:osteosarcoma [Neoplastic Process]
   753   C2697383:OSTEOSARCOMA [Gene or Genome]
   753   C3282337:Cells [Cell]
   753   C3541899:Osteosarcoma [Intellectual Product]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "still elusive."
Processing 00000000.tx.236: In intestine we identified only one main band at 4.4 kb, however, at a lower level of expression versus that of the kidney, as was also shown by Chang and co-workers in the human small intestine and colon (13). 

Phrase: "In intestine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021853:Intestine [Body Part, Organ, or Organ Component]
  1000   C1708548:INTESTINE [Tissue]

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "only one main band at 4.4 kb,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0175723:Band [Medical Device]
   744   C0439645:Band [Spatial Concept]
   744   C1521913:band [Cell Component]

Phrase: "however,"

Phrase: "at a lower level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "of expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "versus"

Phrase: "that of the kidney,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0022646:Kidney [Body Part, Organ, or Organ Component]
   770   C0227665:kidney [Body Part, Organ, or Organ Component]
   770   C1278978:Kidney [Body Part, Organ, or Organ Component]
   770   C1514845:KIDNEY [Tissue]

Phrase: "as"

Phrase: "was"

Phrase: "also"

Phrase: "shown by Chang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "co-workers in the human small intestine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0024752:workers [Functional Concept]
   748   C1306056:workers [Occupation or Discipline]
   748   C1527116:Workers [Population Group]

Phrase: "and"

Phrase: "colon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009368:Colon [Body Part, Organ, or Organ Component]
  1000   C1281569:Colon [Body Part, Organ, or Organ Component]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.237: It has to be mentioned that no signal was found by Northern blot in rat small intestine by Gamba and co-workers (26). 

Phrase: "It"

Phrase: "has"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "mentioned"

Phrase: "that"

Phrase: "no signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "found by Northern blot"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005861:Northern Blot [Molecular Biology Research Technique]
   833   C1621557:Northern Blot [Research Device]
   770   C0150312:Found [Quantitative Concept]
   770   C1709269:Northern [Spatial Concept]
   737 E C0243095:Find [Finding]

Phrase: "in rat small intestine"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1882857:Rat Small Intestine [Body Part, Organ, or Organ Component]
   901   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
   901   C1268998:Small intestine [Body Part, Organ, or Organ Component]
   901   C1519375:SMALL INTESTINE [Tissue]
   845 E C1304890:Enteral [Spatial Concept]
   845 E C1522196:Enteral [Functional Concept]
   827   C0021853:Intestine [Body Part, Organ, or Organ Component]
   827   C0700321:Small [Quantitative Concept]
   827   C1708548:INTESTINE [Tissue]

Phrase: "by Gamba"

Phrase: "and"

Phrase: "co-workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024752:workers [Functional Concept]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.238: The differing finding may be a result of more sensitive conditions we introduced, because we used poly(A)RNA and radioactive labeled probes instead of total RNA and digoxigenin-labeled probes. 

Phrase: "The differing finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "a result of more sensitive conditions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "we"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: ","

Phrase: "because"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "poly(A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "radioactive labeled probes instead of total RNA"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   774   C0035683:RNA Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0182400:Probes [Medical Device]
   714 E C1704681:Probe [Gene or Genome]
   714 E C2347609:Probe [Chemical Viewed Functionally]
   714 E C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "digoxigenin-labeled probes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0182400:Probes [Medical Device]
   793 E C1704681:Probe [Gene or Genome]
   793 E C2347609:Probe [Chemical Viewed Functionally]
   793 E C3536729:Probe [Manufactured Object]
Processing 00000000.tx.239: Confirming RT-PCR data, the NCC protein was also identified by Western blot experiments, both in the jejunum and ileum. 

Phrase: "Confirming RT-PCR data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "the NCC protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420092:Na-Cl Cotransporter [Gene or Genome]

Phrase: "was"

Phrase: "also"

Phrase: "identified by Western blot experiments,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0949466:Western Blot [Laboratory Procedure]
   760   C0205396:Identified [Qualitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "both in the jejunum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0022378:Jejunum [Body Part, Organ, or Organ Component]
   770   C0238767:Both [Spatial Concept]
   770   C1278922:Jejunum [Body Part, Organ, or Organ Component]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "ileum."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020885:ileum [Body Part, Organ, or Organ Component]
  1000   C1278923:Ileum [Body Part, Organ, or Organ Component]
Processing 00000000.tx.240: In accordance with the Northern blot experiments, the intensity of the signal was lower than in the kidney. 

Phrase: "In accordance with the Northern blot experiments,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0005861:Northern Blot [Molecular Biology Research Technique]
   734   C1621557:Northern Blot [Research Device]

Phrase: "the intensity of the signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0871362:signal intensity [Quantitative Concept]
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0441994:Lower [Spatial Concept]
   833   C1548802:Lower [Body Location or Region]
   833   C2003888:Lower [Activity]

Phrase: "in the kidney."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]
Processing 00000000.tx.241: The band appeared less broad and frequent, depending on the protein preparations, at a slightly lower molecular weight level. 

Phrase: "The band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175723:Band [Medical Device]
  1000   C0439645:Band [Spatial Concept]
  1000   C1521913:band [Cell Component]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "less broad"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332464:Broad [Spatial Concept]

Phrase: "and"

Phrase: "frequent,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0332183:Frequent [Temporal Concept]
   928 E C0376249:frequency [Quantitative Concept]
   928 E C0439603:Frequencies [Temporal Concept]
   928 E C0871396:Frequency [Quantitative Concept]
   928 E C1561548:Frequency [Qualitative Concept]
   928 E C1705502:Frequency [Quantitative Concept]

Phrase: "depending on the protein preparations,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C0455052:Preparation [Health Care Activity]
   726   C0725813:depend [Medical Device]
   726   C1521827:Preparation [Functional Concept]

Phrase: "at a slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "molecular weight level."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
   734   C0026385:Molecular Weight [Quantitative Concept]
Processing 00000000.tx.242: This may be a consequence of different glycosylation levels, because the Northern blot experiments indicate that the core protein is likely to be of the same molecular weight as the kidney isoform. 

Phrase: "This"

Phrase: "may"

Phrase: "be"

Phrase: "a consequence of different glycosylation levels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "because"

Phrase: "the Northern blot experiments"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0005861:Northern Blot [Molecular Biology Research Technique]
   734   C1621557:Northern Blot [Research Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "the core protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0444669:Core [Spatial Concept]
   861   C1167518:core [Cell Component]
   861   C1706352:Core [Medical Device]
   861   C1882467:Core [Manufactured Object]
   861   C3274653:Core [Body Substance]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be of the same molecular weight"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0026385:Molecular Weight [Quantitative Concept]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1705104:Weight [Idea or Concept]
   753   C2987476:Be [Conceptual Entity]

Phrase: "as the kidney isoform."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoform [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.243: Experiments performed with F-glycosidase-treated or -untreated membrane protein preparations indicate that native NCC is a glycosylated protein and the molecular mass of the core protein (about 110 kDa) is comparable to that of the kidney isoform (27, 28). 

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "performed with F-glycosidase-treated or -untreated membrane protein preparations"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   760   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   757   C2945724:f-protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   739   C0017976:Glycosidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   739   C0025255:Membrane [Tissue]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0332155:untreated [Finding]
   739   C0439133:(f) [Intellectual Product]
   739   C0596901:Membrane [Cell Component]
   739   C0884358:Performed [Functional Concept]
   739   C1522326:Treated [Functional Concept]
   739   C1553038:[f] [Quantitative Concept]
   739   C1706182:Membrane [Manufactured Object]
   706   C0455052:Preparation [Health Care Activity]
   706 E C1292734:TREAT [Functional Concept]
   706   C1521827:Preparation [Functional Concept]
   706 E C2947996:Perform [Pharmacologic Substance]

Phrase: "indicate"

Phrase: "that native NCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1420092:Na-Cl Cotransporter [Gene or Genome]
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "is"

Phrase: "a glycosylated protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "the molecular mass of the core protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   748   C0577559:Mass [Finding]
   748   C1306372:*Mass [Quantitative Concept]

Phrase: "(about 110 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: "is"

Phrase: "comparable to that of the kidney isoform"

Phrase: "(27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.244: A different level of glycosylation could be due to a different preservation of the integrity of the transporter during membrane preparation or due to a tissue-specific glycosylation pattern, as it has been proposed for other transport proteins (47). 

Phrase: "A different level of glycosylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "could"

Phrase: "be due to a different preservation of the integrity of the transporter"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0678226:Due to [Functional Concept]
           due
   736   C0033085:Preservation [Laboratory Procedure]
   736   C0205266:integrity [Qualitative Concept]
   736   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0872403:integrity [Individual Behavior]
   736   C1514402:Preservation [Laboratory Procedure]
   736   C1705242:Different [Qualitative Concept]
   736   C1947912:Integrity [Qualitative Concept]
   736   C2987476:Be [Conceptual Entity]
   736   C3146286:Due [Idea or Concept]

Phrase: "during membrane preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "or due to a tissue-specific glycosylation pattern,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0678226:Due to [Functional Concept]
           due
   770   C1955394:Tissue specific [Body Substance]
   744   C0017982:glycosylation [Natural Phenomenon or Process]
   744   C0040300:Tissue [Tissue]
   744   C0205369:Specific [Qualitative Concept]
   744   C0376322:Glycosylation [Molecular Function]
   744   C0449774:Pattern [Spatial Concept]
   744   C1547928:Tissue [Intellectual Product]
   744   C1552740:specific [Intellectual Product]
   744   C3146286:Due [Idea or Concept]

Phrase: "as"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "proposed for other transport proteins"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0007292:Transport Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781 E C0599895:protein transport [Cell Function]
   781 E C1159772:Protein Transport [Cell Function]
   760   C0005528:Transport, NOS [Cell Function]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1317949:Transport [Manufactured Object]
   760   C1441414:PROPOSED [Idea or Concept]
   760   C1553874:Proposed [Qualitative Concept]
   760   C1578820:Proposed [Idea or Concept]
   760   C3495449:transport [Medical Device]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.245: Western blot and immunohistochemistry experiments demonstrate that NCC expression in the intestine is mainly confined to the enterocytes in the apical region of the villi, whereas the majority of the signals seem to be located at the apical membranes of the cells. 

Phrase: "Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "immunohistochemistry experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "that NCC expression in the intestine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "mainly"

Phrase: "confined to the enterocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0682610:Enterocytes [Cell]

Phrase: "in the apical region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of the villi,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0227266:Villus [Body Part, Organ, or Organ Component]
   966   C1519988:Villus [Body Part, Organ, or Organ Component]

Phrase: "whereas"

Phrase: "the majority of the signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "located at the apical membranes of the cells."
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   754   C0596119:apical membrane [Cell Component]
   750   C0007603:Cell membranes [Cell Component]
   744   C0007634:Cells [Cell]
   744   C0025255:Membranes [Tissue]
   744   C0205111:Apical [Spatial Concept]
   744   C3282337:Cells [Cell]
   734 E C3161472:Cell Membrane [Cell Component]
   711 E C0596901:Membrane [Cell Component]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1706182:Membrane [Manufactured Object]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.246: The localization of the transporter suggests its involvement in NaCl absorption from the intestinal lumen, in analogy to the sodium reabsorption from the DCT lumen in the kidney. 

Phrase: "The localization of the transporter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "its involvement in NaCl absorption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "from the intestinal lumen,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0545876:Intestinal lumen [Body Space or Junction]
   861   C0021853:Intestinal [Body Part, Organ, or Organ Component]
   861   C0524461:Lumen [Body Space or Junction]
   861   C1282864:Lumen [Body Space or Junction]
   861   C1301906:Lumen [Qualitative Concept]
   861   C1551056:Lumen [Quantitative Concept]
   789 E C0524462:Luminal [Spatial Concept]
   789 E C1708548:INTESTINE [Tissue]

Phrase: "in analogy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0679213:analogy [Idea or Concept]
   900 E C0243071:Analog [Chemical Viewed Structurally]

Phrase: "to the sodium reabsorption"

Phrase: "from the DCT lumen"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0524461:Lumen [Body Space or Junction]
   812   C1282864:Lumen [Body Space or Junction]
   812   C1301906:Lumen [Qualitative Concept]
   812   C1551056:Lumen [Quantitative Concept]
   756   C0022676:Distal convoluted tubule [Body Part, Organ, or Organ Component]
   741 E C0524462:Luminal [Spatial Concept]

Phrase: "in the kidney."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]
Processing 00000000.tx.247: Whereas in the DCT the NCC cotransporter represents the main pathway for NaCl absorption, in the intestine additional transporters, such as the Na+/H+-Cl/HCO3 double exchange (48, 49), are likely to interact with NCC. 

Phrase: "Whereas in the DCT"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0022676:Distal convoluted tubule [Body Part, Organ, or Organ Component]
   790   C1707510:Convoluted Tubule [Tissue]
   753   C0205108:Distal [Spatial Concept]
   753   C0205401:Convoluted [Qualitative Concept]
   753   C1880179:Convoluted [Spatial Concept]

Phrase: "the NCC cotransporter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1420092:Na-Cl Cotransporter [Gene or Genome]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the main pathway for NaCl absorption,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "in the intestine additional transporters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596902:transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "such as the Na+/H+-Cl/HCO3 double exchange"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0678640:exchange [Social Behavior]

Phrase: "(48,"

Phrase: "49"

Phrase: ")"

Phrase: ","

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "interact with NCC."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1420092:Na-Cl Cotransporter [Gene or Genome]
   770   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C1959973:% NaCl [Quantitative Concept]
Processing 00000000.tx.248: This redundancy of the NaCl transport systems could justify the lower expression of NCC compared with that of the kidney. 

Phrase: "This redundancy of the NaCl transport systems"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1313915:Redundancy [Functional Concept]

Phrase: "could"

Phrase: "justify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552821:justify [Functional Concept]

Phrase: "the lower expression of NCC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "compared with that of the kidney."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0022646:Kidney [Body Part, Organ, or Organ Component]
   753   C0227665:kidney [Body Part, Organ, or Organ Component]
   753   C1278978:Kidney [Body Part, Organ, or Organ Component]
   753   C1514845:KIDNEY [Tissue]
   753   C1707455:Compared [Activity]
Processing 00000000.tx.249: Nevertheless, the contribution of NCC to sodium and chloride entry into the cells in our experimental setting appears to be substantial, given that HCTZ leads to significant changes of Vms. 

Phrase: "Nevertheless,"

Phrase: "the contribution of NCC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "to sodium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
  1000   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "chloride entry into the cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705654:Entry [Intellectual Product]

Phrase: "in our experimental setting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0542559:setting [Functional Concept]
   861   C1318139:{Setting} [Quantitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "substantial,"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "leads to significant changes of Vms."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0181586:leads [Medical Device]
   753   C0237881:significant [Quantitative Concept]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   753   C0750502:Significant [Idea or Concept]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C1546944:Significant [Qualitative Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]
   719 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.250: Our hypothesis on how HCTZ facilitates the reduction of Vms implies the presence of an active Cl conductance, and our data obtained by using NPPB, a known Cl channel inhibitor, are in agreement with this assumption. 

Phrase: "Our hypothesis on how HCTZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1512571:Hypothesis [Idea or Concept]

Phrase: "facilitates"

Phrase: "the reduction of Vms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "implies"

Phrase: "the presence of an active Cl conductance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "obtained by"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   833   C1301820:Obtained [Functional Concept]
   799 E C1706701:Obtain [Activity]
   761 E C1517378:Gain [Quantitative Concept]
   740 E C0205217:Increased [Quantitative Concept]
   740 E C0439661:Acquired [Temporal Concept]
   740 E C0442805:Increase [Functional Concept]
   740 E C0442808:Increasing [Functional Concept]
   740 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "NPPB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0049330:NPPB [Organic Chemical,Pharmacologic Substance]
  1000   C1417808:NPPB [Gene or Genome]

Phrase: "a known Cl channel inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "are in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C1551058:Are [Quantitative Concept]

Phrase: "with this assumption."
Processing 00000000.tx.251: In addition, the inhibition of NCC by HCTZ may reduce the uptake of Na+ into the cell, lowering the intracellular sodium concentration, and thus causing an increase in the activity of the basolateral Na+/Ca2+ exchanger (4951) alongside a decrease in that of the Na+-K+ pump, and consequently contributing to the depolarization of Vms. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the inhibition of NCC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "by HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "may"

Phrase: "reduce"

Phrase: "the uptake of Na+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243144:Uptake [Physiologic Function]
   770   C0347980:% uptake [Quantitative Concept]

Phrase: "into the cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "lowering"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0441994:lowering [Spatial Concept]
  1000   C2003888:Lowering [Activity]
   966 E C1548802:Lower [Body Location or Region]

Phrase: "the intracellular sodium concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "thus"

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "an increase in the activity of the basolateral Na+/Ca2+ exchanger"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0442805:Increase [Functional Concept]

Phrase: "(4951"

Phrase: ")"

Phrase: "alongside a decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "in that"

Phrase: "of the Na+-K+ pump,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1149024:Na+,K+ pump [Molecular Function]
   827   C0182537:Pump [Medical Device]
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1272460:{NA} [Qualitative Concept]
   827   C1706421:Pump [Manufactured Object]
   827   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "consequently"

Phrase: "contributing to the depolarization of Vms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880177:Contributing [Activity]
Processing 00000000.tx.252: As mentioned earlier, apart from its diuretic effect, HCTZ is also applied in a therapeutic context based on its action on Ca2+ homeostasis related to its hypocalciuric effects (8, 5254). 

Phrase: "As"

Phrase: "mentioned"

Phrase: "earlier,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "apart from its diuretic effect,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0948429:Diuretic Effect [Finding]
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "also"

Phrase: "applied in a therapeutic context"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   760   C0185125:Applied [Health Care Activity]
   760   C0302350:Therapeutic [Functional Concept]
   760   C0449255:Context [Finding]
   760   C0542559:Context [Functional Concept]
   726 E C1632850:Apply [Functional Concept]
   726 E C1879355:Apply [Functional Concept]

Phrase: "based on its action"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0441472:Action [Functional Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C3266814:Action [Activity]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "on Ca2+ homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "related to its hypocalciuric effects"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1280500:effects [Qualitative Concept]
   726 E C0163712:Relate [Organic Chemical]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "(8,"

Phrase: "5254"

Phrase: ")."
Processing 00000000.tx.253: This mechanism is the result of an increased Ca2+ reabsorption by DCT cells; 

Phrase: "This mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "the result of an increased Ca2+ reabsorption"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "by DCT cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   858   C0333859:Convoluted cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756   C0022676:Distal convoluted tubule [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.254: however, it must be considered also that the intestine could be a target of HCTZ, a commonly discussed scenario ever since 1970 (55, 56). 

Phrase: "however,"

Phrase: "it"

Phrase: "must"

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "also"

Phrase: "that"

Phrase: "the intestine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021853:Intestine [Body Part, Organ, or Organ Component]
  1000   C1708548:INTESTINE [Tissue]

Phrase: "could"

Phrase: "be"

Phrase: "a target of HCTZ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1521840:Target [Functional Concept]
   770   C2986546:TARGET [Diagnostic Procedure]

Phrase: "a commonly"

Phrase: "discussed"

Phrase: "scenario ever since 1970"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0683579:scenario [Functional Concept]

Phrase: "(55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "56"

Phrase: ")."
Processing 00000000.tx.255: An increased intestinal Ca2+ absorption in response to thiazides treatment has been reported (17, 18). 

Phrase: "An increased intestinal Ca2+ absorption in response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0021826:Intestinal Absorption [Organ or Tissue Function]
   748   C0000854:Absorption [Natural Phenomenon or Process]
   748   C0220777:absorption [Functional Concept]
   748   C2347023:Absorption [Phenomenon or Process]
   748   C2347080:Absorption [Phenomenon or Process]
   748   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   748   C2825050:Absorption [Phenomenon or Process]

Phrase: "to thiazides treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.256: More recently, in a clinical study, it has been proposed that the Ca2+ balance in thiazide-treated subjects may be more positive, not only due to reduced renal loss but also as a result of a possible concomitant increase in intestinal calcium reabsorption (5). 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "in a clinical study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0008972:Clinical Study [Research Activity]
   861   C0205210:Clinical [Qualitative Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that"

Phrase: "the Ca2+ balance in thiazide-treated subjects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0014653:Balance [Organism Function]
   748   C0205415:Balance [Functional Concept]
   748   C0560184:Balance [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "more positive,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]

Phrase: "not only due to reduced renal loss"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0022646:Renal [Body Part, Organ, or Organ Component]
   748   C0205171:Only [Quantitative Concept]
   748   C0392756:Reduced [Qualitative Concept]
   748   C1517945:Loss [Quantitative Concept]
   748   C1518422:Not [Functional Concept]
   748   C1720467:Only [Intellectual Product]
   748   C3146286:Due [Idea or Concept]

Phrase: "but"

Phrase: "also as a result of a possible concomitant increase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0332149:Possible [Qualitative Concept]
   742   C0442805:Increase [Functional Concept]
   742   C0521115:Concomitant [Temporal Concept]
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C1705910:Possible [Qualitative Concept]
   742   C2362652:Possible [Qualitative Concept]
   742   C2825142:Result [Finding]

Phrase: "in intestinal calcium reabsorption"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.257: View larger version (25K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.258: 8. 

Phrase: "8."
Processing 00000000.tx.259: Voltage clamp experiments (whole cell configuration) performed on HT-29 cells. a, example of whole cell current traces obtained in control conditions (bath solution is free of divalent cations) when voltage increments from 100 to +100 mV were applied (increment is 20 mV, holding potential is +20 mV). 

Phrase: "Voltage clamp experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0872303:voltage clamp [Research Activity]

Phrase: "(whole cell configuration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449830:Configuration [Spatial Concept]
   827   C2827597:Configuration [Conceptual Entity]

Phrase: ")"

Phrase: "performed on HT-29 cells."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   862   C0282639:HT-29 Cells [Cell]
           HT-29
   760   C0007634:Cells [Cell]
   760   C0018510:HT [Geographic Area]
   760   C0677607:HT [Disease or Syndrome]
   760   C0884358:Performed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a,"

Phrase: "example of whole cell current traces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707959:Example [Conceptual Entity]

Phrase: "obtained in control conditions"
Meta Candidates (Total=15; Excluded=6; Pruned=0; Remaining=9)
   770   C0243148:control [Qualitative Concept]
   770   C1301820:Obtained [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
   737 E C1706701:Obtain [Activity]
   715 E C0040607:Training [Educational Activity]
   715 E C0220931:Training [Educational Activity]
   715 E C0336809:Train [Manufactured Object]
   715 E C1552514:Train [Manufactured Object]
   715 E C2673163:training [Qualitative Concept]

Phrase: "(bath solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "is"

Phrase: "free of divalent cations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332296:free [Functional Concept]
   770   C1880497:Free [Qualitative Concept]
   770   C1996904:Free [Qualitative Concept]

Phrase: ")"

Phrase: "when"

Phrase: "voltage increments from 100 to +100 mV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1705117:Increment [Quantitative Concept]

Phrase: "were"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "(increment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705117:Increment [Quantitative Concept]

Phrase: "is"

Phrase: "20 mV,"

Phrase: "holding potential is +20 mV"

Phrase: ")."
Processing 00000000.tx.260: b, current to voltage relationship obtained in control condition, or in the presence of the blocker ruthenium red. 

Phrase: "b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "current to voltage relationship"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0521116:Current [Temporal Concept]
   770   C1705970:Current [Natural Phenomenon or Process]

Phrase: "obtained in control condition,"
Meta Candidates (Total=15; Excluded=6; Pruned=0; Remaining=9)
   770   C0012634:condition [Disease or Syndrome]
   770   C0243148:control [Qualitative Concept]
   770   C0348080:Condition [Qualitative Concept]
   770   C1301820:Obtained [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1705253:Condition [Conceptual Entity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1706701:Obtain [Activity]
   715 E C0040607:Training [Educational Activity]
   715 E C0220931:Training [Educational Activity]
   715 E C0336809:Train [Manufactured Object]
   715 E C1552514:Train [Manufactured Object]
   715 E C2673163:training [Qualitative Concept]

Phrase: "or in the presence of the blocker ruthenium red."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0035975:Ruthenium Red [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   742   C0035973:Ruthenium [Element, Ion, or Isotope]
   742   C0332575:Red [Finding]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C1260956:Red [Qualitative Concept]
Processing 00000000.tx.261: The effect of ruthenium red is reversible (washout). 

Phrase: "The effect of ruthenium red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "reversible"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205343:Reversible [Functional Concept]
   928 E C0449261:Reversibility [Temporal Concept]

Phrase: "(washout"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1710661:Washout [Temporal Concept]
  1000   C2986829:Washout [Functional Concept]

Phrase: ")."
Processing 00000000.tx.262: The outward current in the presence of ruthenium red was only observed in three out of five experiments. 

Phrase: "The outward current in the presence of ruthenium red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0521116:Current [Temporal Concept]
   742   C1705970:Current [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "observed in three"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205449:Three [Quantitative Concept]
   790   C1441672:Observed [Functional Concept]

Phrase: "out of five experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.263: Histograms represent % currents measured at 100 mV in control condition or in the presence of the blocker.  

Phrase: "Histograms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348974:Histogram [Manufactured Object]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "% currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521116:currents [Temporal Concept]
   966 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "measured at 100 mV"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "in control condition"
Meta Candidates (Total=17; Excluded=9; Pruned=0; Remaining=8)
   861   C0012634:condition [Disease or Syndrome]
   861   C0243148:control [Qualitative Concept]
   861   C0348080:Condition [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1705253:Condition [Conceptual Entity]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]

Phrase: "or in the presence of the blocker."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.264: View larger version (24K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.265: 9. 

Phrase: "9."
Processing 00000000.tx.266: Fura-2 experiments performed on HT-29 cells demonstrate that HCTZ induce Ca2+ entry in HT-29 cells. 

Phrase: "Fura-2 experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "performed on HT-29 cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   862   C0282639:HT-29 Cells [Cell]
           HT-29
   760   C0007634:Cells [Cell]
   760   C0018510:HT [Geographic Area]
   760   C0677607:HT [Disease or Syndrome]
   760   C0884358:Performed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "demonstrate"

Phrase: "that HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Ca2+ entry in HT-29 cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705654:Entry [Intellectual Product]
Processing 00000000.tx.267: Cyan line, cells were exposed to a bicarbonate-free solution containing 2 mM Ca2+, followed by exposure to 1 mM HCTZ in the same Ca2+ containing buffer for 6 min and by subsequent removal from the drug by replacement with the control solution. 

Phrase: "Cyan line,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to a bicarbonate-free solution"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   753   C0037633:Solution [Substance]
   753   C0332296:free [Functional Concept]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C0973231:Bicarbonate [Inorganic Chemical]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2 mM Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "followed by exposure"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "to 1 mM HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   771 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   771 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   771 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "in the same Ca2+ containing buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 6 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and by subsequent removal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0015252:Removal [Therapeutic or Preventive Procedure]
   770   C0332282:Subsequent [Temporal Concept]
   770   C0728940:Removal [Therapeutic or Preventive Procedure]
   770   C1515981:And [Idea or Concept]

Phrase: "from the drug"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0013227:Drug [Pharmacologic Substance]
  1000   C1254351:Drug [Pharmacologic Substance]
   944 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   944 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   907 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "by replacement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035139:Replacement [Therapeutic or Preventive Procedure]
  1000   C0559956:Replacement [Functional Concept]
  1000   C1555302:Replacement [Idea or Concept]

Phrase: "with the control solution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.268: Red line, the same protocol was used with butyrate-treated cells. 

Phrase: "Red line,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205132:Line [Spatial Concept]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "the same protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "was"

Phrase: "used with butyrate-treated cells."
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   797   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0006521:butyrate [Lipid]
   760   C0007634:Cells [Cell]
   760   C0220802:butyrate [Lipid]
   760   C1273517:used [Finding]
   760   C1522326:Treated [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1269647:Cell [Cell]
   726 E C1292734:TREAT [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1947944:Use [Intellectual Product]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.269: Green line, butyrate-treated cells were exposed to Ca2+ free extracellular buffer for 4 min before exposure to 1 mM HCTZ in the same Ca2+-free buffer. 

Phrase: "Green line,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "butyrate-treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to Ca2+ free extracellular buffer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0332296:free [Functional Concept]
   753   C0521119:Extracellular [Cell Component]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]

Phrase: "for 4 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "before exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to 1 mM HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   771 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   771 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   771 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "in the same Ca2+-free buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.270: Washing out of the drug was achieved by repeatedly exchanging the bath solution with the Ca2+ free extracellular buffer. 

Phrase: "Washing out of the drug"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0022100:washing out [Therapeutic or Preventive Procedure]
   760   C0441648:Washing [Activity]

Phrase: "was"

Phrase: "achieved by repeatedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205341:Repeatedly [Functional Concept]

Phrase: "exchanging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678640:exchanging [Social Behavior]

Phrase: "the bath solution with the Ca2+ free extracellular buffer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0037633:Solution [Substance]
   742   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.271: Blue line, control experiments: cells were exposed to three subsequent changes of the Ca2+ containing bath solution with an identical one. 

Phrase: "Blue line,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "control experiments"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009932:control experiments [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0681814:Experiments [Research Activity]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: ":"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to three subsequent changes of the Ca2+ containing bath solution"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   756   C0332157:Exposed to [Clinical Attribute]
           Exposed
   738   C0037633:Solution [Substance]
   738   C0150141:Bath [Therapeutic or Preventive Procedure]
   738   C0205449:Three [Quantitative Concept]
   738   C0332256:Containing [Functional Concept]
   738   C0332282:Subsequent [Temporal Concept]
   738   C0392747:changes [Functional Concept]
   738   C0443172:changes [Quantitative Concept]
   738   C0525069:Solution [Biomedical or Dental Material]
   738   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   738   C2700400:Containing [Activity]
   704 E C1705241:Change [Quantitative Concept]

Phrase: "with an identical one."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]
Processing 00000000.tx.272: Vertical lines represent standard error.  

Phrase: "Vertical lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "standard error."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1710181:Standard Error [Quantitative Concept]
   861   C0743559:error [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1608199:Error [Functional Concept]
   861   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.273: View larger version (31K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.274: 10. 

Phrase: "10."
Processing 00000000.tx.275: Single cell Fura-2 experiments in the presence of HCTZ. 

Phrase: "Single cell Fura-2 experiments in the presence of HCTZ."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0681814:Experiments [Research Activity]
   706 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.276: a, average intracellular Ca2+ response of butyrate-treated HT-29 cells to HCTZ. 

Phrase: "a,"

Phrase: "average intracellular Ca2+ response of butyrate-treated HT-29 cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0871261:Response [Organism Attribute]
   739   C1704632:Response [Finding]
   739   C1706817:Response [Intellectual Product]
   739   C2911692:Response [Mental Process]

Phrase: "to HCTZ."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.277: Cells were exposed to a bicarbonate-free solution containing 2 mM Ca2+, followed by exposure to 1 mM HCTZ in the same buffer and by the subsequent washing out of the drug by replacement with the control solution. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to a bicarbonate-free solution"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   753   C0037633:Solution [Substance]
   753   C0332296:free [Functional Concept]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C0973231:Bicarbonate [Inorganic Chemical]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2 mM Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "followed by exposure"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "to 1 mM HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   771 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   771 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   771 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "in the same buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and by the subsequent washing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332282:Subsequent [Temporal Concept]
   760   C0441648:Washing [Activity]
   760   C1515981:And [Idea or Concept]

Phrase: "out of the drug"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0013227:Drug [Pharmacologic Substance]
  1000   C1254351:Drug [Pharmacologic Substance]
   944 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   944 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   907 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "by replacement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035139:Replacement [Therapeutic or Preventive Procedure]
  1000   C0559956:Replacement [Functional Concept]
  1000   C1555302:Replacement [Idea or Concept]

Phrase: "with the control solution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.278: Dotted lines represent the standard error (this trace was taken from Fig. 9). 

Phrase: "Dotted lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the standard error"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1710181:Standard Error [Quantitative Concept]
   861   C0743559:error [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1608199:Error [Functional Concept]
   861   C2828392:Standard [Intellectual Product]

Phrase: "("

Phrase: "this trace"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0442822:Trace [Quantitative Concept]
  1000   C1524031:Trace [Qualitative Concept]
  1000   C1883002:Trace [Functional Concept]

Phrase: "was"

Phrase: "taken from Fig. 9"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   770   C1883727:Taken [Conceptual Entity]
   737 E C1515187:Take [Health Care Activity]

Phrase: ")."
Processing 00000000.tx.279: b, single cell responses. 

Phrase: "b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "single cell responses."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]
Processing 00000000.tx.280: Two different cells (red line, cell A; blue line, cell B) elicit responses of different intensity as a reaction to the treatment with HCTZ.  

Phrase: "Two different cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(red line,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205132:Line [Spatial Concept]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "cell A"

Phrase: "; blue line,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "responses of different intensity"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "as a reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "to the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with HCTZ."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.281: To test whether HCTZ can alter Ca2+ uptake in the intestinal epithelium, we used as experimental model the HT-29 cell line. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "can"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "Ca2+ uptake in the intestinal epithelium,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "we"

Phrase: "used as experimental model"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0086272:Experimental Model [Intellectual Product]
   770   C1273517:used [Finding]
   770   C1517586:Experimental [Qualitative Concept]
   770   C3161035:Model [Intellectual Product]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "the HT-29 cell line."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0282639:HT-29 Cell [Cell]
   861   C0007600:Cell Line [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.282: We used these cells successfully to demonstrate the expression of NCC, facilitated via RT-PCR and by Western blot, and, in addition, the expression as well as function of ECaC by using RT-PCR and patch clamp experiments. 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "these cells successfully to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "demonstrate"

Phrase: "the expression of NCC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "facilitated via RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]

Phrase: "and by Western blot,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C1515981:And [Idea or Concept]
   770   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: ","

Phrase: "in addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "as well as"

Phrase: "function of ECaC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "patch clamp experiments."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0920630:patch clamp [Research Activity]
Processing 00000000.tx.283: The biophysical properties of the measured current (strong inward rectification, very positive reversal potential, and block by ruthenium red) are similar to those reported for ECaC in other systems (37). 

Phrase: "The biophysical properties of the measured current"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0871161:properties [Qualitative Concept]
   748   C1292721:properties [Functional Concept]
   714 E C1882134:Property [Conceptual Entity]
   714 E C2347695:Property [Entity]

Phrase: "(strong inward rectification,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683891:rectification [Human-caused Phenomenon or Process]

Phrase: "very positive reversal potential,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0443290:Reversal [Functional Concept]
   812   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "block by ruthenium red"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0028778:Block [Pathologic Function]
   770   C0332206:Block [Functional Concept]
   770   C1533157:Block [Substance]
   770   C1706084:Block [Geographic Area]
   770   C2828370:Block [Quantitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "reported for ECaC"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0221908:Epithelial [Qualitative Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726   C0439799:Channel [Spatial Concept]
   726   C1706095:Channel [Conceptual Entity]
   726 E C3273238:Report [Intellectual Product]

Phrase: "in other systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0449913:System [Functional Concept]
   966   C1553451:System [Manufactured Object]
   966   C1704459:System [Medical Device]
   916 E C0205373:Systemic [Functional Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.284: This, however, is the first characterization of ECaC in their native cell environment, because previous functional studies have been performed on cells overexpressing ECaC (3437). 

Phrase: "This,"

Phrase: "however,"

Phrase: "is"

Phrase: "the first characterization of ECaC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]

Phrase: "in their native cell environment,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014406:Environment [Spatial Concept]

Phrase: "because"

Phrase: "previous functional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "been"

Phrase: "performed on cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0884358:Performed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "(3437"

Phrase: ")."
Processing 00000000.tx.285: The characterization of ECaC in their native cell environment could account for the lower intensity of the currents we measured, if compared with those ECaC currents reported by other authors (35). 

Phrase: "The characterization of ECaC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "in their native cell environment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014406:Environment [Spatial Concept]

Phrase: "could"

Phrase: "account for the lower intensity of the currents"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   744   C0441994:Lower [Spatial Concept]
   744   C0521116:currents [Temporal Concept]
   744   C0522510:Intensity [Qualitative Concept]
   744   C1548802:Lower [Body Location or Region]
   744   C1551359:account [Idea or Concept]
   744   C2003888:Lower [Activity]
   744   C2741673:Account # [Clinical Attribute]
   744   C2981730:Account [Classification]
   711 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: ","

Phrase: "if"

Phrase: "compared with those ECaC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0221908:Epithelial [Qualitative Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1707455:Compared [Activity]

Phrase: "ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521116:currents [Temporal Concept]
   966 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "reported by other authors"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1709908:Reported By [Group]
   770   C0221193:Authors [Professional or Occupational Group]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.286: Expression of ECaC1 and ECaC2 in human duodenum and jejunum has already been documented (37, 57, 57), and ECaC1 has been localized in the apical membrane of intestinal absorptive cells (58). 

Phrase: "Expression of ECaC1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "ECaC2 in human duodenum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1422342:ECAC2 [Gene or Genome]
   770   C2986600:ECAC2 [Gene or Genome]
   770   C2986601:ECaC2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "jejunum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022378:Jejunum [Body Part, Organ, or Organ Component]
  1000   C1278922:Jejunum [Body Part, Organ, or Organ Component]

Phrase: "has"

Phrase: "already"

Phrase: "been"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "(37,"

Phrase: "57,"

Phrase: "57"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "ECaC1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414243:ECAC1 [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "localized in the apical membrane of intestinal absorptive cells"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   764   C0596119:apical membrane [Cell Component]
   762   C0007603:cells membrane [Cell Component]
   745   C0814997:Intestinal cell [Cell]
   745 E C3161472:Cell Membrane [Cell Component]
   742   C0007634:Cells [Cell]
   742   C0021853:Intestinal [Body Part, Organ, or Organ Component]
   742   C0025255:Membrane [Tissue]
   742   C0205111:Apical [Spatial Concept]
   742   C0392752:Localized [Spatial Concept]
   742   C0596901:Membrane [Cell Component]
   742   C1706182:Membrane [Manufactured Object]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "(58"

Phrase: ")."
Processing 00000000.tx.287: However, according to our experiments, we are unable to discriminate whether the measured current in HT-29 cells is based on the activity of ECaC1, ECaC2, or both. 

Phrase: "However,"

Phrase: "according to our experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "are"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "discriminate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205235:Discriminate [Qualitative Concept]

Phrase: "whether"

Phrase: "the measured current in HT-29 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0521116:Current [Temporal Concept]
   748   C1705970:Current [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "based on the activity of ECaC1,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1414243:ECAC1 [Gene or Genome]
   753   C1527178:Based [Functional Concept]
   753   C1561536:*Activity [Idea or Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "ECaC2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1422342:ECAC2 [Gene or Genome]
  1000   C2986600:ECAC2 [Gene or Genome]
  1000   C2986601:ECaC2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "both."
Processing 00000000.tx.288: HCTZ leads to a transient increase of the intracellular Ca2+ of HT-29 cells, and the Ca2+ peak is abolished in the absence of extracellular Ca2+ or the presence of ruthenium red, indicating that calcium enters from the outside. 

Phrase: "HCTZ"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "leads to a transient increase of the intracellular Ca2+"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   742   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   742   C0040704:Transient [Population Group]
   742   C0175996:intracellular [Cell Component]
   742   C0178719:Intracellular [Spatial Concept]
   742   C0181586:leads [Medical Device]
   742   C0205374:Transient [Temporal Concept]
   742   C0442805:Increase [Functional Concept]
   742   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   742   C1522538:Lead [Functional Concept]
   742   C2348269:Lead [Element, Ion, or Isotope]
   742   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "of HT-29 cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0282639:HT-29 Cells [Cell]
           HT-29
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the Ca2+ peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "is"

Phrase: "abolished in the absence of extracellular Ca2+"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0332197:absence [Quantitative Concept]
   748   C0521119:Extracellular [Cell Component]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "the presence of ruthenium red,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "indicating"

Phrase: "that calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "enters from the outside."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205101:Outside [Spatial Concept]
   770   C1522196:ENTER [Functional Concept]
Processing 00000000.tx.289: On the single cellular level we observed that the Ca2+ entry was effected by multiple and irregular calcium oscillations. 

Phrase: "On the single cellular level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "the Ca2+ entry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705654:Entry [Intellectual Product]

Phrase: "was"

Phrase: "effected by multiple"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439064:Multiple [Quantitative Concept]
   756   C1280500:Effect [Qualitative Concept]
   756   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "irregular calcium oscillations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0600430:Calcium Oscillations [Cell Function]
   827   C0695434:oscillations [Therapeutic or Preventive Procedure]
Processing 00000000.tx.290: It is important to note that in butyrate-treated cells the first Ca2+ transient was followed by a series of minor oscillations, showing a higher frequency as compared with untreated cells, and leading to a sustained increase of the intracellular Ca2+ concentration of an entire cell population. 

Phrase: "It"

Phrase: "is"

Phrase: "important to"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that in butyrate-treated cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0006521:butyrate [Lipid]
   760   C0007634:Cells [Cell]
   760   C0220802:butyrate [Lipid]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C1522326:Treated [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1292734:TREAT [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "the first Ca2+ transient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040704:Transient [Population Group]
   827   C0205374:Transient [Temporal Concept]

Phrase: "was"

Phrase: "followed by a series of minor oscillations,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0026193:Minor [Population Group]
   748   C0205165:Minor [Qualitative Concept]
   748   C0205549:Series [Quantitative Concept]
   748   C0695434:oscillations [Therapeutic or Preventive Procedure]
   748   C2348044:Series [Intellectual Product]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a higher frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   983   C0205212:High frequency [Temporal Concept]
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: "as"

Phrase: "compared with untreated cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0332155:untreated [Finding]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "leading to a sustained increase of the intracellular Ca2+ concentration"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   739   C0086045:Concentration [Mental Process]
   739   C0175996:intracellular [Cell Component]
   739   C0178719:Intracellular [Spatial Concept]
   739   C0332152:Leading [Temporal Concept]
   739   C0442805:Increase [Functional Concept]
   739   C0443318:Sustained [Functional Concept]
   739   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C1446561:Concentration [Quantitative Concept]
   739   C1522538:Leading [Functional Concept]
   706 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   706 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   706 E C2348269:Lead [Element, Ion, or Isotope]
   706 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "of an entire cell population."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
   734   C1269647:Entire cell [Cell]
Processing 00000000.tx.291: These results are in agreement with the observation that the use of sodium butyrate induces the differentiation of cultured intestinal cells toward a mature and more homogeneous enterocyte phenotype (33), showing the characteristics of absorptive cells. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C1551058:Are [Quantitative Concept]

Phrase: "with the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that"

Phrase: "the use of sodium butyrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the differentiation of cultured intestinal cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0007589:cells differentiation [Cell Function]
           Differentiation
   753   C1511938:Differentiation [Clinical Attribute]
   753   C2945687:Differentiation [Functional Concept]

Phrase: "toward a mature"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205286:Mature [Temporal Concept]
   928 E C0449989:Maturity [Qualitative Concept]
   928 E C0700597:Maturity [Temporal Concept]

Phrase: "and"

Phrase: "more homogeneous enterocyte phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031437:Phenotype [Organism Attribute]
   812   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the characteristics of absorptive cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521970:Characteristics [Qualitative Concept]
Processing 00000000.tx.292: In HT-29 cells, the butyrate-induced differentiation is followed by a selective down-regulation of the NKCC1 cotransporter, typical of crypt cells, and an up-regulation of brush border markers (59); 

Phrase: "In HT-29 cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0282639:HT-29 Cells [Cell]
           HT-29
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "the butyrate-induced differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0007589:Differentiation [Cell Function]
   827   C1511938:Differentiation [Clinical Attribute]
   827   C2945687:Differentiation [Functional Concept]
   755 E C0205615:Differentiated [Qualitative Concept]

Phrase: "is"

Phrase: "followed by a selective down-regulation of the NKCC1 cotransporter,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0013081:Down-Regulation [Cell Function,Molecular Function]
   760   C0332283:Followed by [Temporal Concept]
           followed
   760   C0525933:NKCC1 Cotransporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1327622:Regulation [Biologic Function]
   739   C1420091:NKCC1 [Gene or Genome]
   739   C3537460:NKCC1 [Gene or Genome]
   706 E C1719822:Follow [Intellectual Product]

Phrase: "typical of crypt cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3538928:Typical [Qualitative Concept]

Phrase: "and"

Phrase: "an up-regulation of brush border markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "(59"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.293: in other intestinal cell lines the differentiation is accompanied by a decrease in the Cl secretion (59). 

Phrase: "in other intestinal cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0007600:Cell lines [Cell]
   901   C0814997:Intestinal cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "the differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "is"

Phrase: "accompanied by a decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "in the Cl secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.294: This suggests a physiological, biochemical, and morphological differentiation of the cells from a crypt-type cell involved in secretion, to a typical villous cell involved in reabsorption. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a physiological, biochemical,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "morphological differentiation of the cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0007589:cells differentiation [Cell Function]
           Differentiation
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "from a crypt-type cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0677646:crypt cell [Cell]
   901   C0449475:type cell [Intellectual Product]
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "involved in secretion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036536:secretion [Biologic Function]
   790   C0036537:Secretion [Body Substance]
   790   C1314939:Involved [Functional Concept]

Phrase: "to a typical villous cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "involved in reabsorption."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1314939:Involved [Functional Concept]
Processing 00000000.tx.295: Interestingly, butyrate impacts also the intact intestine by stimulating electroneutral NaCl absorption (60). 

Phrase: "Interestingly,"

Phrase: "butyrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006521:butyrate [Lipid]
  1000   C0220802:butyrate [Lipid]

Phrase: "impacts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1825598:IMPACT [Gene or Genome]

Phrase: "also"

Phrase: "the intact intestine by stimulating electroneutral NaCl absorption"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0021853:Intestine [Body Part, Organ, or Organ Component]
   744   C1708548:INTESTINE [Tissue]
   731   C0021826:Intestinal Absorption [Organ or Tissue Function]

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.296: In accordance with these data, our immunofluorescence experiments show that the number of HT-29 cells expressing the NCC cotransporter is actually increased by sodium butyrate treatment, confirming the role of the transporter in intestinal NaCl absorption. 

Phrase: "In accordance with these data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "our immunofluorescence experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the number of HT-29 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "expressing"

Phrase: "the NCC cotransporter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1420092:Na-Cl Cotransporter [Gene or Genome]

Phrase: "is"

Phrase: "actually"

Phrase: "increased by sodium butyrate treatment,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   806   C0142812:Sodium Butyrate [Lipid,Pharmacologic Substance]
   797   C0595879:SODIUM INCREASED [Finding]
   760   C0006521:butyrate [Lipid]
   760   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0205217:Increased [Quantitative Concept]
   760   C0220802:butyrate [Lipid]
   760   C0442805:Increased [Functional Concept]
   760   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the role of the transporter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in intestinal NaCl absorption."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0021826:Intestinal Absorption [Organ or Tissue Function]
   827   C0000854:Absorption [Natural Phenomenon or Process]
   827   C0220777:absorption [Functional Concept]
   827   C2347023:Absorption [Phenomenon or Process]
   827   C2347080:Absorption [Phenomenon or Process]
   827   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   827   C2825050:Absorption [Phenomenon or Process]
Processing 00000000.tx.297: In conclusion, our data demonstrate that the functional combination of sodium and Ca2+ transport by ECaC and NCC, originally described for the kidney (53, 61), may also hold true for the intestine. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the functional combination of sodium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205195:Combination [Qualitative Concept]
   760   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "Ca2+ transport by ECaC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0005528:Transport, NOS [Cell Function]
   753   C1317949:Transport [Manufactured Object]
   753   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "NCC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420092:Na-Cl Cotransporter [Gene or Genome]
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "originally"

Phrase: "described for the kidney"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0022646:Kidney [Body Part, Organ, or Organ Component]
   770   C0227665:kidney [Body Part, Organ, or Organ Component]
   770   C1278978:Kidney [Body Part, Organ, or Organ Component]
   770   C1514845:KIDNEY [Tissue]
   770   C1552738:described [Idea or Concept]

Phrase: "(53,"

Phrase: "61"

Phrase: ")"

Phrase: ","

Phrase: "may"

Phrase: "also"

Phrase: "hold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553387:Hold [Idea or Concept]
  1000   C1948035:Hold [Activity]

Phrase: "true for the intestine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205238:True [Qualitative Concept]
Processing 00000000.tx.298: This suggests that the role of HCTZ in Ca2+ homeostasis should be extended from the kidney to a more comprehensive perspective, including the intestine.  

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the role of HCTZ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in Ca2+ homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "should"

Phrase: "be"

Phrase: "extended from the kidney"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0022646:Kidney [Body Part, Organ, or Organ Component]
   770   C0227665:kidney [Body Part, Organ, or Organ Component]
   770   C0231448:Extended [Functional Concept]
   770   C0231449:Extended [Spatial Concept]
   770   C0439792:extended [Spatial Concept]
   770   C1278978:Kidney [Body Part, Organ, or Organ Component]
   770   C1514845:KIDNEY [Tissue]

Phrase: "to a more comprehensive perspective,"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the intestine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021853:Intestine [Body Part, Organ, or Organ Component]
  1000   C1708548:INTESTINE [Tissue]
Processing 00000000.tx.299: FOOTNOTES  * This research was supported by the Italian Ministry of Instruction, University and Research (Fondo per gli Investimenti della Ricerca di Base (FIRB) RBAU01RANB_003). 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "was"

Phrase: "supported by the Italian Ministry of Instruction,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0022275:ITALIAN [Language]
   748   C0039401:Instruction [Educational Activity]
   748   C0302828:Instruction [Intellectual Product]
   748   C0337810:Italian [Population Group]
   748   C1442085:instruction [Idea or Concept]
   748   C1521721:Supported [Conceptual Entity]
   714 E C0183683:Support [Medical Device]

Phrase: "University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041740:University [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "(Fondo per gli Investimenti della Ricerca di Base"

Phrase: "(FIRB"

Phrase: ")"

Phrase: "RBAU01RANB_003"

Phrase: ")."
Processing 00000000.tx.300: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.301: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.302: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.303: ** To whom correspondence may be addressed. 

Phrase: "*"

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.304: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.305: 39-02-5031-4947; 

Phrase: "39-02-5031-4947"

Phrase: ";"
Processing 00000000.tx.306: Fax: 39-02-5031-4948; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "39-02-5031-4948"

Phrase: ";"
Processing 00000000.tx.307: E-mail: guido.botta{at}unimi.it . To whom correspondence may be addressed. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "guido.botta{at}unimi."

Phrase: "it ."

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.308: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.309: 43-512-507-3756; 

Phrase: "43-512-507-3756"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450381:507 [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.310: Fax: 43-512-577-656; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "43-512-577-656"

Phrase: ";"
Processing 00000000.tx.311: E-mail: markus.paulmichl{at}uibk.ac or markus.paulmichl{at}unimi.it . 1 The abbreviations used are: NCC, NaCl-cotransporter; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "markus.paulmichl{at}uibk.ac"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1412573:AC [Gene or Genome]
   804   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   804   C3539770:AC [Gene or Genome]

Phrase: "or"

Phrase: "markus.paulmichl{at}unimi."

Phrase: "it . 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "NCC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420092:Na-Cl Cotransporter [Gene or Genome]
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "NaCl-cotransporter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420092:Na-Cl Cotransporter [Gene or Genome]
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.312: DCT, distal convoluted tubule; 

Phrase: "DCT,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0022676:Distal convoluted tubule [Body Part, Organ, or Organ Component]
   901   C1707510:Convoluted Tubule [Tissue]
   827   C0205108:Distal [Spatial Concept]
   827   C0205401:Convoluted [Qualitative Concept]
   827   C1880179:Convoluted [Spatial Concept]

Phrase: "distal convoluted tubule"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0022676:Distal convoluted tubule [Body Part, Organ, or Organ Component]
   901   C1707510:Convoluted Tubule [Tissue]
   827   C0205108:Distal [Spatial Concept]
   827   C0205401:Convoluted [Qualitative Concept]
   827   C1880179:Convoluted [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.313: ECaC, epithelial Ca2+ channels; 

Phrase: "ECaC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "epithelial Ca2+ channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.314: HCTZ, Hydrochlorothiazide; 

Phrase: "HCTZ,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: "Hydrochlorothiazide"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0020261:Hydrochlorothiazide [Organic Chemical,Pharmacologic Substance]
   944 E C0700694:Esidrix [Organic Chemical,Pharmacologic Substance]
   944 E C0700696:Oretic [Organic Chemical,Pharmacologic Substance]
   944 E C0700698:HydroDIURIL [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.315: RT, reverse transcription; 

Phrase: "RT,"

Phrase: "reverse transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035380:Reverse Transcription [Genetic Function]
   861   C0040649:Transcription [Genetic Function]
   861   C1555029:Reverse [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.316: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.317: BSA, bovine serum albumin; 

Phrase: "BSA,"

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ";"
Processing 00000000.tx.318: NPPB, 5-nitro-2-(3-phenylpropylamino)-benzoic acid.  

Phrase: "NPPB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0049330:NPPB [Organic Chemical,Pharmacologic Substance]
  1000   C1417808:NPPB [Gene or Genome]

Phrase: "5-nitro-2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(3-phenylpropylamino"

Phrase: ")-"

Phrase: "benzoic acid."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0053225:Benzoic Acid [Organic Chemical,Pharmacologic Substance]
           benzoic
  1000   C1161334:benzoic acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.319: ACKNOWLEDGMENTS  We wish to express our gratitude to Prof. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "wish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1423524:WISH [Gene or Genome]
  1000   C3273411:WISH [Gene or Genome]
  1000   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "our gratitude to Prof."
Processing 00000000.tx.320: D. 

Phrase: "D."
Processing 00000000.tx.321: Mount and Prof. 

Phrase: "Mount"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181909:Mount [Medical Device]
  1000   C0449878:mount [Finding]

Phrase: "and"

Phrase: "Prof."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599518:Prof. [Professional or Occupational Group]
Processing 00000000.tx.322: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.323: Hebert for supplying anti-rNCC2112 antibodies. 

Phrase: "Hebert for supplying anti-rNCC2112 antibodies."
Processing 00000000.tx.324: Furthermore, we would like to extend our gratitude to Prof. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "would like to"

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "our gratitude to Prof."
Processing 00000000.tx.325: D. 

Phrase: "D."
Processing 00000000.tx.326: Ellison for supplying anti-rNCC191 antibodies. 

Phrase: "Ellison for supplying anti-rNCC191 antibodies."
Processing 00000000.tx.327: We wish to also thank Dr. 

Phrase: "We"

Phrase: "wish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1423524:WISH [Gene or Genome]
  1000   C3273411:WISH [Gene or Genome]
  1000   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "to also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.328: Igea D'Agnano, CNR, Milan, for her advice on HT 29 cell line treatment  REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Chobanian, A. 

Phrase: "Igea"

Phrase: "D'"

Phrase: "Agnano,"

Phrase: "CNR,"

Phrase: "Milan,"

Phrase: "for her advice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150600:Advice [Health Care Activity]

Phrase: "on HT 29 cell line treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0039798:treatment [Functional Concept]
   804   C0087111:Treatment [Therapeutic or Preventive Procedure]
   804   C1522326:Treatment [Functional Concept]
   804   C1533734:Treatment [Therapeutic or Preventive Procedure]
   804   C1705169:Treatment [Conceptual Entity]
   804   C3538994:TREATMENT [Research Activity]
   717   C0282639:HT-29 Cell [Cell]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Chobanian,"

Phrase: "A."
Processing 00000000.tx.329: V., Bakris, G. 

Phrase: "V., Bakris,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.330: L., Black, H. 

Phrase: "L., Black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0005680:Black [Population Group]
   861   C0027567:Black [Population Group]
   861   C0085756:Black [Population Group]
   861   C0439541:Black [Qualitative Concept]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.331: R., Cushman, W. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cushman,"

Phrase: "W."
Processing 00000000.tx.332: C., Green, L. 

Phrase: "C., Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332583:Green [Qualitative Concept]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.333: A., Izzo, J. 

Phrase: "A.,"

Phrase: "Izzo,"

Phrase: "J."
Processing 00000000.tx.334: L., Jr., Jones, D. 

Phrase: "L., Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "D."
Processing 00000000.tx.335: W., Materson, B. 

Phrase: "W., Materson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.336: J., Oparil, S., Wright, J. 

Phrase: "J.,"

Phrase: "Oparil,"

Phrase: "S."

Phrase: ","

Phrase: "Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "J."
Processing 00000000.tx.337: T., Jr., and Roccella, E. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "and"

Phrase: "Roccella,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1029254:Roccella [Fungus]

Phrase: "E."
Processing 00000000.tx.338: J. 

Phrase: "J."
Processing 00000000.tx.339: (2003) JAMA 289, 25602572[Abstract/Free FullText] Aubin, R., Menard, P., and Lajeunesse, D. 

Phrase: "(2003"

Phrase: ")"

Phrase: "JAMA 289,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: "25602572"

Phrase: "[Abstract/Free FullText"

Phrase: "] Aubin,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Menard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Lajeunesse,"

Phrase: "D."
Processing 00000000.tx.340: (1996) Kidney Int. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Kidney Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063789:INT [Organic Chemical]
   861   C3272375:INT [Intellectual Product]
Processing 00000000.tx.341: 50, 14761482[Medline] [OrderarticleviaInfotrieve] Gall, M. 

Phrase: "50,"

Phrase: "14761482"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700230:Gall [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.342: A., Rossing, P., Skott, P., Hommel, E., Mathiesen, E. 

Phrase: "A.,"

Phrase: "Rossing,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Skott,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hommel,"

Phrase: "E.,"

Phrase: "Mathiesen,"

Phrase: "E."
Processing 00000000.tx.343: R., Gerdes, L. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gerdes,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.344: U., Lauritzen, M., Volund, A., Faergeman, O., Beck-Nielsen, H., et al. 

Phrase: "U.,"

Phrase: "Lauritzen,"

Phrase: "M."

Phrase: ","

Phrase: "Volund,"

Phrase: "A.,"

Phrase: "Faergeman,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Beck-Nielsen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.345: (1992) Am. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.346: J. 

Phrase: "J."
Processing 00000000.tx.347: Hypertens. 

Phrase: "Hypertens."
Processing 00000000.tx.348: 5, 257265[Medline] [OrderarticleviaInfotrieve] LaCroix, A. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "257265"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] LaCroix,"

Phrase: "A."
Processing 00000000.tx.349: Z., Ott, S. 

Phrase: "Z.,"

Phrase: "Ott,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1423088:OTT [Gene or Genome]
  1000   C3273338:OTT [Gene or Genome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.350: M., Ichikawa, L., Scholes, D., and Barlow, W. 

Phrase: "M."

Phrase: ","

Phrase: "Ichikawa,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Scholes,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Barlow,"

Phrase: "W."
Processing 00000000.tx.351: E. 

Phrase: "E."
Processing 00000000.tx.352: (2000) Ann. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.353: Intern. 

Phrase: "Intern."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1144859:INTERN [Professional or Occupational Group]
Processing 00000000.tx.354: Med. 

Phrase: "Med."
Processing 00000000.tx.355: 133, 516526[Abstract/Free FullText] Rejnmark, L., Vestergaard, P., Heickendorff, L., Andreasen, F., and Mosekilde, L. 

Phrase: "133,"

Phrase: "516526"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rejnmark,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Vestergaard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Heickendorff,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Andreasen,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Mosekilde,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.356: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.357: Intern. 

Phrase: "Intern."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1144859:INTERN [Professional or Occupational Group]
Processing 00000000.tx.358: Med. 

Phrase: "Med."
Processing 00000000.tx.359: 250, 144153[CrossRef][Medline] [OrderarticleviaInfotrieve] Schultheis, P. 

Phrase: "250,"

Phrase: "144153"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Schultheis,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.360: J., Lorenz, J. 

Phrase: "J.,"

Phrase: "Lorenz,"

Phrase: "J."
Processing 00000000.tx.361: N., Meneton, P., Nieman, M. 

Phrase: "N., Meneton,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Nieman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.362: L., Riddle, T. 

Phrase: "L., Riddle,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.363: M., Flagella, M., Duffy, J. 

Phrase: "M."

Phrase: ","

Phrase: "Flagella,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016192:Flagella [Cell Component]

Phrase: "M."

Phrase: ","

Phrase: "Duffy,"

Phrase: "J."
Processing 00000000.tx.364: J., Doetschman, T., Miller, M. 

Phrase: "J.,"

Phrase: "Doetschman,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.365: L., and Shull, G. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Shull,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.366: E. 

Phrase: "E."
Processing 00000000.tx.367: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.368: Biol. 

Phrase: "Biol."
Processing 00000000.tx.369: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.370: 273, 2915029155[Abstract/Free FullText] Gesek, F. 

Phrase: "273,"

Phrase: "2915029155"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gesek,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.371: A., and Friedman, P. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Friedman,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.372: A. 

Phrase: "A."
Processing 00000000.tx.373: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.374: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.375: Invest. 

Phrase: "Invest."
Processing 00000000.tx.376: 90, 429438[Medline] [OrderarticleviaInfotrieve] Reilly, R. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "429438"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Reilly,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.377: F., and Ellison, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Ellison,"

Phrase: "D."
Processing 00000000.tx.378: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.379: (2000) Physiol. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Physiol."
Processing 00000000.tx.380: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.381: 80, 277313[Abstract/Free FullText] Sebastian, A. 

Phrase: "80,"

Phrase: "277313"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sebastian,"

Phrase: "A."
Processing 00000000.tx.382: (2000) Am. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.383: J. 

Phrase: "J."
Processing 00000000.tx.384: Med. 

Phrase: "Med."
Processing 00000000.tx.385: 109, 429430[CrossRef][Medline] [OrderarticleviaInfotrieve] Delpire, E., and Mount, D. 

Phrase: "109,"

Phrase: "429430"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Delpire,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Mount,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181909:Mount [Medical Device]
  1000   C0449878:mount [Finding]

Phrase: "D."
Processing 00000000.tx.386: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.387: (2002) Annu. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.388: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.389: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.390: 64, 803843[CrossRef][Medline] [OrderarticleviaInfotrieve] MacKenzie, S., Vaitkevicius, H., and Lockette, W. 

Phrase: "64,"

Phrase: "803843"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] MacKenzie,"

Phrase: "S."

Phrase: ","

Phrase: "Vaitkevicius,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Lockette,"

Phrase: "W."
Processing 00000000.tx.391: (2001) Biochem. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.392: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.393: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.394: Commun. 

Phrase: "Commun."
Processing 00000000.tx.395: 282, 9911000[CrossRef][Medline] [OrderarticleviaInfotrieve] Cremaschi, D., Porta, C., Botta, G., Bazzini, C., Baroni, M. 

Phrase: "282,"

Phrase: "9911000"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Cremaschi,"

Phrase: "D."

Phrase: ","

Phrase: "Porta,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   928   C0205054:Portal [Body Location or Region]
   900 E C0452253:Port [Food]
   900 E C0475311:port [Manufactured Object]
   900 E C1706409:Port [Medical Device]
   900 E C1880253:Port [Conceptual Entity]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Botta,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bazzini,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Baroni,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.396: D., and Garavaglia, M. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Garavaglia,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.397: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.398: Membr. 

Phrase: "Membr."
Processing 00000000.tx.399: Biol. 

Phrase: "Biol."
Processing 00000000.tx.400: 176, 5365[CrossRef][Medline] [OrderarticleviaInfotrieve] Chang, H., Tashiro, K., Hirai, M., Ikeda, K., Kurokawa, K., and Fujita, T. 

Phrase: "176,"

Phrase: "5365"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tashiro,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hirai,"

Phrase: "M."

Phrase: ","

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kurokawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Fujita,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.401: (1996) Biochem. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.402: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.403: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.404: Commun. 

Phrase: "Commun."
Processing 00000000.tx.405: 223, 324328[CrossRef][Medline] [OrderarticleviaInfotrieve] Barry, E. 

Phrase: "223,"

Phrase: "324328"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Barry,"

Phrase: "E."
Processing 00000000.tx.406: L., Gesek, F. 

Phrase: "L., Gesek,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.407: A., Kaplan, M. 

Phrase: "A.,"

Phrase: "Kaplan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.408: R., Hebert, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hebert,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.409: C., and Friedman, P. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Friedman,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.410: A. 

Phrase: "A."
Processing 00000000.tx.411: (1997) Am. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.412: J. 

Phrase: "J."
Processing 00000000.tx.413: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.414: 272, C109C116[Medline] [OrderarticleviaInfotrieve] Abuladze, N., Yanagawa, N., Lee, I., Jo, O. 

Phrase: "272,"

Phrase: "C109C116"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Abuladze,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Yanagawa,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lee,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Jo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022418:JO [Geographic Area]

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.415: D., Newman, D., Hwang, J., Uyemura, K., Pushkin, A., Modlin, R. 

Phrase: "D."

Phrase: ","

Phrase: "Newman,"

Phrase: "D."

Phrase: ","

Phrase: "Hwang,"

Phrase: "J.,"

Phrase: "Uyemura,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Pushkin,"

Phrase: "A.,"

Phrase: "Modlin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.416: L., and Kurtz, I. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Kurtz,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.417: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.418: Am. 

Phrase: "Am."
Processing 00000000.tx.419: Soc. 

Phrase: "Soc."
Processing 00000000.tx.420: Nephrol. 

Phrase: "Nephrol."
Processing 00000000.tx.421: 9, 819826[Abstract/Free FullText] Bernstein, P. 

Phrase: "9,"

Phrase: "819826"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bernstein,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.422: I., Zawalach, W., Bartiss, A., Reilly, R., Palcso, M., and Ellison, D. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Zawalach,"

Phrase: "W.,"

Phrase: "Bartiss,"

Phrase: "A.,"

Phrase: "Reilly,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Palcso,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ellison,"

Phrase: "D."
Processing 00000000.tx.423: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.424: Am. 

Phrase: "Am."
Processing 00000000.tx.425: Soc. 

Phrase: "Soc."
Processing 00000000.tx.426: Nephrol. 

Phrase: "Nephrol."
Processing 00000000.tx.427: 6, 732 Jorgensen, F. 

Phrase: "6,"

Phrase: "732 Jorgensen,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.428: S., and Transbol, I. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Transbol,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.429: (1974) Acta Med. 

Phrase: "(1974"

Phrase: ")"

Phrase: "Acta Med."
Processing 00000000.tx.430: Scand. 

Phrase: "Scand."
Processing 00000000.tx.431: 12, 3336 Yendt, E. 

Phrase: "12,"

Phrase: "3336 Yendt,"

Phrase: "E."
Processing 00000000.tx.432: R., Gagne, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gagne,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.433: J., and Cohanim, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Cohanim,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.434: (1965) Trans. 

Phrase: "(1965"

Phrase: ")"

Phrase: "Trans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2826298:TRANS [Idea or Concept]
Processing 00000000.tx.435: Am. 

Phrase: "Am."
Processing 00000000.tx.436: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.437: Climatol. 

Phrase: "Climatol."
Processing 00000000.tx.438: Assoc. 

Phrase: "Assoc."
Processing 00000000.tx.439: 77, 96110[Medline] [OrderarticleviaInfotrieve] Musch, M. 

Phrase: "77,"

Phrase: "96110"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Musch,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.440: W., vis-Amaral, E. 

Phrase: "W., vis-Amaral,"

Phrase: "E."
Processing 00000000.tx.441: M., Vandenburgh, H. 

Phrase: "M."

Phrase: ","

Phrase: "Vandenburgh,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.442: H., and Goldstein, L. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Goldstein,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.443: (1998) Pflugers Arch. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Pflugers Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0230467:arch [Body Location or Region]
   861   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.444: 436, 415422[CrossRef][Medline] [OrderarticleviaInfotrieve] Orsenigo, M. 

Phrase: "436,"

Phrase: "415422"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Orsenigo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.445: N., Tosco, M., Laforenza, U., and Faelli, A. 

Phrase: "N., Tosco,"

Phrase: "M."

Phrase: ","

Phrase: "Laforenza,"

Phrase: "U.,"

Phrase: "and"

Phrase: "Faelli,"

Phrase: "A."
Processing 00000000.tx.446: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.447: Membr. 

Phrase: "Membr."
Processing 00000000.tx.448: Biol. 

Phrase: "Biol."
Processing 00000000.tx.449: 158, 257264[CrossRef][Medline] [OrderarticleviaInfotrieve] Tosco, M., Orsenigo, M. 

Phrase: "158,"

Phrase: "257264"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tosco,"

Phrase: "M."

Phrase: ","

Phrase: "Orsenigo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.450: N., Gastaldi, G., and Faelli, A. 

Phrase: "N., Gastaldi,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Faelli,"

Phrase: "A."
Processing 00000000.tx.451: (2002) Cell Physiol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Cell Physiol."
Processing 00000000.tx.452: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.453: 12, 918[CrossRef][Medline] [OrderarticleviaInfotrieve] Plotkin, M. 

Phrase: "12,"

Phrase: "918"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Plotkin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.454: D., Kaplan, M. 

Phrase: "D."

Phrase: ","

Phrase: "Kaplan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.455: R., Verlander, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Verlander,"

Phrase: "J."
Processing 00000000.tx.456: W., Lee, W. 

Phrase: "W., Lee,"

Phrase: "W."
Processing 00000000.tx.457: S., Brown, D., Poch, E., Gullans, S. 

Phrase: "S."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "D."

Phrase: ","

Phrase: "Poch,"

Phrase: "E.,"

Phrase: "Gullans,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.458: R., and Hebert, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Hebert,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.459: C. 

Phrase: "C."
Processing 00000000.tx.460: (1996) Kidney Int. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Kidney Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063789:INT [Organic Chemical]
   861   C3272375:INT [Intellectual Product]
Processing 00000000.tx.461: 50, 174183[Medline] [OrderarticleviaInfotrieve] Bostanjoglo, M., Reeves, W. 

Phrase: "50,"

Phrase: "174183"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bostanjoglo,"

Phrase: "M."

Phrase: ","

Phrase: "Reeves,"

Phrase: "W."
Processing 00000000.tx.462: B., Reilly, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Reilly,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.463: F., Velazquez, H., Robertson, N., Litwack, G., Morsing, P., Dorup, J., Bachmann, S., Ellison, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Velazquez,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Robertson,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Litwack,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Morsing,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Dorup,"

Phrase: "J.,"

Phrase: "Bachmann,"

Phrase: "S."

Phrase: ","

Phrase: "Ellison,"

Phrase: "D."
Processing 00000000.tx.464: H., and Bostonjoglo, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Bostonjoglo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.465: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.466: Am. 

Phrase: "Am."
Processing 00000000.tx.467: Soc. 

Phrase: "Soc."
Processing 00000000.tx.468: Nephrol. 

Phrase: "Nephrol."
Processing 00000000.tx.469: 9, 13471358[Abstract/Free FullText] Meyer, G., Botta, G., and Cremaschi, D. 

Phrase: "9,"

Phrase: "13471358"

Phrase: "[Abstract/Free FullText"

Phrase: "] Meyer,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Botta,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Cremaschi,"

Phrase: "D."
Processing 00000000.tx.470: (1997) Cell Mol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Cell Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0027960:Mole [Neoplastic Process]
   861   C0324740:Mole [Mammal]
   861   C0439189:Mole [Quantitative Concept]
   861   C1456781:mole [Neoplastic Process]
   861   C1824986:mol [Gene or Genome]
   777 E C0026367:Molar [Body Part, Organ, or Organ Component]
   761 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.471: Life Sci. 

Phrase: "Life Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.472: 53, 769775[CrossRef][Medline] [OrderarticleviaInfotrieve] Tsien, R. 

Phrase: "53,"

Phrase: "769775"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tsien,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.473: Y., Rink, T. 

Phrase: "Y.,"

Phrase: "Rink,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.474: J., and Poenie, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Poenie,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.475: (1985) Cell Calcium 6, 145157[CrossRef][Medline] [OrderarticleviaInfotrieve] Gamba, G., Miyanoshita, A., Lombardi, M., Lytton, J., Lee, W. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Cell Calcium 6,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: "145157"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gamba,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Miyanoshita,"

Phrase: "A.,"

Phrase: "Lombardi,"

Phrase: "M."

Phrase: ","

Phrase: "Lytton,"

Phrase: "J.,"

Phrase: "Lee,"

Phrase: "W."
Processing 00000000.tx.476: S., Hediger, M. 

Phrase: "S."

Phrase: ","

Phrase: "Hediger,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.477: A., and Hebert, S. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Hebert,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.478: C. 

Phrase: "C."
Processing 00000000.tx.479: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.480: Biol. 

Phrase: "Biol."
Processing 00000000.tx.481: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.482: 269, 1771317722[Abstract/Free FullText] De Jong, J. 

Phrase: "269,"

Phrase: "1771317722"

Phrase: "[Abstract/Free FullText"

Phrase: "] De Jong,"

Phrase: "J."
Processing 00000000.tx.483: C., Van, D., V, van den Heuvel, L. 

Phrase: "C., Van,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0557775:Van [Manufactured Object]

Phrase: "D."

Phrase: ","

Phrase: "V,"

Phrase: "van den Heuvel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.484: P., Willems, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Willems,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.485: H., Knoers, N. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Knoers,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.486: V., and Bindels, R. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Bindels,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.487: J. 

Phrase: "J."
Processing 00000000.tx.488: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.489: Am. 

Phrase: "Am."
Processing 00000000.tx.490: Soc. 

Phrase: "Soc."
Processing 00000000.tx.491: Nephrol. 

Phrase: "Nephrol."
Processing 00000000.tx.492: 13, 14421448[Abstract/Free FullText] Hoover, R. 

Phrase: "13,"

Phrase: "14421448"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hoover,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.493: S., Poch, E., Monroy, A., Vazquez, N., Nishio, T., Gamba, G., and Hebert, S. 

Phrase: "S."

Phrase: ","

Phrase: "Poch,"

Phrase: "E.,"

Phrase: "Monroy,"

Phrase: "A.,"

Phrase: "Vazquez,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Nishio,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Gamba,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Hebert,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.494: C. 

Phrase: "C."
Processing 00000000.tx.495: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.496: Am. 

Phrase: "Am."
Processing 00000000.tx.497: Soc. 

Phrase: "Soc."
Processing 00000000.tx.498: Nephrol. 

Phrase: "Nephrol."
Processing 00000000.tx.499: 14, 271282[Abstract/Free FullText] Cremaschi, D., and Porta, C. 

Phrase: "14,"

Phrase: "271282"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cremaschi,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Porta,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   928   C0205054:Portal [Body Location or Region]
   900 E C0452253:Port [Food]
   900 E C0475311:port [Manufactured Object]
   900 E C1706409:Port [Medical Device]
   900 E C1880253:Port [Conceptual Entity]

Phrase: "C."
Processing 00000000.tx.500: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.501: Membr. 

Phrase: "Membr."
Processing 00000000.tx.502: Biol. 

Phrase: "Biol."
Processing 00000000.tx.503: 141, 2942[Medline] [OrderarticleviaInfotrieve] Cremaschi, D., Vallin, P., and Porta, C. 

Phrase: "141,"

Phrase: "2942"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Cremaschi,"

Phrase: "D."

Phrase: ","

Phrase: "Vallin,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Porta,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   928   C0205054:Portal [Body Location or Region]
   900 E C0452253:Port [Food]
   900 E C0475311:port [Manufactured Object]
   900 E C1706409:Port [Medical Device]
   900 E C1880253:Port [Conceptual Entity]

Phrase: "C."
Processing 00000000.tx.504: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.505: Membr. 

Phrase: "Membr."
Processing 00000000.tx.506: Biol. 

Phrase: "Biol."
Processing 00000000.tx.507: 147, 159171[Medline] [OrderarticleviaInfotrieve] Pickkers, P., Garcha, R. 

Phrase: "147,"

Phrase: "159171"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pickkers,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Garcha,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.508: S., Schachter, M., Smits, P., and Hughes, A. 

Phrase: "S."

Phrase: ","

Phrase: "Schachter,"

Phrase: "M."

Phrase: ","

Phrase: "Smits,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Hughes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551730:Hughes [Population Group]

Phrase: "A."
Processing 00000000.tx.509: D. 

Phrase: "D."
Processing 00000000.tx.510: (1999) Hypertension 33, 10431048[Abstract/Free FullText] Barry, E. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Hypertension 33,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020538:Hypertension [Disease or Syndrome]
   861   C1963138:Hypertension [Finding]

Phrase: "10431048"

Phrase: "[Abstract/Free FullText"

Phrase: "] Barry,"

Phrase: "E."
Processing 00000000.tx.511: L., Gesek, F. 

Phrase: "L., Gesek,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.512: A., Yu, A. 

Phrase: "A.,"

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "A."
Processing 00000000.tx.513: S., Lytton, J., and Friedman, P. 

Phrase: "S."

Phrase: ","

Phrase: "Lytton,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Friedman,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.514: A. 

Phrase: "A."
Processing 00000000.tx.515: (1998) J Membr. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J Membr."
Processing 00000000.tx.516: Biol. 

Phrase: "Biol."
Processing 00000000.tx.517: 161, 5564[CrossRef][Medline] [OrderarticleviaInfotrieve] Hodin, R. 

Phrase: "161,"

Phrase: "5564"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hodin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.518: A., Meng, S., Archer, S., and Tang, R. 

Phrase: "A.,"

Phrase: "Meng,"

Phrase: "S."

Phrase: ","

Phrase: "Archer,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Tang,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.519: (1996) Cell Growth & Differ. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cell Growth &"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cell Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "Differ."
Processing 00000000.tx.520: 7, 647653[Abstract] Nilius, B., Prenen, J., Vennekens, R., Hoenderop, J. 

Phrase: "7,"

Phrase: "647653"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Nilius,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Prenen,"

Phrase: "J.,"

Phrase: "Vennekens,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hoenderop,"

Phrase: "J."
Processing 00000000.tx.521: G., Bindels, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bindels,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.522: J., and Droogmans, G. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Droogmans,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.523: (2001) Br. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Br."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]
Processing 00000000.tx.524: J. 

Phrase: "J."
Processing 00000000.tx.525: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.526: 134, 453462[CrossRef][Medline] [OrderarticleviaInfotrieve] Nilius, B., Vennekens, R., Prenen, J., Hoenderop, J. 

Phrase: "134,"

Phrase: "453462"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nilius,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Vennekens,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Prenen,"

Phrase: "J.,"

Phrase: "Hoenderop,"

Phrase: "J."
Processing 00000000.tx.527: G., Bindels, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bindels,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.528: J., and Droogmans, G. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Droogmans,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.529: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.530: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.531: 527, 239248[Abstract/Free FullText] Vennekens, R., Hoenderop, J. 

Phrase: "527,"

Phrase: "239248"

Phrase: "[Abstract/Free FullText"

Phrase: "] Vennekens,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hoenderop,"

Phrase: "J."
Processing 00000000.tx.532: G., Prenen, J., Stuiver, M., Willems, P. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Prenen,"

Phrase: "J.,"

Phrase: "Stuiver,"

Phrase: "M."

Phrase: ","

Phrase: "Willems,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.533: H., Droogmans, G., Nilius, B., and Bindels, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Droogmans,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Nilius,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Bindels,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.534: J. 

Phrase: "J."
Processing 00000000.tx.535: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.536: Biol. 

Phrase: "Biol."
Processing 00000000.tx.537: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.538: 275, 39633969[Abstract/Free FullText] Hoenderop, J. 

Phrase: "275,"

Phrase: "39633969"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hoenderop,"

Phrase: "J."
Processing 00000000.tx.539: G., Vennekens, R., Muller, D., Prenen, J., Droogmans, G., Bindels, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Vennekens,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Muller,"

Phrase: "D."

Phrase: ","

Phrase: "Prenen,"

Phrase: "J.,"

Phrase: "Droogmans,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bindels,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.540: J., and Nilius, B. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Nilius,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.541: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.542: Physiol 537, 747761[Abstract/Free FullText] Bouillon, R., Van, C. 

Phrase: "Physiol 537,"

Phrase: "747761"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bouillon,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Van,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0557775:Van [Manufactured Object]

Phrase: "C."
Processing 00000000.tx.543: S., and Carmeliet, G. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Carmeliet,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.544: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.545: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.546: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.547: 88, 332339[CrossRef][Medline] [OrderarticleviaInfotrieve] Hoenderop, J. 

Phrase: "88,"

Phrase: "332339"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hoenderop,"

Phrase: "J."
Processing 00000000.tx.548: G., Nilius, B., and Bindels, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Nilius,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Bindels,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.549: J. 

Phrase: "J."
Processing 00000000.tx.550: (2002) Biochim. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.551: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.552: Acta 1600, 611[Medline] [OrderarticleviaInfotrieve] Peng, J. 

Phrase: "Acta 1600,"

Phrase: "611"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Peng,"

Phrase: "J."
Processing 00000000.tx.553: B., Brown, E. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "E."
Processing 00000000.tx.554: M., and Hediger, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Hediger,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.555: A. 

Phrase: "A."
Processing 00000000.tx.556: (2003) News Physiol. 

Phrase: "(2003"

Phrase: ")"

Phrase: "News Physiol."
Processing 00000000.tx.557: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.558: 18, 158163[Medline] [OrderarticleviaInfotrieve] Ellison, D. 

Phrase: "18,"

Phrase: "158163"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ellison,"

Phrase: "D."
Processing 00000000.tx.559: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.560: (2000) Am. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.561: J. 

Phrase: "J."
Processing 00000000.tx.562: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.563: 279, F616F625 Hoenderop, J. 

Phrase: "279,"

Phrase: "F616F625 Hoenderop,"

Phrase: "J."
Processing 00000000.tx.564: G., Nilius, B., and Bindels, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Nilius,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Bindels,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.565: J. 

Phrase: "J."
Processing 00000000.tx.566: (2002) Annu. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.567: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.568: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.569: 64, 529549[CrossRef][Medline] [OrderarticleviaInfotrieve] Rottingen, J., and Iversen, J. 

Phrase: "64,"

Phrase: "529549"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rottingen,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Iversen,"

Phrase: "J."
Processing 00000000.tx.570: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.571: (2000) Acta Physiol. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Acta Physiol."
Processing 00000000.tx.572: Scand. 

Phrase: "Scand."
Processing 00000000.tx.573: 169, 203219[CrossRef][Medline] [OrderarticleviaInfotrieve] Thomas, A. 

Phrase: "169,"

Phrase: "203219"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Thomas,"

Phrase: "A."
Processing 00000000.tx.574: P., Renard, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Renard,"

Phrase: "D."
Processing 00000000.tx.575: C., and Rooney, T. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Rooney,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.576: A. 

Phrase: "A."
Processing 00000000.tx.577: (1991) Cell Calcium 12, 111126[CrossRef][Medline] [OrderarticleviaInfotrieve] Simon, D. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Cell Calcium 12,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: "111126"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Simon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443058:Simon [Intellectual Product]

Phrase: "D."
Processing 00000000.tx.578: B., Nelson-Williams, C., Bia, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Nelson-Williams,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Bia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1061346:Bia [Eukaryote]
  1000   C1704746:BIA [Diagnostic Procedure]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.579: J., Ellison, D., Karet, F. 

Phrase: "J.,"

Phrase: "Ellison,"

Phrase: "D."

Phrase: ","

Phrase: "Karet,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.580: E., Molina, A. 

Phrase: "E.,"

Phrase: "Molina,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1915092:Molina [Eukaryote]

Phrase: "A."
Processing 00000000.tx.581: M., Vaara, I., Iwata, F., Cushner, H. 

Phrase: "M."

Phrase: ","

Phrase: "Vaara,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Iwata,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Cushner,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.582: M., Koolen, M., Gainza, F. 

Phrase: "M."

Phrase: ","

Phrase: "Koolen,"

Phrase: "M."

Phrase: ","

Phrase: "Gainza,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.583: J., Gitleman, H. 

Phrase: "J.,"

Phrase: "Gitleman,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.584: J., and Lifton, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Lifton,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.585: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.586: (1996) Nat. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.587: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.588: 12, 2430[CrossRef][Medline] [OrderarticleviaInfotrieve] Gamba, G. 

Phrase: "12,"

Phrase: "2430"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gamba,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.589: (2001) Am. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.590: J. 

Phrase: "J."
Processing 00000000.tx.591: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.592: 281, F781F794 Schmieder, S., Lindenthal, S., and Ehrenfeld, J. 

Phrase: "281,"

Phrase: "F781F794 Schmieder,"

Phrase: "S."

Phrase: ","

Phrase: "Lindenthal,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Ehrenfeld,"

Phrase: "J."
Processing 00000000.tx.593: (2001) Biochem. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.594: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.595: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.596: Commun. 

Phrase: "Commun."
Processing 00000000.tx.597: 286, 635640[CrossRef][Medline] [OrderarticleviaInfotrieve] Gawenis, L. 

Phrase: "286,"

Phrase: "635640"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gawenis,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.598: R., Stien, X., Shull, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stien,"

Phrase: "X.,"

Phrase: "Shull,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.599: E., Schultheis, P. 

Phrase: "E.,"

Phrase: "Schultheis,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.600: J., Woo, A. 

Phrase: "J.,"

Phrase: "Woo,"

Phrase: "A."
Processing 00000000.tx.601: L., Walker, N. 

Phrase: "L., Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043016:Walker [Medical Device]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.602: M., and Clarke, L. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Clarke,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.603: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.604: (2002) Am. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.605: J. 

Phrase: "J."
Processing 00000000.tx.606: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.607: 282, G776G784 Sundaram, U., Knickelbein, R. 

Phrase: "282,"

Phrase: "G776G784 Sundaram,"

Phrase: "U.,"

Phrase: "Knickelbein,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.608: G., and Dobbins, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Dobbins,"

Phrase: "J."
Processing 00000000.tx.609: W. 

Phrase: "W."
Processing 00000000.tx.610: (1991) Am. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.611: J. 

Phrase: "J."
Processing 00000000.tx.612: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.613: 260, G440G449[Medline] [OrderarticleviaInfotrieve] Bronner, F. 

Phrase: "260,"

Phrase: "G440G449"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bronner,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.614: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.615: Nutr. 

Phrase: "Nutr."
Processing 00000000.tx.616: 128, 917920[Abstract/Free FullText] Kumar, V., and Prasad, R. 

Phrase: "128,"

Phrase: "917920"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kumar,"

Phrase: "V.,"

Phrase: "and"

Phrase: "Prasad,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.617: (2003) Biochim. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.618: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.619: Acta 1639, 185194[Medline] [OrderarticleviaInfotrieve] Hoenderop, J. 

Phrase: "Acta 1639,"

Phrase: "185194"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hoenderop,"

Phrase: "J."
Processing 00000000.tx.620: G., Hartog, A., Stuiver, M., Doucet, A., Willems, P. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hartog,"

Phrase: "A.,"

Phrase: "Stuiver,"

Phrase: "M."

Phrase: ","

Phrase: "Doucet,"

Phrase: "A.,"

Phrase: "Willems,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.621: H., and Bindels, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Bindels,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.622: J. 

Phrase: "J."
Processing 00000000.tx.623: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.624: Am. 

Phrase: "Am."
Processing 00000000.tx.625: Soc. 

Phrase: "Soc."
Processing 00000000.tx.626: Nephrol. 

Phrase: "Nephrol."
Processing 00000000.tx.627: 11, 11711178[Abstract/Free FullText] Loffing, J., Loffing-Cueni, D., Valderrabano, V., Klausli, L., Hebert, S. 

Phrase: "11,"

Phrase: "11711178"

Phrase: "[Abstract/Free FullText"

Phrase: "] Loffing,"

Phrase: "J.,"

Phrase: "Loffing-Cueni,"

Phrase: "D."

Phrase: ","

Phrase: "Valderrabano,"

Phrase: "V.,"

Phrase: "Klausli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hebert,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.628: C., Rossier, B. 

Phrase: "C., Rossier,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.629: C., Hoenderop, J. 

Phrase: "C., Hoenderop,"

Phrase: "J."
Processing 00000000.tx.630: G., Bindels, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bindels,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.631: J., and Kaissling, B. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Kaissling,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.632: (2001) Am. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.633: J. 

Phrase: "J."
Processing 00000000.tx.634: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.635: Renal Physiol. 

Phrase: "Renal Physiol."
Processing 00000000.tx.636: 281, F1021F1027[Abstract/Free FullText] Nijenhuis, T., Hoenderop, J. 

Phrase: "281,"

Phrase: "F1021F1027"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nijenhuis,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hoenderop,"

Phrase: "J."
Processing 00000000.tx.637: G., Loffing, J., van der Kemp, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Loffing,"

Phrase: "J.,"

Phrase: "van der Kemp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "A."
Processing 00000000.tx.638: W., van Os, C. 

Phrase: "W., van Os,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0230028:Os [Body Location or Region]
   827   C0262950:Os [Body Part, Organ, or Organ Component]
   827   C1561953:Os [Body Part, Organ, or Organ Component]

Phrase: "C."
Processing 00000000.tx.639: H., and Bindels, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Bindels,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.640: J. 

Phrase: "J."
Processing 00000000.tx.641: (2003) Kidney Int. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Kidney Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063789:INT [Organic Chemical]
   861   C3272375:INT [Intellectual Product]
Processing 00000000.tx.642: 64, 555564[CrossRef][Medline] [OrderarticleviaInfotrieve] Donath, A., Nordio, S., Macagno, F., and Gatti, R. 

Phrase: "64,"

Phrase: "555564"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Donath,"

Phrase: "A.,"

Phrase: "Nordio,"

Phrase: "S."

Phrase: ","

Phrase: "Macagno,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Gatti,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.643: (1970) Helv. 

Phrase: "(1970"

Phrase: ")"

Phrase: "Helv."
Processing 00000000.tx.644: Paediatr. 

Phrase: "Paediatr."
Processing 00000000.tx.645: Acta 25, 293300[Medline] [OrderarticleviaInfotrieve] Donath, A., Nordio, S., Macagno, F., and Gatti, R. 

Phrase: "Acta 25,"

Phrase: "293300"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Donath,"

Phrase: "A.,"

Phrase: "Nordio,"

Phrase: "S."

Phrase: ","

Phrase: "Macagno,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Gatti,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.646: (1971) Isr. 

Phrase: "(1971"

Phrase: ")"

Phrase: "Isr."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022271:ISR [Geographic Area]
Processing 00000000.tx.647: J. 

Phrase: "J."
Processing 00000000.tx.648: Med. 

Phrase: "Med."
Processing 00000000.tx.649: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.650: 7, 393 Barley, N. 

Phrase: "7,"

Phrase: "393 Barley,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004755:Barley [Plant]
   861   C0331554:barley [Plant]
   861   C1095831:Barley [Food]
   861   C1533312:barley [Pharmacologic Substance]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.651: F., Howard, A., O'Callaghan, D., Legon, S., and Walters, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Howard,"

Phrase: "A.,"

Phrase: "O'Callaghan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "D."

Phrase: ","

Phrase: "Legon,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Walters,"

Phrase: "J."
Processing 00000000.tx.652: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.653: (2001) Am. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.654: J. 

Phrase: "J."
Processing 00000000.tx.655: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.656: 280, G285G290 Zhuang, L., Peng, J. 

Phrase: "280,"

Phrase: "G285G290 Zhuang,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Peng,"

Phrase: "J."
Processing 00000000.tx.657: B., Tou, L., Takanaga, H., Adam, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tou,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Takanaga,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Adam,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.658: M., Hediger, M. 

Phrase: "M."

Phrase: ","

Phrase: "Hediger,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.659: A., and Freeman, M. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Freeman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.660: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.661: (2002) Lab. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.662: Invest. 

Phrase: "Invest."
Processing 00000000.tx.663: 82, 17551764[Medline] [OrderarticleviaInfotrieve] Matthews, J. 

Phrase: "82,"

Phrase: "17551764"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Matthews,"

Phrase: "J."
Processing 00000000.tx.664: B., Hassan, I., Meng, S., Archer, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hassan,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Meng,"

Phrase: "S."

Phrase: ","

Phrase: "Archer,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.665: Y., Hrnjez, B. 

Phrase: "Y.,"

Phrase: "Hrnjez,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.666: J., and Hodin, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Hodin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.667: A. 

Phrase: "A."
Processing 00000000.tx.668: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.669: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.670: Invest. 

Phrase: "Invest."
Processing 00000000.tx.671: 101, 20722079[Abstract/Free FullText] Vidyasagar, S., and Ramakrishna, B. 

Phrase: "101,"

Phrase: "20722079"

Phrase: "[Abstract/Free FullText"

Phrase: "] Vidyasagar,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Ramakrishna,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.672: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.673: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.674: Physiol 539, 163173[Free FullText] Friedman, P. 

Phrase: "Physiol 539,"

Phrase: "163173"

Phrase: "[Free FullText"

Phrase: "] Friedman,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.675: A. 

Phrase: "A."
Processing 00000000.tx.676: (2000) Exp. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.677: Nephrol. 

Phrase: "Nephrol."
Processing 00000000.tx.678: 8, 343350[CrossRef][Medline] [OrderarticleviaInfotrieve]

Phrase: "8,"

Phrase: "343350"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

